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While antibiotics have been critical over the last decade for curbing infectious diseases,
they have contributed to the rise of antimicrobial resistance (AMR). Infections resulting from
antimicrobial-resistant pathogens are correlated with severe morbidity, mortality, and healthcare
costs. With the increasing concerns regarding AMR and its emergence, it is paramount to
understand not only the effects of antibiotics on microbial community and diversity, but also to
develop a novel tool that gives us a better understanding of the spread and functional traits of
AMR genes.

To this end, rumen, fecal, and pen surface samples were collected from 72 animals at US
Meat Animal Research Center consisting of antibiotic-treated and antibiotic-free animals. To
characterize these specific microbiomes, the 16s rRNA gene was sequenced, with the aim of
identifying the effects of feeding Monensin/Tylosin versus injectable antibiotics i.e., ceftiofur
(Excede), tulathromycin (Draxxin), enrofloxacin (Baytril), florfenicol (Nuflor). We observe i)
increased Prevotella abundance in the rumen following monensin/tylosin feeding and injectible
treatment, ii) decreased Ruminococcus abundance, a key player in rumen degradation, iii)
reduced presence of Clostridium and Lachnospiraceae in fecal samples, iv) reduced species
interactions as a result of selection due to antibiotic treatment, and v) differential taxa in soil

(Comamonas, Fermentimonas) to be more abundant based on timepoint and presence of animal
excretion.

Current explorations of AMR genes and their abundance traditionally relied on PCRbased analyses of AMR genes that fail to identify variants within AMR genes and whether they
are functional in an environment. As such, we developed a novel amplicon-based
sequencing strategy to evaluate AMR genes and their hosts. We identified no differences in in
AMR richness across the AMR genes (tetW, sul1, ermB) detected. However, AMR gene
abundance was different across treatments and day. Very few differential ASV were identified in
the TetW and sul1 gene, with a much higher abundance of differential ASV observed in the
ermB gene, suggesting gene enrichment and selection based on antimicrobial used. This
sequence-based AMR gene analysis approach provides information into the diversity and
ecology of AMR genes.
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CHAPTER 1: LITERATURE REVIEW

1.1 INTRODUCTION
Antimicrobial therapies have conferred immense benefits in both human and animal health for
disease prevention, treatment, and growth promotion in food animals (Menkem et al., 2019). In
2013, an estimated 131, 109 tons of all antimicrobials were used in food animals, with this figure
expected to rise to 200, 235 tons by 2030 (Pokharel et al., 2020). Persistent use of antimicrobials
is hypothesized to result in the selection for resistant bacteria and antimicrobial resistance
(AMR) genes that can be disseminated between environments. The rise of antimicrobial use and
resistance in food animals is concerning for not only the future of animal health, but also for the
large global population that relies on these animals for subsistence (Criscuolo et al., 2021). There
exists an expanding body of literature suggesting that resistant bacteria can transfer between
animals to humans, thus potentially resulting in drug-resistant zoonotic infections in humans
(Tang et al., 2017). With rising concerns of antimicrobial resistance and transference between
animals and humans, it is vital to explore the effects of antibiotic use on the microbial
community and its relationship with host health, while also expanding our knowledge on the
emergence and spread of AMR genes. The studies described here attempts to characterize
antibiotic-mediated changes in bacterial community composition and showcases the use of
amplicon sequencing to target AMR genes to allow for prediction of functionality and potential
carriers of AMR genes. Here, we describe a literature review on the current state of antimicrobial
resistance.

1.2 THE CURRENT STATE OF ANTIMICROBIAL RESISTANCE
Antimicrobial resistance (AMR) is recognized as a significant and inevitable threat to human and
animal health. Infections stemming from antimicrobial-resistant pathogens are correlated with

severe morbidity, mortality, and healthcare costs (Weis et al., 2022). According to estimates by
the US Center for Disease Control and Prevention (CDC), more than 2.9 million people
experience antibiotic-resistant infections, with almost 36,000 deaths due to infection each year
(CDC, 2019).

The main risk factor for emergence and spread of AMR is the overuse and inappropriate use of
antibiotics of clinical importance, environmental contamination, poor infection prevention and
control practices, and poor sanitation (Canica et al., 2015). Recent data has shown a direct
correlation between antibiotic use and resistance (van der Velden et al., 2013) where, higher
resistance rates are observed in countries with high levels of antibiotic use (van der Velden et al.,
2013). However, emergence of resistance is a highly complex phenomenon that is not thoroughly
understood. AMR gene reservoirs are found in human, animals, and environmental samples, with
complex transmission pathways between them (Canica et al., 2015).

The current state of antimicrobial resistance is concerning as infections associated with AMR
result in serious illness and prolonged hospital stays, increase in healthcare costs, and treatment
failures (Dadgostar, 2019; Prestinaci et al., 2015). The Organisation for Economic Co-operation
and Development (OECD) predicts that 2.4 million people in Europe, North America, and
Australia will die from diseases stemming from resistant microorganisms between 2015 - 2050
(OECD, 2018). Meanwhile, the Centers for Disease Control and Prevention (CDC) estimates a
20-billion-dollar surplus in direct healthcare costs due to AMR, totaling a 35 billion dollar loss in
productivity annually (CDC, 2019).

The global effect of AMR is difficult to quantify due to sparse epidemiological data in many
parts of the word (Marston et al., 2016). Regardless, if prevailing trends in the spread of
resistance are followed, a ‘post-antibiotic era’ is a future risk (Hwang and Gums, 2016).
Strategies to slow this progression have been suggested, mainly focusing on enforcing
antimicrobial stewardship programs, limiting misuse of antimicrobials, and promoting the
discovery of new antimicrobial agents (Hwang and Gums, 2016). For example, in 1999 the
European Union (EU) imposed a ban on the use of bacitracin, spiramycin, tylosin, and
virginiamycin as antimicrobial growth promoters (AGP) as they are also used in human
medicine, In 2006, the EU withdrew the use of all AGPs based on a cautionary principle.

1.3 ANTIMICROBIAL USE IN AGRICULTURE
While antimicrobial therapies have conferred immense benefits in both animal and human
health, agricultural use has largely contributed to antimicrobial resistance, affecting both
agricultural and nonagricultural use (Heilig, 2002). Antimicrobial agents have long been used in
agriculture, including livestock and poultry, to treat infections and improve growth and feed
efficiency (Angulo et al., 2004). It is estimated that approximately 40% of all antibiotics
produced are utilized for the sole purpose of acting as livestock feed additives in accordance with
the National Center for Biotechnology Information (NCBI) in 2017. To combat this, the Food
and Drug Administration (FDA) has banned the use of drugs related to human health for growth
promotion. The Veterinary Feed Directive (VFD) is a guideline that states antimicrobials in feed
must have veterinary oversight and a defined duration of use, a directive that has proven to be
effective. Between 2009 and 2019, sales of medically important sulfonamides and tetracyclines
has decreased by 40% and 22%, respectively.

In food animals, antimicrobial drugs are used for one of four purposes: treatment, metaphylaxis,
prophylaxis, and growth promotion (Innes et al., 2020). Treatment refers to animals with
definitive symptoms or diagnostic tests that suggest an infection. Meanwhile, metaphylaxis is the
process of administering antimicrobials to animals without clinical symptoms of infection that
have been exposed to infected animals in the same population. The term prophylaxis is used for
disease prevention even though no animals display clinical illness but are at high risk for clinical
disease through stress or other mechanisms. Lastly, growth promotion is the practice of
administering antimicrobials to animals in order to increase growth rates (Innes et al., 2020).

Antibiotic use in animal feed is believed to promote higher feed efficiency and growth rates, with
the foundational goal of reducing overall feed consumption. The role of antimicrobials in
improving feed conversion ratio (FCR), animal growth, and reproductive performance has been
well-established (Hao et al., 2014). In food-producing animals, supplementation of
antimicrobials (tiamulin, nosiheptide, salinomycin, and tylosin) were shown to improve carcass
quality by decreasing fat thickness and increasing the animal’s lean meat (Hao et al., 2014).
Meanwhile, addition of drugs such as chlortetracycline, sulfonamide, folic acid, and carbadox in
feed has been observed to improve conception rate, farrowing rate, milk secretion, and live birth
rate of piglets (Hao et al., 2014; Weber et al, 2001).

Early research has proven that antimicrobial drugs attenuate the intestinal wall and improved
digestibility of nutrients (Manson, 1968; Franti et al., 1971, 1972). A review by Allen et al.
(2013) summarizes the multifunctional role of antimicrobials in animals as 1) reducing the

colonization of intestinal bacteria and inhibit growth of pathogens, 2) thinning the mucous
membrane to result in more nutrient absorption and reduced fermentations, and 3) directly
neutralizing host immune response.

In animal production, antibiotics are used as growth promoters that yield larger animals at an
earlier age due to their ability to modulate the microbiota to a more efficient arrangement
(Brown et al., 2007). However, this long-standing practice comes with a disturbing downside: as
more antibiotics are introduced into the environment through feed, manure, and contaminated
soils, risk for development and dispersal of resistance increases. In ruminants, some of the most
frequently used antibiotics are ionophores, a distinctive class of antibiotics that alter intestinal
flora to achieve increased energy and amino acid availability, as well as improved nutrient
utilization (Landers et al., 2012). Mechanistically, ionophores transport ions across cell
membranes of susceptible bacteria, dissipating ion gradients and killing bacteria by uncoupling
their energy expenditures (Callaway et al., 2003). Ionophores are used solely in animals and are
thus not considered medically important by major regulatory agencies (Wong, 2019). As such,
potential resistance arising from the use of ionophores is related to its permeability, making it a
lower risk of transmission to humans. Still, the possibility of AMR transmission exists owing to
the occurrence of cross-resistance or co-selection (Wong, 2019).

In addition to the use of antibiotics as feed additives, antibiotics are also employed in veterinary
practice for the treatment of disease. According to Dobrzanska et al. (2019), antibiotics can be
used in livestock both as a treatment or as a prophylactic to protect animals from infections
(Dobrzanska, 2019). The study administered florfenicol to sheep and evaluated gut microbiome

changes in animals with and without antibiotics. They observed sheep given the antibiotic to
have a less diverse gut microbial community compared to the control animals with no antibiotics.
Moreover, phylogenetic analysis using16s rRNA amplicon data, they determined that there was a
10-fold increase in facultative anaerobic Escherichia spp, suggesting dysbiosis.

1.4 THE RESISTOME
The term “antibiotic resistome” was coined in 2006 by D’Costa et al, who defined the soil
resistome as “resistance determinants present in the soil”. Later, the definition was expanded to
“a collection of all the antimicrobial resistant genes (ARGs) and their precursors in pathogenic
and nonpathogenic bacteria” (Wright, 2007). Its components were specified as “all ARGs,
including those circulating in pathogenic bacteria, antibiotic producers, and benign
nonpathogenic bacteria” (Wright, 2007). In essence, the antibiotic resistome encompasses all
types of AMR genes, their precursors, and other potential resistance mechanisms (Kim & Cha,
2021).

Ever since the concept of the resistome and AMR was initialized, new findings have been found,
such as: i) AMR is ancient and pervasive in various microbiomes (D’Costa et al., 2011;
Pawlowski et al., 2016), ii) the antibiotic resistome is complex and diverse (D’Costa et al., 2007;
Dantas & Sommer, 2012), iii) the resistome is generally influenced by microbial community
structure and its environment (D’Costa et al., 2007), iv) mobile genetic elements are responsible
for AMR gene transmission (Perry & Wright, 2013), and v) AMR genes circulate between
humans, animals, and the environment (Hu et al., 2017; Kim & Cha, 2021).

RUMEN AND FECAL BOVINE RESISTOME
The rumen holds a dense microbiota composed of bacteria, methanogens, protozoa, fungi and
phages (Ma et al., 2021). As such, the resistome of this unique microbial community has been
explored in several studies (Thomas et al., 2017; Auffret et al., 2019). There is currently a lack of
information concerning the effect of antimicrobials on the bovine resistome. As studies describe
the effects of therapeutic and subtherapeutic antimicrobial administration, suggesting that rumen
microbiota of cattle and sheep are large reservoirs of AMR genes, with factors such as diet
and/or use of antimicrobials affecting the abundance and type of these AMR genes (Ma et al.,
2021).

Hitch et al. (2018) reported the identification of 30 AMR genes in the sheep rumen, with a high
abundance of them being daptomycin and colistin resistance genes, both of which are often
classified as “last-resort” antimicrobials against gram-positive bacterial infections in humans
(Ma et al., 2021). Also, Auffret et al. (2017) comparatively explored the effects of diet
(concentrate to forage ratio) and breed on resistome profiles in cattle and discovered AMR genes
belonging predominantly to the groups macrolide, chloramphenicol, β-lactam, and
aminoglycoside classes to be present in the rumen. Interestingly, chloramphenicol and
aminoglycoside resistant genes were prevalent in the rumen samples of beef cattle fed either high
forage or high concentrate diets, with breed showing no significant effect on the AMR gene
profile. This study suggests that diet may play a larger role in influencing the rumen resistome
(Auffret et al., 2017).

In a study by Sabino et al. (2019), the occurrence and distribution of AMR genes in ruminal
microbial genomes were explored using the Hungate1000 project. The authors reported a wide
distribution of AMR genes among ruminal bacteria, with genes conferring resistance to
tetracycline being frequently detected in the genomes of several species. Furthermore, the
regions flanking the tetracycline-resistant genes showed a conserved pattern in a novel
integrative and conjugative element (ICE_RbtetW_07), indicating that spread of AMR may occur
in the rumen via horizontal gene transfer. Finally, the study also showed evidence of positive
selection pressure on the tet(W) gene, which may advance the selection of genetic variants of this
gene, granting ribosomal protection against tetracycline antibiotics in rumen bacterial
species. These results provide evidence that the gastrointestinal tract (GIT) of ruminants should
be considered as a relevant source for AMR genes.

In the fecal samples of ruminants, tetracycline is believed to be the most abundant class of AMR
genes, with macrolide-lincosamide-streptogamin (MLS) and aminoglycoside AMR
genes accounting for a large proportion of the fecal resistome (Ma et al., 2021). Generally, the
diversity of the fecal resistome decreases as the animals age (Noyes et al., 2016). Past research
has evaluated the impact of antimicrobial use on the profiles of the fecal resistome in cattle. In
cattle that had been administered in-feed antimicrobials, more abundant tetracycline, macrolide,
and aminoglycoside AMR genes were detected in comparison to animals that did not receive
antibiotics (Rovira et al., 2019). Detected ARGs are similar to those reported in rumen samples,
suggesting consistency of ARG profiles between the rumen and feces (Ma et al., 2022).

1.5 ACQUISITION AND DISSEMINATION OF AMR GENES
Understanding the pathways leading to the rise and dissemination of antimicrobial
resistance (AMR) is paramount to mitigating its spread and controlling infectious
diseases. As mentioned, the use of antibiotics at sub-therapeutic levels as a growth promotant in
animal feed is likely a major factor contributing to emergence of antibiotic resistance. The gut
microbiota of an animal can be impacted by the addition of antibiotics, allowing for the
proliferation of antimicrobial-resistant (AMR) microbes, an increased in AMR gene frequency,
and a decrease in overall gut microbial diversity. Antimicrobial use in food animals is one of
several factors that promotes resistance in both animals and humans, with many antimicrobials
used in food animals belonging to the same classes as those used in human medicine (Innes et
al., 2020). Furthermore, resistance can be intrinsic or acquired (MacGowan & Macnanughton,
2013). Intrinsic resistance refers to resistance that is always expressed in the species (Reygaert,
2018). Intrinsic resistance is also defined as a trait that is shared universally within a bacterial
species, independent of previous antibiotic exposure, and is not related to horizontal gene
transfer (Reygaert, 2018; Cox & Wright, 2013; Martinez, 2014). Since intrinsic resistance is
shared universally within a bacterial species, from a clinical perspective, a bacterial species is
considered intrinsically resistant to a given antibiotic if the minimum inhibitory concentration
(MIC) in all strains are above a previously defined breakpoint (Martinez, 2014).

On the other hand, acquired resistance refers to the acquisition of genetic material that confers
resistance through whichever mechanisms bacteria may acquire genetic material. This includes,
horizontal gene transfer (transformation, transposition, conjugation) and mutations of the
bacterium’s own chromosomal DNA, with the acquisition being temporary or permanent
(Reygaert, 2018). Acquired resistance that develops due to chromosomal mutation and selection

is termed “vertical evolution” (Tenover, 2006). Antimicrobial genes that are acquired are carried
on mobile genetic elements can include plasmids, which are circular molecules of doublestranded DNA independent of the chromosome, or transposons, that are mobile sequences of
DNA that can move to different positions in the genome (MacGowan & Macnaughton, 2013).
Transfer through horizontal gene transfer can occur by several methods: 1) conjugation or direct
cell-to-cell contact with plasmid transfer, 2) transduction via transfer of bacterial DNA by a
bacteriophage, and 3) transformation due to uptake of DNA from the environment (MacGowan
& Macnaughton, 2013).

Differences between intrinsic and acquired resistance can be viewed mechanistically. Intrinsic
resistance mechanisms are usually chromosome-encoded and include activity of efflux pumps,
antibiotic inactivating enzymes, or mechanisms that serve as permeability barriers (Peterson &
Kaur, 2018; Cox & Wright, 2013). A well-studied example of an intrinsic resistance system is
vancomycin resistance in E. coli and other Gram-negative bacteria due to the action of
permeability barriers (Peterson & Kaur, 2018). A defining characteristic is that these
mechanisms are fixed in the core genetic makeup of an organism (Peterson & Kaur, 2018).
Acquired resistance mechanisms are generally obtained by horizontal gene transfer and include
plasmid-encoded specific efflux pumps, as well as enzymes that can modify the antibiotic or its
target (Peterson & Kaur, 2018; van Hoek et al., 2011). While intrinsic mechanisms confer low
antimicrobial resistance in their host, acquired mechanisms are believed to be a more serious
threat to human health due to resistance moving from chromosomal to plasmid-mediated,
resulting in greater expression and spread (Martinez, 2018).

Antibiotic use results in a selection pressure that favors bacteria carrying resistance mechanisms,
creating a survival advantage for such species to pass on resistance to other bacteria.
Antimicrobial use and resistance can be correlated at the individual and population level
(MacGowan & Macnaughton, 2013). The case of colistin (a 12olymyxin antibiotic) used in
animal agriculture for prevention of gastrointestinal infections has been linked to emergence,
selection, and transmission of genetic determinants of AMR stemming from antimicrobial use in
animal agriculture (Webb et al., 2017). It is believed that the administration of colistin in food
animals has resulted in selection of a novel mobile colistin resistance gene, or mcr-1, in chicken
and pig E. coli isolates. Since then, this gene has been identified in human, animal, and food
samples across 30 countries (Webb et al., 2017). Prevalence of mcr-1 in animal samples appear
to be proportional to its use in animals. Despite lack of reported information worldwide, this
illustrates an example of emergence, selection, and widespread dissemination of a resistance
gene stemming from antimicrobial use in food animals.

A similar chain of events can be traced for the antibiotic group known as streptothricins,
belonging to the class of aminoglycoside antibiotics, whose use has been largely limited to
China and Germany (Webb et al., 2017). Prior to mainstream utilization of nourseothricin - a
mixture of streptothricin D and F was used in the German swine industry. In 1981, less than a
year after introducing nourseothricin to the swine industry, a streptothricin-streptomycinspectinoycin resistant phenotype was observed in E. coli isolated from rectal swabs of pigs on
multiple farms, sewage, and stool samples of farm personnel (Tschape, 1994). This resistance
was found to be mediated by streotothricin-acetyltransferase (sat) genes encoding for a
nourseothricin-inactivating enzyme that was carried on a Tn1825 transposon (Tschape, 1994).

Prior the introduction of nourseothricin, acquired nourseothricin resistance in
Enterobacteriaceae among animal and human isolates was rare and believed to be solely
associated with chromosomal mutations (Tschape, 1994; Webb et al., 2017).

Interestingly, this plasmid-mediated streptothricin resistance was not observed in samples from
piglets or humans in regions where nourseothricin was not being used. Despite the
discontinuation of nourseothricin use in 1988, its resistance and associated resistance
determinants have continued and broadened without direct selection pressure. Streptothricin
resistance has now been associated with sat, stat, and nat genes and are often harbored in
integrons with resistance determinants present in other antimicrobial agents (Webb et al., 2017).
With few studies reporting streptothricin resistance prior to the 1980s, it is difficult to determine
if these determinants were present in bacteria before this time. Still, this example outlines a
published account of the likely emergence and dissemination of plasmid-borne resistance from
swine to humans (Webb et al., 2017).

In addition to antibiotic agents, heavy metals used in animal farming and aquaculture may aid in
the spread of AMR (Seiler & Berendonk, 2012). Application of metal-containing fertilizers,
sewage sludge, and liquid manure is common practice worldwide. Additionally, metals such as
iron (Fe), cobalt (Co), manganese (Mn), copper (Cu), and zinc (Zn) are applied as nutritional
additives in animal feed for livestock farming in Europe (Seiler & Berendonk, 2012).

The presence of heavy metals plays a role in exerting long-term and continuous selective
pressure on antimicrobial-resistant genes via co-resistance or cross-resistance (Seiler &

Berendonk, 2012). Cross-resistance involves mechanisms that provide tolerance to more than
one antimicrobial agent like antibiotics and heavy metals (Chapman, 2003). By way of an
example, several multi drug efflux pumps have been reported to mediate reduced sensitivity
towards antibiotics and heavy metals by rapid export out of the cell, as seen in the multi-drug
resistance (MDR) pump in Listeria monocytogenes (Baker-Austin et al., 2006). Meanwhile, coresistance is defined as “two or more genetically linked resistance genes” (Seiler & Berendonk,
2012). A key characteristic of co-resistance is genes encoding for two or more resistances being
located next to one another on a single mobile genetic element (Chapman, 2003).

Previous research has established a correlation between mobile genetic elements, metals, and
AMR genes present in various environments. Ding and colleagues (2019) reports a strong
synergistic effect when Zn or Cu were present with the antibiotic oxytetracycline that increased
the selection of antimicrobial resistant genes (ARGs) in the gut microbiota of collembolans. The
combined effects of heavy metals and oxytetracycline on the ARGs were greater than their
individual effects (Ding et al., 2019). These results broaden our understanding on the effects of
heavy metals inducing co-selection of AMR genes. Thus, it is imperative that the ecological
impact of using heavy metals be evaluated to identify how such practices could lead to
emergence of antimicrobial resistance.

1.6 THE ROLE OF HORIZONTAL GENE TRANSFER IN AMR SPREAD
Horizontal gene transfer has been shown to spread antimicrobial resistance genes from
commensal and environmental species to pathogenic species (von Wintersdorff et al., 2016).
Conjugation is believed to have the greatest influence on the dissemination of AMR genes.

Although, transformation and transduction were previously thought to be less important, recent
discoveries suggest their role to be more significant than initially thought (von Wintersdorff et
al., 2016). The role of HGT in spreading AMR genes far predates modern production and use of
antibiotics. For example, OXA-type β-lactamases were found to be plasmid-borne and
transmissible between bacterial species millions of years ago (Barlow & Hall, 2002). However,
the rate at which these processes now occur and the number of reported resistant strains has
increased exponentially in recent years due to selective pressure of antibiotic use (von
Wintersdorff et al., 2016).

To fully illustrate the spread of antimicrobial resistance, it is important to explore the role of
horizontal gene transfer in detail. The most studied mechanisms of HGT, conjugation, is defined
as “the transfer of DNA through a multi-step process requiring cell to cell contact via cell surface
pili or adhesins” Huddleston, 2014; (von Wintersdorff et al., 2016). The general sequence of
events include 1) cell-to-cell contact, 2) mating pair formation, and 3) transfer of plasmid DNA
through a conjugative pilus (Huddleston, 2014).

CONJUGATION
A key characteristic of conjugation is its requirement for cell-to-cell contact, either via a pilus or
channel-forming pore to allow for the movement of plasmids (Huddleston, 2014). Plasmids are
covalently closed, circular molecules of DNA that are able to replicate independent of the host
chromosome (Huddleston, 2014). Plasmids that are conjugative, or self-transmissible, hold genes
for the transfer machinery while non-conjugative plasmids can be transferred if they are
transported through conjugation in the presence of a helper self-transmissible plasmid

(Huddleston, 2014). The role of conjugation in HGT is impeded by the fact that other mobile
genetic elements (MGEs) besides plasmids can be transferred by conjugative machinery
(Huddleston, 2014). Even though transfer of mobile genetic elements can occur through
transformation or transduction, conjugation is usually considered the most likely mechanisms as
it offers enhanced protection from the surrounding environment and has advantages over the
other methods. This includes a more efficient means of entry into the host cell than
transformation and a broader host range than transduction (von Wintersdorff et al., 2016).

The role of conjugation in conferring AMR has been well-established in various environments
including bacteria in insects, soil, water, as well as pathogens in food and healthcare (Davison,
1999). Moreover, the transfer of plasmids and conjugative transposons, like those of the Tn916
family, have been reported between unrelated bacteria over large taxonomic distances,
highlighting that the conjugative mechanism contributes substantially to the spread of AMR
genes between different reservoirs (Shoemaker et al., 2001; Roberts & Mullany, 2009; von
Wintersdorff et al., 2016). Notably, the spread of AMR plasmids in human pathogens showcases
that once resistance genes are established on a plasmid, they may spread quickly across different
bacterial strains, species, and even genera (von Wintersdorff et al., 2016). This has been
described to be the case with the blaCTX−M ESBL genes, which spread to multiple narrow and
broad host range plasmids within Enterobacteriaceae, as well as to other opportunistic human
pathogens (Canton et al., 2012; von Wintersdorff et al., 2016).

TRANSFORMATION

Transformation involves uptake, integration, and functional expression of naked fragments of
extracellular DNA (von Wintersdorff et al., 2016). The overall process of natural transformation
occurs in 6 stages: 1) release of DNA from donor cells, 2) dispersal of DNA, 3) persistence of
DNA in the environment, 4) recipient cells becoming competent for DNA uptake, 5) interaction,
uptake, and incorporation of DNA into the recipient’s genome and finally 6) expression of the
donor DNA in the recipient cells (Huddleston, 2014). Species such as Neisseria spp. are
naturally competent to transformation, while other species only become competent under specific
conditions such as nutritional status or other stressful conditions (Johnston et al., 2014). The
competent state involves the expression of a specialized, well-conserved DNA uptake machinery
necessary for entry of exogenous DNA (Charpentier et al., 2011). Notably, previous research has
established that antibiotic exposure can prompt competence in many bacterial species, suggesting
that antibiotics not only select for resistant strains, but also encourage transformation of their
AMR genes (Prudhomme et al., 2006; von Wintersdorff et al., 2016). In vitro studies have been
conducted to understand the role of transformation in disseminating AMR genes. Early research
has proven that AMR genes can be transformed. For an example, streptomycin, rifampicin,
erythromycin, nalidixic acid, and kanamycin resistance have previously been transformed into
Bacillus spp. (Harford and Mergeay, 1973), Gallibacterium anatis (Kristensen et al., 2012), and
S. pneumoniae (Prudhomme et al., 2006).

TRANSDUCTION
Transduction is an important horizontal gene transfer mechanism that utilizes bacteriophages.
Compared to studies about AMR spread via conjugation and transformation, there is limited
information on the role of bacteriophages in the spread of AMR. Bacteriophages are viruses that

infect bacteria and are lysogenic when they integrate into the host genome and turn into
prophages when environmental conditions trigger their lytic growth (Huddleston, 2014).
Bacteriophages can transfer genes that are advantageous to their microbial hosts, in turn ensuring
their own survival and spread (Modi et al., 2013; von Wintersdorff et al., 2016). These
transmittable genes can be chromosomal DNA or mobile genetic elements like plasmids,
transposons, and genomic islands (Brown-Jacque et al., 2015). Transduction happens when a
previously replicated bacteriophage packages a portion of the host/donor genome into the phage
genome and transfers the genes to a recipient bacterial cell (Huddleston, 2014). In specialized
transduction, only the genomic DNA neighboring the prophage DNA is packaged and inserted to
the recipient cell. Meanwhile, in general transduction, any gene from a host can be randomly
packaged along with viral DNA and subsequently transferred to a new recipient. This occurs in
bacteriophage P22 of Salmonella (Fillol-Salom et al., 2021). In either case, donor and recipient
strains do not have to be physically or temporally close to one another as bacteriophages can
remain in the environment for varying time periods (Huddleston, 2014).

Transduction as a key player of horizontal gene transfer in naturally occurring environments has
historically been underestimated (Huddleston, 2014). Still, the transmission of AMR genes has
been reported for some bacterial species, including but not limited to: transduction of
erythromycin (Hyder & Streitfeld, 1978), transfer of tetracycline, macrolides and other
resistances between S. pyogenes strains (Ubukata et al., 1975), transfer of tetracycline and
gentamicin resistance between enterococci (Mazaheri Nezhad Fard et al., 2011), and the transfer
of antibiotic resistance plasmids in methicillin-resistant Staphylococcus aureus (MRSA) (Varga
et al., 2012). Importantly, Stanczak-Mrozek et al. (2017) exposed isolates of MRSA carriers to

antimicrobials and found that antibiotics induced AMR gene transduction, showing that
antibiotic use can increase phage mobilization and transduction of AMR genes.

Furthermore, recent metagenomic studies have also suggested that bacteriophages play a bigger
part in the spread of AMR genes than previously thought (von Wintersdorff et al., 2016). For
instance, Colomer-Lluch et al. (2011) reported using quantitative PCR to show that β-lactam
AMR genes blaTEM, blaCTX−M and mecA were found in bacteriophages sourced from a river
and urban sewage water samples. Modi et al. (2013) demonstrated the supposition that antibiotic
treatment increases the number of AMR genes in the intestinal phageome of mice and
interactions between phage and bacterial species (Modi et al., 2013). With several studies
detailing the presence of AMR genes in bacteriophages in wastewater samples (Colomer-Lluch
et al. 2011) and animal and human fecal samples (Quiros et al., 2014), there is strong indication
that bacteriophages are significant reservoirs of AMR genes.

1.7 CHARACTERIZING ANTIMICROBIAL RESISTANCE IN BOVINE PATHOGENS
While concerns regarding antimicrobial-resistant (AMR) genes in food animals highlight
concerns for human health, dissemination and proliferation of AMR genes is very much also a
veterinary problem (Cameron & McAllister, 2016). There is a lack of information regarding
emergence of resistance in exclusively bovine pathogens as compared to zoonotic enteric
pathogens such as Campylobacter, Salmonella, E. coli and Enterococcus spp. found in cattle.
These pathogenic species are often used as ‘indicators’ of AMR in production animals due to
their significance in human health and disease, ease of culturing, ease of isolation from healthy

animals, and well-established AMR minimum inhibitory concentration (MIC) breakpoints
(Cameron & McAllister, 2016).
In reviews of scientific literature conducted by Cameron and McAllister in 2016, they reported
that differing levels of tetracycline resistance were present in cattle-associated bacteria (Cameron
& McAllister, 2016). Resistance to macrolide antibiotics were described in BRD and liver
abscess pathogens (Cameron & McAllister, 2016). Resistance to at least one antimicrobial from
each major class was observed for almost every species (Cameron and McAllister, 2016).

The digestive tract of cattle hold many distinct microbial species (Cameron and McAllister,
2016). As part of a symbiotic relationship, the cattle are dependent on rumen microbes for feed
digestion where the microbes help degrade complex polysaccharides to produce volatile fatty
acids which are absorbed by the host animal as an energy source (Cameron and McAllister,
2016). The intestinal microbiota holds a significant portion of the cattle resistome (Cameron and
McAllister, 2016).
To date, research and surveillance have typically focused on resistance patterns of pathogenic
bacteria that are typically isolated from infected individuals or animals (Davison et al., 2000).

CURRENT APPROACHES TO AMR DETECTION
Traditional methods of AMR detection rely on culturing of microbes under specific conditions in
the presence of antibiotics to determine morphological and biochemical characteristics (Galhano
et al., 2021). In particular, the broth microdilution method is considered the gold standard for
confirming susceptibility of bacteria to antibiotics (Khan et al., 2019). This assay involves using
a 96-well microdilution tray with drug dilution steps, following by evaluating bacterial growth or

non-growth after overnight culturing. Another assay, Epsilometer testing (Etest), consists of a
predefined, continuous, exponential gradient of antibiotic concentrations immobilized along a
rectangular plastic test strip. Following incubation, inhibition zones are visible along the strips
where bacterial growth is prevented (Blackberg & Lood, 2022). Culture-based methods
described above allow for determination of minimum inhibitory concentrations (MIC) and
fractional inhibitory concentrations (FIC), important metrics for characterizing AMR activity.
However, these methods are time-consuming, limited to only culturable bacteria, and provide no
information about resistance mechanisms (Galhano et al., 2021).

Since then, molecular methods based on amplification of target genes (i.e. PCR, real-time PCR
(qPCR), multiplex PCR, random amplified polymorphic DNA (RAPD), whole-genome
sequencing, and metagenomics), have gained traction as they overcome the issue of unculturable
microbes (Galhano et al., 2021). DNA microarrays and DNA chips have also proven to be
promising technologies for screening susceptibility (Khan et al., 2019; Frye et al., 2010).
Determination of isoniazid resistance in M. tuberculosis has been performed using DNA
microarrays (Gryadunov et al., 2005).

While these genotypic methods are direct, sensitive, and allow for specific detection of resistance
genes, they also have some disadvantages, mainly: i) individual AMR genes to be tested need
specific assays. ii) only potential/key resistance genes can be detected, variation in the gene is
undetected, iii) resistance mechanisms remain unexplained and iv) expression of the gene is
undetermined (Khan et al., 2019).

In recent years, the advent of next-generation sequencing (NGS) has provided a promising tool
in surveillance and characterization of AMR prevalence (Klima et al., 2017). Multiple studies
have shown its efficacy in detecting antimicrobial resistance using whole genome sequencing.
Oniciuc et al. (2019) summarizes currently available information on the use of whole-genome
sequencing for AMR surveillance in foodborne pathogenic bacteria, such as Salmonella,
Campylobacter spp., Shiga toxin-producing E. coli, Listeria monocytogenes or S. aureus. While
WGS for AMR surveillance in foodborne pathogens is in its infancy, it is a potentially
encouraging tool when coupled with open access AMR databases and bioinformatic tools. Noyes
et al. (2016) utilized next-generation sequencing to characterize antibiotic resistance potential in
different types of samples collected from feedlots and abattoirs in the beef production system.
Samples were pooled and collected from 8 groups of 1741 commercial cattle while the resistome
was characterized at various points of production. Reads corresponding to genes encoding
resistance to tetracycline and the macrolide-lincosamide-streptogramin classes of antimicrobials
were the most abundant detected. The study found a reduction in microbiome diversity in the
post-slaughter samples compared to the pre-slaughter samples, indicating changes in the
microbial community that were potentially brought byantibiotic intervention during slaughter
(Noyes et al., 2016). To further investigate whether the microbiome was driving changes in the
resistome, Noyes et al. (2016) performed post-hoc procrustes analysis, to determine the degree of
correlation between two ordinations (Peres-Neto and Jackson, 2001). Interestingly, a tighter
correlation was observed on arrival than on exit, suggesting that additional factors like AMR
exposures may have affected changes in the resistome without largely influencing the
microbiome (Noyes et al., 2016).

In addition to next generation sequencing, novel technologies are being introduced for AMR
detection. Some emerging techniques include microfluidics-based diagnostics, electrochemical
devices, and artificial intelligence (Liu et al., 2017; Lau et al., 2021). For large quantities of
samples, microfluidics has emerged as a promising tool as processing is done in smaller scales,
allowing for higher throughput leading to smaller footprints for experimentation and analysis
(Liu et al., 2017). Microfluidics may enable discoveries related to single-cell analysis of
unknown bacteria, as well as manipulate bacterial population distributions to observe their
interactions (Liu et al., 2017). Using the microfluidic approach for tracking bacteria at the singlecell level.

Additionally, several electrochemical devices have been developed for AMR testing. Tibbits et
al. (2021) tested antibiotics with diverse mechanisms of action (ciprofloxacin, imipenem,
oxacillin, or tobramycin) with nosocomial pathogens including S. aureus and E. coli by adding
the bacterial culture into a custom-designed electrochemical cell with a glassy-carbon electrode
and growth media supplemented with a soluble electron transfer mediator, phenzine methosulfate
(PMS). Using this novel approach, they were able to consistently classify strains as antibioticresistant or -susceptible in <90 min for methodology development and <150 min for blinded tests
(Tibbits et al., 2021).

Recently, there has been interest in the use of artificial intelligence (AI) for AMR detection (Lau
et al., 2021). Lau et al. (2021) hypothesize that with the help of AI, prediction and identification
of AMR genes can be performed efficiently. Briefly, with machine learning (ML), a computer
can anticipate future outcomes through a learned model using massive amounts of training data.

Using known AMR determinant databases such as CARD (Comprehensive Antibiotic Resistance
Database) (Alcock et al. 2020) and MegaRES (Doster et al., 2020), algorithms can be trained to
generate a learned model to

pinpoint known or novel AMR genes (Arango-Argoty et al., 2018),

with capabilities of predicting minimum inhibitory concentration (MIC) of multidrug-resistant
bacteria (Nguyen et al., 2019). These algorithms are also capable of identifying AMR genes
using protein structure information in contrast to identification through DNA information (Liu et
al., 2021). The pairwise comparative modelling (PCM) algorithm compares the number of times
a protein is partly homologous to the known antimicrobial-resistant protein (ARP) determinants
and non-ARP determinants (Ruppe et al., 2019). An extension of the PCM algorithm, the gametheoretic-dynamic-weighting-based-feature-evaluation (GTDWFE) accounts for composition,
physiochemical, and structural characteristics of protein sequences to determine interrelationships of these features and their role in bacterial AMR with relative accuracy (93-99%)
(Chowdhury et al., 2019).

To date, many machine learning algorithms for antimicrobial resistance discovery have produced
accurate results and outperformed traditional methods that are reliant on comparisons against a
databases (Liu et al., 2021)). Undoubtedly, further research and more comprehensive databases
would lead to further improve AI integration for AMR detection.

1.8 DISSEMINATION OF AMR GENES FROM THE FOOD CHAIN TO HUMANS
Over the years, many scientific studies have asserted that food animals are a source of AMR
genes due to antibiotic use in agriculture (Wang et al., 2012). The food chain, from production to
consumption, can be a major source of AMR bacteria (Wang et al., 2012). While many studies

have investigated this occurrence, foodborne pathogens are only a small percentage of the overall
food microbiota and likely result in minimal numbers of AMR foodborne pathogens (Wang et
al., 2012). Also, many believe that since raw food animal products are processed or cooked
before consumption, the impact of AMR transmission from foodborne pathogens is probably
minimal. However, several studies have reported that this is in conclusive. In retail foods,
including restaurant and ready-to-consume foods, there are large pools of AMR genes, up to 108
copies per gram of food (Luo et al., 2005), along with a broad spectrum of pathogens being
identified as AMR gene carriers (Duran et al., 2005; Wang et al., 2012; Kurekci et al., 2016). As
these foods are usually consumed without further processing, a significant number of AMR
bacteria can be directly introduced to humans. Due to the lack of information and knowledge
gaps, it is likely that the reported prevalence rate of antimicrobial resistance in food products is
underreported (Wang et al., 2012).
Dominant AMR gene carriage can vary among ecosystems by the antibiotics used and even by
the specific AMR genes present within the same host or environmental microbiota (Wang et al.,
2012). For example, Alexander et al. (2009) studied the effects of
chlortetracycline/sulfamethazine on AMR E. coli prevalence and concluded that AMR E. coli
were disseminated from the food to humans (Alexander et al., 2009). In fermented dairy
products, AMR genes are mainly carried by lactic acid bacteria and Staphylococcus spp. as
opposed to E. coli (Wang et al., 2006). Zhang et al. (2011) examined the gut microbiota of
infants and discovered that while Tet bacteria and the tetM gene pool established in their
gastrointestinal tracts, the main AMR gene carriers were Enterococcus spp., rather than E. coli.
These findings suggest that AMR bacteria can vary greatly depending on the microbial
ecosystem. As such, further examination of the role of commensal bacteria can help identify the

organisms involved in AMR dissemination in different microbial ecosystems to facilitate the
development of targeted mitigation strategies (Wang and Schaffner, 2011).

Furthermore, during food processing, foodborne microbes are susceptible to many different
antimicrobial agents such as nisin, lysozyme, lactoferrin, essential oils and organic acids
(Oniciuc et al., 2019). These processing methods may result in an increase of AMR bacteria
because of cross-resistance, co-selection and stress adaptation (Oniciuc et al., 2019). Crossresistance can occur due to mutations at a common cellular target or the amassing of a general
efflux pumps (Oniciuc et al., 2019). Meanwhile, exposure of the microbe to different antibiotics,
heavy metals, biocides or disinfects that each have unique mechanisms of action, can lead to coselection (Oniciuc et al., 2019). In the case of stress adaptation, while integrons and plasmidencoded gene determinants usually play a role in increasing cross-resistance, activation of the
MDR operon by antimicrobial agents commonly found in the food industry e.g. chlorine, sodium
nitrite, sodium benzoate, or acetic acid also contribute to this increased resistance in some
pathogens like E. coli O157:H7 and Salmonella Enteritidis (Potenski et al., 2003; Oniciuc et al.,
2019).

1.9 CURRENT ANTIMICROBIAL USE AND MITIGATION STRATEGIES TO
COMBAT AMR
Beef production is the third largest meat industry worldwide, behind swine and poultry
production. The major beef producing countries include the United States, Brazil, the European
Union, China, and India (Food and Agriculture Organization of the United Nations, 2015). The
beef production system is complex and involves multiple stages. Mainly, these consist of moving

animals from (i) cow-calf systems to (ii) backgrounding and (iii) feed/finishing operations, with
the animals ultimately being transported to a slaughterhouse for processing. Antimicrobials may
be administered for both therapeutic and non-therapeutic purposes at any point in the timeline
(Cameron & McAllister, 2016).

Mainly, antimicrobials are utilized for therapeutic treatment of infections caused by bacteria or
other microbes (Table 1.1). These pathogens are often overlooked but compromise cattle health,
affect growth performance, and weaken farm profitability (Cameron & McAllister, 2016).
Disease transmission is problematic in high-density feedlots as importation of diseased animals
into the beef production system introduces both endemic and exotic diseases (Cameron &
McAllister, 2016). As such, risk of disease transmission has propelled antimicrobial usage for
prevention of infectious bovine diseases (Cameron & McAllister, 2016).

Type of

Purpose

antimicrobial use
Therapeutic

Therapy

Route of

Administration to

administration

individual or groups

Injection, in-feed,

Both

water
Metaphylactic

Disease prophylaxis

Injection, in-feed,

Group

Therapy

water

Prophylactic

Disease prevention

In-feed

Group

Subtherapeutic

Growth promotion

In-feed

Group

Feed efficiency

In-feed

Group

Disease prophylaxis

In-feed

Group

Table 1.1. Antimicrobial use in food animals.

To combat AMR, several countries have restricted or banned the use of antimicrobials in food
animals (Xiong et al., 2018). In 1999, the European Union (EU) banned the use of bacitracin,
spiramycin, tylosin, and virginiamycin as antimicrobial growth promoters (AGPs) due to their
use in human medicine, subsequently withdrawing the use of all AGPs as a precaution in 2006
(Xiong et al., 2018), However, the Food and Drug Administration (FDA) of the US has
historically upheld antimicrobial use in food animals (Allen & Stanton, 2014). The FDA only
began pushing guidelines to withdraw medically important antimicrobials as growth promoters
in 2012 (Xiong et al., 2018).

Denmark has seen success in slowing down AMR transfer as a result of prohibiting antimicrobial
growth promoters (Xiong et al., 2018). According to Levy (2014), a reduction of greater than
50% in the use of antimicrobials for pigs was achieved from 1992 to 2008 while overall
productivity rose (Levy, 2014). Levels of vancomycin-resistant Enterococcus (VRE) and
extended spectrum cephalosporinase-producing bacteria were effectively reduced following
restrictions on avoparcin and cephalosporin (Agersø & Aarestrup, 2013). A comprehensive
AMR surveillance system was also created (DANMAP) to track antimicrobial use in animals,
food products and humans (Agersø & Aarestrup, 2013). Although resistance of key zoonotic and
resistant bacteria has remained the same, total antibiotic consumption in food animals has
decreased. While this model may be difficult for other countries to emulate, it exemplifies efforts
made towards reducing AMR (Levy, 2014).

Since surveillance is paramount to mitigating AMR, many countries have developed monitoring
systems such as the U.S. National Antimicrobial Resistance Monitoring System for Enteric
Bacteria and the European Antimicrobial Resistance Surveillance Network that collect
information on antimicrobial consumption and resistance (Xiong et al., 2018). However, smallerscale, local efforts are inconsistent and patchy (Woolhouse & Farrar, 2014).

1.10 DIRECT AND INDIRECT ASSOCIATIONS OF ANTIMICROBIAL USE ON AMR
GENE PREVALENCE
Among the many factors associated with antimicrobial resistance, antimicrobial use is presumed
to be the main aggressor leading to AMR (Galhano et al., 2021). There exists documented
evidence for and against direct associations between antimicrobial drugs and resistance (Wee et
al., 2020). Classically, investigations into indirect associations between antibiotic use and
resistance has compared resistance as a result of conventional practices that utilize antimicrobials
to production systems that have specifically excluded the use of antimicrobials (Benedict, 2011).
Previous explorations on the effects of differential treatment strategies on the prevalence of
AMR determinants in the fecal metagenome have been conducted (Benedict, 2011). Kanwar et
al. (2014) conducted a 26-day field trial on 176 steers divided into 4 cohorts, administering
therapeutic doses of ceftiofur and/or chlortetracycline. One of the four cohorts included steers in
which only 1 of the animals was administered a mixture of ceftiofur and chlortetracycline, while
the remaining animals received chlortetracycline alone. Through real-time PCR, the researchers
were able to quantify blaCMY-2, blaCTX-M, tet(A), tet(B) and 16S rRNA gene copies/gram of feces
from community DNA. Greater numbers of blaCMY-2 and blaCTX-M ceftiofur resistance
determinants were observed in pens where all cattle were treated with ceftiofur. Similarly,

chlortetracycline treatment increased levels of blaCMY-2 and blaCTX-M gene copies in comparison to
cattle in pens that did not receive chlortetracycline. In contrast, the prevalence of tetracycline
AMR genes decreased in pens where all cattle received ceftiofur compared to pens where only
one animal received ceftiofur. This lead to an interesting observation of the possibility of
expansion or suppression of singly- or co-resistant AMR bacterial populations under
antimicrobial selection, showcasing the complexities of antimicrobial effects on the resistome, as
well as the potential for discrepancies between culture- and non-culture-based AMR quantitation
methodologies (Kanwar et al., 2014).

As dairy manure is a particularly understudied environment, Chambers et al. (2015) examined
the effect of ceftiofur treatment on the prevalence of AMR genes in the bovine fecal microbiome
by using metagenomics. They observed increased levels of β-lactam AMR genes, predominantly
CfxA2 and CfxA3 in the feces of cows that had been fed ceftiofur as opposed to control cows
(Chambers et al., 2015). Higher levels of β-lactam AMR genes are consistent with results
observed by Kanwar et al. (2014). Also, taxonomic composition (microbial makeup) was used as
an indicator of difference in AMR gene profiles and their effect on shifts in fecal microbial
community. Based on PERMANOVA analysis, Chambers et al. (2015) reported that fluctuations
in the bacterial community are associated with both treated and control cows 3 days posttreatment. Furthermore, functional analysis using MG-RAST displayed ceftiofur therapy
culminated in a larger number of sequences associated with “phages, prophages, transposable
elements, and plasmids,” indicating that antibiotic treatment can propel horizontal gene transfer.

Another study aimed at defining the AMR makeup of cattle raised with no prior exposure to
antibiotics was reported by Vikram et al. (2017). In this study, fecal samples (n = 719) collected
from 36 pens each having 10 head of cattle “raised without antibiotics” (RWA) and 36 pens of
“conventional” (CONV) beef cattle were investigated using a variety of methods including
culturing, quantitative PCR of AMR genes, and metagenomic sequencing. The results
demonstrated AMR levels to be similar, with some higher levels of AMR in CONV beef cattle.
AMR occurrence quantified by metagenomic sequencing showed that aggregated abundances of
AMR genes in the aminoglycoside, β-lactam, macrolide-lincosamide-streptogramin B (MLS),
and tetracycline AM classes did not differ between the two systems. Differences in abundance
mainly involved specific macrolide-lincosamide-streptogamin or tetracycline AMR genes such
as tet(A), tet(B), tet(C), and erm(B), which showed higher abundances (p < 0.01) in CONV than
RWA systems. Given the moderate AMR reductions observed, it is unclear whether curtailing
antimicrobial use in U.S. beef cattle production would result in significant AMR reductions
beyond MLS and tetracycline resistance (Vikram et al., 2017). Inconsistent conclusions from
these “association” studies highlight the need for more direct explorations of the relationship
between antimicrobial use and resistance. Well-designed association studies are paramount to
explain for other variables and biases in our understanding of AMR. As such, in this study, we
investigate AMR gene reservoirs in beef cattle to i) evaluate baseline levels before exposure to
any antibiotic and ii) evaluate changes/enrichment of AMR genes and microbial populations due
to selection pressures caused by antibiotic use to gain a better understanding of the effect
antibiotic use on emergence and persistence of antimicrobial resistance.
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CHAPTER 2: ANTIBIOTIC-MEDIATED CHANGES IN BACTERIAL
COMMUNITY COMPOSITION IN BEEF CATTLE

2.1 ABSTRACT
While antimicrobial therapies have conferred immense benefits in both human and animal
health, widespread metaphylactic use of antibiotics has largely contributed to antimicrobial
resistance. It is estimated that approximately 40% of all antibiotics produced are used in
livestock as feed additives. Since the bovine gastrointestinal tract microbiota has critical
consequences on animal health and production, it is important to evaluate the effect of utilizing
antibiotics on the gut microbiome and its subsequent effect on the environment. To better
understand the effect of antibiotics on the gastrointestinal microbiome and the environment in
beef cattle production, we utilized 16s rRNA gene sequencing of rumen and fecal samples of
beef cattle, soil samples from their pens and runoff samples from the pen floor to characterize
microbial community differences in animals treated or not treated with antibiotics across
multiple time points. Specifically, we focused on the effects of feeding monensin/tylosin versus
injectable antibiotics i.e. Baytril, Draxxin, Excede, Nuflor. We evaluated baseline and postantibiotic microbial communities from the rumen and feces in 72 animals. We observe increased
Prevotella abundance in the rumen following monensin/tylosin feeding and injectible treatment,
ii) decreased Ruminococcus abundance, a key player in rumen degradation, iii) reduced presence
of Clostridium and Lachnospiraceae in fecal samples, and iv) changes in interactions of different
taxa as a result of selection due to antibiotic treatment.

2.2 INTRODUCTION
The microbiome of the gastrointestinal (GI) tract is critical for maintaining equilibrium and
harbors antimicrobial resistance (AMR) genes (Dobrzanska et al., 2019). In livestock farming,
antibiotics are frequently used as growth promoters, as well as for the prevention and treatment

of diseases (Dobrzanska et al., 2019). Until November 2017, beef cattle in the US were
administered antibiotic classes that were also used in humans for both therapeutic and growth
promotion purposes (Keenum et al., 2021). Not long after, the US Food and Drug Administration
(FDA) set a Veterinary Feed Directive to restrict antibiotic use to therapeutic uses only (FDA,
2017). Long-standing use of antimicrobials has been hypothesized to result in the selection for
bacteria that are resistant to the prescribed antibiotic and thus, cause the emergence of resistance
determinants that are specific to the administered antibiotic (Sanchez Garcia et al., 2010;
Endimiani et al. 2011). Moreover, antimicrobial treatment can cause imbalances in the gut
microbiota such as disproportionate changes in species abundance (Dobrzanska et al., 2019).

An important aspect of microbiome studies is the exploration of antimicrobial use on the
composition of the gut microbiome in relation to host well-being. There exists a growing body of
literature to support the role of the gut microbiota on human and animal health and disease
(Holmes et al., 2011). In the rumen, microbes produce short chain fatty acids (SFCAs) like
acetate, butyrate, and propionate from undigested dietary polysaccharides, with these SCFAs
making up 70% of the energy intake in the animal (Holman & Gzyl, 2019). Furthermore, this
microbial community plays a key role in developing and maintaining the immune system, as well
as preventing pathogen colonization (Baumler & Sperandio, 2016). Accordingly, antimicrobial
treatment is likely to produce both short and long-term effects on the commensal microbiota and
disturb the carefully curated homeostasis of the microbiota-host relationship, even affecting host
physiology and health (Sommer & Dantas, 2011).

Several studies have examined the impact of antibiotics on the microbial community using 16s
rRNA gene sequencing alone (Pérez-Cobas et al., 2013; Raymond et al., 2015) or in combination
with metatranscriptomics (Maurice et al., 2013). The 16s rRNA gene is ubiquitous, meaning it is
present in all bacterial genomes while being conserved and specific (Liu et al., 2019). In the
present study, we administered Monensin/Tylosin and injectible antibiotics (i.e. Baytril, Draxxin,
Excede Nuflor) to conventional animals at therapeutic doses and left control (antibiotic-free)
animals untreated. Administration of the feed additives (Monensin/Tylosin) and injectible
antibiotics was performed in different phases to allow us to investigate shifts in the microbial
community of the rumen, feces, and soil following each phase of antibiotic treatment. The aim of
this study was to determine the effects of preventive antibiotic therapy on the gut microbial
community composition and identify species that may be more affected than others.

2.2 MATERIALS AND METHODS
2.3.1 EXPERIMENTAL DESIGN AND SAMPLE COLLECTION
All animal handling treatment procedures, protocols and husbandry practices were conducted in
accordance with regulations by the Institutional Animal Care and Use Committee (IACUC). A
feedlot facility at U.S. Meat Animal Research Center (USMARC) containing 18 pens with 4
head per pen was utilized for this study. The facility had no exposure to antibiotics over the last 5
years. Additionally, the cattle population utilized for this study had never received antibiotics
including in-utero exposure. The study was performed over a whole production season with the
steers being sourced from USMARC commercial angus cattle populations at weaning. During
weaning, all animals were fed a ground forage-based ration without dietary antimicrobials

consisting of 40% corn silage, 35% alfalfa hay, 20% earlage, 4% vitamin and mineral
supplement on a dry matter basis.

Following weaning, 72 steers (36 steers per treatment) were sorted into 9 replicate pens of 4
steers per pen and transported to the new USMARC AMR research facility. At the facility, the
conventional group of steers (antibiotic-treated) were fed a growing diet supplemented with
Monensin and Tylosin while the control (antibiotic-free steers) were given the same diet with no
supplementation of Monensin and Tylosin. To minimize possible cross-contamination across
pens, the antibiotic-free steers were housed in pens on the east side of the building while the
conventional steers were housed in the west side with 3 empty pens separating the two treatment
groups. Animals were weighed four times after adaptation to the finishing ration (day 0),
approximately every 50 days for two mid-point weights, and just prior to shipping (final weight).
The growing phase, or period when animals were supplemented only with Monensin/Tylosin,
lasted 96 days.

Following adaptation and sample collection, each animal in the conventional pens were treated
after with 1 of 5 antibiotics i.e. Baytril, Excede, Draxxin, Nuflor (Table 2.1) at recommended
dosages consistent with standard USMARC livestock feeding operations. with one animal in
each pen left untreated and serving as the negative control. For the remainder of this study,
“Phase 1: Antibiotic-Fed study” refers to the portion of the study when animals were fed
Monensin and Tylosin with no further antibiotic treatment while “Phase 2: Antibiotic-Injected
study” refers to the portion of the study when animals were administered the “injectable”
antibiotics i.e. Baytril, Draxxin, Excede, Nuflor.

Following both phases, rumen, fecal, soil, and pen surface samples were collected. During the
first growing phase, fecal samples were collected on the first day of animal entry into the pen
(day 0) and 42 days after (day 42). During the finishing phase, rumen and fecal samples were
collected on the first day of injectible antibiotic administration (day 0) and 42 days after (day
42). Soil/runoff samples were collected prior to any animal entry into the pen (day 0), followed
by collection on days 172, 196, and 226. Soil and runoff samples were analyzed as one sample
type.

Pen surface samples were collected by randomly sampling 10 locations within each pen and
pooled to obtain a representative sample. Rumen samples were collected from each animal using
esophageal tubing as described by Paz et al., 2016. All samples were snap frozen in liquid
nitrogen until used for microbial community analysis.

2.3.2 DNA EXTRACTION OF RUMEN, FECAL, AND SOIL SAMPLES
DNA was extracted from all samples collected using the Mag-Bind® Stool DNA 96 Kit (Omega
Bio-tek Inc., Norcross, GA, USA) according to the manufacturer’s protocol with some
modifications. To lyse and homogenize samples, a bead-beating step was added with 0.5 g of
acid washed beads (Scientific Asset Management, Basking Ridge, NJ) using a TissueLyser
(Qiagen Inc., Valencia, CA, USA) for 10 minutes at 20 Hz. Following lysis and inhibitor
removal, nucleic acids were precipitated using isopropanol as described by Yu and Morrison
(2004). The resulting DNA pellets was further purified using magnetic bead-based purification
using the KingFisher™ Flex Purification System (ThermoFisher Scientific, Lenexa, KS). The

resulting DNA was stored at −20°C until used for library preparation for bacterial community
analysis.

2.3.2 LIBRARY PREPARATION AND SEQUENCING ON THE ILLUMINA MISEQ
The V4 region of the 16S rRNA gene was amplified as described by Kozich et al. (2013) for
barcoding, pooling and custom sequencing. Briefly, the PCR reactions with fusion barcoded
primers contained 0.75 units of Terra PCR Direct Polymerase Mix (Clontech Laboratories Inc.,
Mountain View, CA, USA), 1X Terra PCR Direct Buffer (Clontech Laboratories Inc., Mountain
View, CA, USA), 0.4 uM indexed primers, and 20-50 ng of extracted DNA. Amplifications were
performed on a Veriti 96-Well Thermocycler (Life Technologies, Carlsbad, CA, USA) using the
following PCR cycling conditions.: 98°C for 2 minutes followed by 25 cycles of 98°C for 30s,
58°C for 30 seconds, 68°C for 45s, with a final extension of 68℃ for 4 minutes. Multiple
negative controls were included in each PCR run. The resulting PCR products were separated
using 1.5% agarose gel, stained (ethidium bromide), and photographed to visualize PCR
amplification products and confirm PCR product sizes.

Following amplification of the 16S rRNA V4 region, the resulting amplicons were normalized
using the NGS Normalization 96-Well Kit (Norgen Biotek, ON, Canada) and pooled for
multiplex sequencing. The resulting pooled libraries were quality controlled using the
BioAnalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA) using Agilent High Sensitivity
DNA chips. The resulting libraries were quantified using the KAPA Library Quantification Kit
(Roche, Basel, Germany) to determine library concentration and sequenced using the 250 bp

paired end sequencing strategy on the Illumina MiSeq platform with V2 500 cycle sequencing kit
as described by the manufacturer (Illumina, San Diego, CA, USA).

2.4 DATA PROCESSING PIPELINES
Detailed information regarding the bioinformatic analyses conducted including the mapping file,
scripts, and commands can be found on the Fernando Lab’s GitHub repository
(https://github.com/FernandoLab/See_2022_16S). To determine effects of feeding Monensin and
Tylosin and the effect of injecting antibiotics on the rumen, fecal, and soil microbiomes across
time, we used the DADA2 pipeline (Callahan et al., 2016) implemented within R (R Core Team,
2019). The ‘DADA2’ pipeline (Callahan et al., 2016) was used for quality filtering, denoising,
and processing raw fastq files. The resulting quality filtered reads were used for downstream
analysis using the ‘phyloseq’ package (McMurdie & Holmes, 2013). To summarize the DADA2
process, low quality reads with a Q score less than 30 were filtered and reads were cropped to
contain bases with Q30 or higher quality. Standard filtering parameters and a set maximum
number of “expected errors” were used to filter forward and reverse reads. After error rates were
estimated to evaluate read quality, forward and reverse reads were merged to obtain full denoised
contig reads. Subsequent filtering was conducted to remove sequences with ambiguous bases and
chimeras and the resulting reads were used to pick unique amplicon sequence variants (ASV).

Taxonomic assignment to 16s rRNA sequence variants was performed using the “SILVA
reference alignment database v123”. Using the ‘decontam’ package (Davis et al., 2018) and
negative controls, contaminants in ASVs were identified and removed. Filtering was done based
on prevalence and abundance by using previously researched positive control sequencing data

using the ‘genefilter’ package (Gentleman et al., 2022). Function parameters were set at 0.15%
abundance within a sample with the criteria in at least 2 samples.

2.5 STATISTICS
All data analyses were performed in R using the ASV count table, taxonomic classification, and
metadata of treatments, using a phyloseq (McMurdie & Holmes, 2013) object. Statistical
analyses were performed using the R package ‘vegan’ (Oksanen et al., 2022) using the adonis
function. PERMANOVA analysis was performed to identify the effect of antibiotic treatment,
timepoint, and the interaction between treatment and timepoint on microbial community
changes. The Permutational Multivariate Analysis of Variance (PERMANOVA) test was
performed using 999 permutations (Anderson, 2017). A nonparametric Kruskal-Wallis equality
of population rank test was performed to determine significant differences between the
treatments. Statistical significance was determined at p < 0.05. Read count data (ASV table)
were normalized by proportions prior to statistical analyses of β-diversity and “between-sample”
comparisons. Bray-Curtis distance matrix was used to perform principal coordinate analysis
(PCoA) to estimate variation of bacterial communities between treatment groups.

Differentially abundant ASV were calculated between antibiotic-fed, antibiotic free, and
antibiotic-treated groups using DESeq2 (Love et al., 2014). Differential ASVs were identified
after using Benjamini-Hochberg false discovery rate adjusted P-value, with those equal to or
<0.05 being considered significant. Following variance stabilization transformations on read
count data, heatmaps of the top differentially abundant ASVs were illustrated with hierarchical
clustering using the ampvis2 package (Andersen et al., 2018).

Network analyses were performed using sparse correlation of compositional data (SparCC)
(Friedman & Alm, 2012) within the NetCoMi package (Peschel et al., 2021) to identify
associations between bacterial community members at the family level. A threshold of 0.3 was
used as a sparsification method, so ASVs with an absolute correlation greater than or equal to 0.3
were connected. Correlation values < 0.3 were reduced to zero for SparCC adjacency matrix.
Each ASV represents a node in the network and there exists an edge between ever two nodes if
they have co-occurred together. Eigenvector centrality was used for defining hubs (nodes with a
centrality value above the empirical 95% quantile). In comparison networks, nodes that remained
unconnected in both groups were omitted.

2.6.1 RESULTS OF FEEDING MONENSIN/TYLOSIN ON BACTERIAL COMMUNITY
SEQUENCE ANALYSIS
Following quality filtration, chimera removal, removal of archaeal and eukaryotic reads, and
prevalence filtration at 0.15% in at least 2 samples, the datasets from the phase 1 (antibiotic-fed)
study resulted in 1, 430, 437 reads (90.8% retained) binned into 621 ASVs for rumen samples
and 6, 619, 827 reads (86.6% retained) binned into 1216 ASVs for fecal samples. Fecal and
rumen datasets of phase 2 (antibiotic-injected) respectively contained 1, 716, 342 reads (91.2%
retained) binned into 640 ASVs and 5, 769, 463 reads (83.7% retained) with a total of 1203
ASVs identified.

TAXA COMPOSITION, ABUNDANCE, AND DIVERSITY IN COLLECTED RUMEN
AND FECAL SAMPLES

Bacterial diversity estimated using Observed ASVs showed no significant differences (KruskalWallis, p > 0.05) between antibiotic-free and antibiotic-treated rumen samples at the day 64 and
134 timepoints. However, Shannon-Weiner diversity estimates displayed a significant difference
(p < 0.05) at day 64 between the Monensin/Tylosin-fed cattle and the antibiotic-free cattle
(Figure 2.2a). Bacterial alpha diversity estimated using the same indices for fecal samples
showed significant differences between antibiotic-free and antibiotic-fed cattle on days 0 and 64,
with only the Shannon-Weiner diversity index showing a significant difference on day 134
(Figure 2.2b).

The principal coordinate analysis (β-diversity) on all pairwise Bray-Curtis distances between
rumen samples did not indicate clustering patterns by treatment group. However, there exists a
distinct stratification by timepoint between days 64 and 134 (Figure 2.3a). Significant clustering
was observed on day 0 compared to days 64 and 134 in fecal samples (Figure 2.3b).
PERMANOVA analysis observed significant differences (p < 0.05) in beta-diversity between
treatments, timepoints, and their interactions in both rumen and fecal samples (Supplementary
Data 2.3). Pairwise post-hoc analysis between timepoints of both antibiotic-treated and
antibiotic-free fecal samples showed significance between each timepoint combination
(Supplementary Data 2.3).

The most abundant genera in rumen samples were Prevotella, Eubacterium coprostanoligenes,
and Lachnospiraceae. Meanwhile, the most abundant genera in fecal samples were Clostridium,
Paeniclostridium, and Lachnospiraceae. The taxonomy and relative abundance at genus level of

the ASVs for each sample type for this phase of the study is provided in Supplementary Data 2.1
and 2.2.

To identify differentially abundant ASV in the rumen and feces that were significantly different
between antibiotic treatment and timepoint, a permutational multivariate analysis of variance test
was performed (Anderson, 2017). A total of 33 differential ASV were observed in rumen
samples. The differential ASVs identified in rumen samples between antibiotic-fed and no
antibiotic groups belonged to the genera Catenisphaera and Ruminococcaceae NK4A214 group,
which were more abundant in the antibiotic-fed group while Prevotella, Succiniclasticum, and
Prevotellaceae UCG-004 being more abundant in the antibiotic-free animals (Figure 2.4a).
Variants of Prevotella were increased in both treatment groups. Hierarchical clustering of these
ASV based on abundance identified 4 distinct groups, with some ASV (belonging to
Corynebacterium, UCG-002, and Coriobacteriaceae, among many other genera) displaying
higher abundance in antibiotic-free cattle at day 64. However, on day 134, higher abundance of
different ASVs (belonging to Prevotella, Lachnospiraceae, and Oribacterium) was observed in
antibiotic-free cattle, as compared to day 64. Generally, Eubacterium, Syntrophococcus, and
Saccharofermentans were found to be more abundant in the antibiotic-free group at both
timepoints. In the antibiotic-fed cattle, we observe higher abundance of ASV belonging to
Prevotellaceae UCG-004, Prevotella, Succinivibrionaceae and Succiniclasticum, to be more
abundant in antibiotic-fed cattle at both days of sample collection. Also, we observed different
variants of the genus Ruminococcaceae NK4A214 to be slightly more abundant in the antibioticfed group.

A total of 55 differential ASVs were identified in the fecal samples, with ASVs belonging to
Lachnospiraceae NK3A20 group, Solobacterium, and Turicibacter showing higher abundance in
the antibiotic-free group (Figure 2.4b). Distinct hierarchical clustering was observed in 3 groups.
Higher abundance of ASV belonging to the genera UCG-005, Coprococcus, and
Lachnospiraceae NK3A20, was seen in antibiotic-fed animals at days 64 and 134. At the same
timepoints, Ruminococcus gauvreauii, Christensenellaceae, and Turicibacter ASVs were
distinctly more abundant in the antibiotic-free group.

NETWORK ANALYSIS AND COMPARISON BASED ON SPARCC CORRELATIONS
To identify key bacterial species and associated bacterial interactions as a result of feeding
Monensin and Tylosin, network analysis was performed at the family level from the identified
ASV in both fecal and rumen samples. For illustration purposes, only the top 50 taxa with the
highest variance and samples with a total number of reads of at least 1000 were selected.

Network comparison for rumen samples showed 2 distinct clusters in both control and antibioticfed animals (Figure 2.5). We observe slight differences in the estimated associations, with both
networks showing similar clustering. Lactobacillaceae and Atopobiaceae were identified as hubs
in control animals while Lachnospiraceae and Lactobacillaceae were identified as hubs in
animals fed Monensin/Tylosin. Comparisons of global network measures and the five genera
with the highest absolute group difference for all centrality measures are given in Supplementary
Data 2.4.

Network comparison for fecal samples showed similar clustering patterns in both control and
antibiotic-fed animals when compared to the rumen samples (Figure 2.6). We observe slight
differences in the estimated associations, with both networks showing similar clustering.
Different hubs were observed in the two treatment groups - Erysipelotrichaceae,
Corynebacteriaceae, and Peptostreptococcaceae in control animals and Lachnospiraceae,
Bacteroidaceae, and Muribaculaceae in animals fed Monensin/Tylosin. Comparisons of global
network measures and the five genera with the highest absolute group difference for all centrality
measures are given in Supplementary Data 2.5.

2.6.2 RESULTS OF INJECTABLE ANTIBIOTICS ON BACTERIAL COMMUNITY
COMPOSITION
TAXA COMPOSITION, ABUNDANCE, AND DIVERSITY FOLLOWING ANTIBIOTIC
INJECTIONS
Bacterial diversity estimated using Observed and Shannon-Weiner diversity indices showed no
significant differences (Kruskal-Wallis, p > 0.05) between treatment groups of rumen samples at
the two timepoints (Figure 2.7). Alpha diversity estimated using the same indices for fecal
samples showed no significant differences between antibiotic-free and antibiotic-injected cattle
at days 0, 7 and 42 (Figure 2.8).

The principal coordinate analysis (β diversity) on all pairwise Bray-Curtis distances between
rumen samples did not display clustering patterns by treatment group or timepoint (Figure 2.9).
However, the PCoA plot displayed some clustering based on if fecal sample collection occurred
before or after antibiotic administration (Figure 2.10a), suggesting a microbial shift due to

antibiotic use. Slight clustering was observed in the AbxFree treatment group, indicating that
microbial shifts occur due to antibiotic use regardless of the type of antibiotic administered. This
observation was supported by PERMANOVA analysis (999 permutations) using Bray-Curtis
dissimilarity matrix with a model considering the effect of antibiotic treatment, timepoint, and
the treatment and timepoint interaction (Supplementary Data 2.8a, 2.9a). Post-hoc analyses
between pairs of treatments in rumen (Supplementary Data 2.8b) samples indicate significant
differences between antibiotic-free and antibiotic-injected samples. However, significance was
not observed when a comparison between antibiotic injections e.g. Baytril vs Excede was
performed.

Post-hoc analyses between pairs of treatments in fecal samples (Supplementary Data 2.9c)
showed no significant differences whether the animals were administered antibiotics or not.
Additionally, all pairs of timepoints were significantly different (Supplementary Data 2.9b).
indicating that timepoint of antibiotic administration may play a larger role than previously
thought, supporting the descriptive analysis of clustering patterns see in Figure 2.9.
Similar to the antibiotic-fed portion of the present study, the most abundant genera in rumen
samples were Prevotella, Eubacterium coprostanoligenes, and Lachnospiraceae (Supplementary
Data 2.6). However, most abundant genera in fecal samples differed from the antibiotic-fed
portion of this study, where we observe Clostridium, Paeniclostridium, and Lachnospiraceae as
the top three most abundant genera. Instead, Clostridium, Turicibacter, and Romboutsia in the
antibiotic-injected animals were found to be the most abundant genera (Supplementary Data 2.7).

Differentially abundant ASV were identified with DESEQ2 analysis. A total of 279 ASVs were
determined as differential in the rumen samples, with the top 50 most significant ASV illustrated
in a heatmap (Figure 2.11a). The differential ASVs identified in rumen samples between
antibiotic-injected and no antibiotic groups belonged to the genera Ruminococcaceae NK4A214
group, Prevotella, Prevotellaceae UCG-004, Prevotellaceae UCG-001, and Rikenellaceae U-29
B03 (Figure 2.11a). Hierarchical clustering of these ASV based on abundance identified 4
distinct groups, with ASVs belonging to Prevotellaceae UCG-001, Prevotella, Desulfovibrio and
Mogibacterium genera displaying higher abundances in antibiotic-treated animals at both days of
sample collection. Higher abundances of Schwartzia, Howardella, Christensenellaceae,
Treponema, and Shuttleworthia were observed in antibiotic-free animals at both timepoints.
Certain ASVs belonging to Prevotella were more abundant in the antibiotic-free group while
others were more abundant in the antibiotic-treated group.

In fecal samples, only 17 ASVs were determined to be differential, with all of them being plotted
in the heatmap (Figure 2.11b). The most significantly differential ASVs belonged to
Spirochaetaceae, Enterococcaceae, Lachnospiraceae, Pasteurellaceae, and Mycoplasmataceae.
Distinct hierarchical clustering was observed in 3 groups, with ASV belonging to the genera
Mycoplasma, Hungatella, Erysipelatoclostridium, Alloprevotella, and Cetobacterium displaying
greater abundance in antibiotic-treated animals on day 7. Highest abundances were seen on day
7, with days 0 and 42 showing little variation in differential ASV, Interestingly, a cluster of
ASVs belonging to Erysipelatoclostridium, Enterococcus, Hungatella, Cetobacterium, and
Mycoplasma appear to be more abundant in animals that had been treated with Excede as
opposed to other antibiotic treatments.

NETWORK ANALYSIS AND COMPARISON OF INJECTABLE ANTIBIOTICS
BASED ON SPARCC ASSOCIATIONS
To identify key bacterial species and associated bacterial interactions as a result of injecting
Baytril, Draxxin, Excede or Nuflor, network analysis was performed at the family level from the
identified ASV at the last day of sample collection in both fecal and rumen using SparCC
associations (Friedman & Alm, 2012). Again, hubs were defined using eigenvector centrality
(nodes with a centrality value above the empirical 95% quantile) to identify key taxa as those
that are the most central to the microbiome networks (i.e., highest degree of interconnectedness).
We select the top 50 taxa with the highest variance and samples with a total number of reads of
at least 1000 to plot smaller networks.

As shown in Figure 2.12, NetCoMi identified four clusters and the following three hub nodes:
Veillonelaceae, Desulfovibrionaceae, Lachnospiraceae in the control/antibiotic-free rumen
samples. The Baytril-injected animals (Figure 2.12a) highlighted three clusters (Veillonelaceae,
Lachnospiraceae, Selenomonadaceae), with two of the clusters (Veillonelaceae,
Lachnospiraceae) also recognized in the antibiotic-free treatment group. The strongest positive
associations were seen in the cluster containing these hubs. The Draxxin-injected animals
(Figure 2.12b) showed three (non-distinct) main clusters, with hubs belonging to Rikenellaceae,
Prevotellaceae, and Desulfovibrionaceae. The Excede and Nuflor-injected animals (Figure
2.12c, 2.12d) showed greater repulsion (that is, clusters were pushed away from one another),
indicating greater shifts in interactions of the microbial community. Hubs were identified as
Eubacterium coprostanoligenes, Anaerovoraceae, and Eggerthellaceae in Excede-treated

animals and Eubacterium coprostanoligenes, Spirochaetaceae, and F082 in Nuflor-treated
animals. Visually, we observe that antibiotic treatment leads to greater repulsion between
clusters. This is apparent when comparing the antibiotic-free treatment group to the Baytril,
Excede, and Nuflor-treated groups. Furthermore, certain taxa that were not strongly associated in
the antibiotic-free treatment groups seem to be show stronger associations when treated with
antibiotics. While not an extensive list, these include Selenomonadaceae, Rikenellaceae,
Eubacterium coprostanoligenes, and Spirochaetaceae.

The bacterial community of fecal samples showed more distinct clustering, with clusters having
a greater degree of repulsion (Figure 2.13). Similar patterns of clustering were observed in all
treatment groups with the exception of the Draxxin-treated group. This pattern showed that there
were two clusters that were negatively associated with one another, with hubs belonging to one
of the two clusters. Additionally, three hubs were identified in the antibiotic-free treatment
group. These hubs belonged to the families Corynebacteriaceae, Anaerovoracaceae, and
Clostridiaceae. The Baytril-injected group identified F082, p-251-05, and Prevotellaceae as
hubs (Figure 2.13a). The Excede-treated group identified Flavobacteriaceae, Prevotellaceae,
and Bacteroidales RF16 group as hubs, while the Nuflor-treated group had Clostridiaceae,
Eubacterium coprostanoligenes, and Peptostreptoccocaceae. As mentioned, the clustering
pattern that was seen in all treatment groups was not seen in the Draxxin-treated group (Figure
2.13c). Here, three clusters were observed, with hubs identified as Bacteroidales RF16,
Prevotellaceae, and Flavobacteriaceae.

When comparing the antibiotic-free to antibiotic-treated networks, it is interesting to note that
certain taxa were consistent in their clusters. For example, regardless of treatment, the
Bacteroidales RF16 group remained in the same cluster as Prevotellaceae and
Flavobacteriaceae. Clostridium, the most abundant genus in fecal samples, was identified as a
hub in only the control and Nuflor treatment groups, indicating that antibiotic treatment changes
the interactions between Clostridium and other taxa. It should be noted that these observations,
beyond hub identification, are not definitive. Due to limitations within SparCC and NetCoMi,
similarity of clustering between groups via Rand index cannot make a conclusion about whether
clusterings are significantly different between groups. Similarly, Jaccard index testing was
unable to identify if the most central nodes of a network are significantly different between
groups.

2.6.3 SHIFTS IN SOIL BACTERIAL COMMUNITY IN RESPONSE TO ANTIBIOTIC
TREATMENT
As soil and runoff samples were analyzed as one sample type, the treatment groups were
classified as i) antibiotic-free, ii) antibiotic-treated, iii) baseline, and iv) no animal controls.
Antibiotic-free and antibiotic-treated soil samples refer to samples that were collected from pens
of animals, depending on whether the animals received antibiotic treatment. The baseline
treatment group refers to soil samples that were collected before animals entered the facilities
while the “no animal control” group corresponds to samples that were collected from pens that
held no animals (the empty pens between treatment groups).

Soil and runoff samples resulted in 1, 845, 327 reads retained following all filtration steps
(72.2% retained) that were binned into 1293 ASVs. Alpha diversity of the baseline group and

treatment groups was analyzed to identify differences in treatment means using Kruskal-Wallis
testing (Figure 2.14, Figure 2.15). Alpha diversity patterns were variable across all timepoints.
Numeric differences in Observed and Shannon-Weiner indices for baseline (day 0) samples in
comparison to post-treatment samples were observed. However, no significant differences were
observed between treatment means for non-baseline treatment groups, apart from day 226 using
the Shannon-Weiner index.

Beta diversity metrics showed distinct clustering by day of sample collection but less obvious
clustering by treatment (Figure 2.16). This observation was supported by PERMANOVA
analysis performed using the Bray-Curtis dissimilarity matrix, with a model that included
treatment, timepoint, and the interaction between treatment and timepoint (Supplementary Data
2.11a). All parameters analyzed were found to be significantly different (p-value < 0.05).
Pairwise post-hoc analyses displayed that all pairs of treatment groups were significantly
different from each other, except for the AbxFree vs AbxTreated group (Supplementary Data
2.11b). The same post-hoc analysis was performed to compare timepoints, with all pairs of
timepoints showing significance (Supplementary Data 2.11c) consistent with the PCoA plot of
Figure 2.17.

At the phylum level, Actinobacteria, Firmicutes, and Proteobacteria dominated read abundance.
The most abundant genera were shown to be Corynebacterium, Nocardioides, and
Pseudarthrobacter (Supplementary Data 2.10). Interestingly, Corynebacterium was most
abundant in the antibiotic-treated group. Differential abundance analysis reveals 77 ASVs to be
differential (Figure 2.17). The most significantly differential ASVs belonged to

Corynebacterium, Chryseobacterium, Aeromicrobium, Pedobacter, and Nocardioides. The
genera Comamonas and Fermentimonas displayed greated abundance in the no animal control
group at day 42. We observe variations in abundance in days 195 and 226, with a large clusters
of ASVs belonging to various genera being more abundant at these timepoints when compared to
the day 0, day 42, and day 172 timepoints.

2.7 DISCUSSION
The emergence of antimicrobial resistance is a growing global problem affecting human and
animal health. This phenomenon can be attributed to the “industrialization of livestock
production and widespread of nontherapeutic antimicrobial growth promotants” (Gilchrist et al.,
2007), resulting in reduced efficacy of the current antibiotics against human and animal diseases.
Additionally, beef cattle are often administered antibiotics for the treatment of BRD and liver
abscess prevention. As such, understanding the effects of antimicrobial use on the ecology of
microbial community is critical.

Previous research (Aminov & Mackie, 2007; Ding & He, 2010) have shown that once antibiotics
enter the ecosystem, they can act as an ecological factor to drive the evolution of microbial
community structure. Effects of antimicrobial ‘disturbance’ are mainly inconclusive. However, it
is expected that such a disturbance may have significant and long-term effects on the rate and
stability of an ecosystem (Ding & He, 2010). We believe these effects are especially important to
understand in cattle as complex and diverse microbial communities facilitate the degradation of
nutrients (Anderson et al., 2016). To better understand the effect of antimicrobial use on the
rumen and fecal microbiome composition and downstream effects on the environment, we

phenotyped ruminal, fecal, and soil microbial communities by sequencing the V4 region of 16s
rRNA gene to characterize the gastrointestinal tract microbiome of cattle throughout the
production cycle in antibiotic treated and not treated animals.

MONENSIN/TYLOSIN FEEDING ALTERS BACTERIAL COMMUNITY
COMPOSITIION
Monensin and tylosin are major antimicrobials used in cattle production for limiting the effects
of ruminal acidosis and increase animal productivity (Clemmons et al., 2019). Often monensin
and tylosin are fed concurrently to cattle in North American feedlots (Thomas et al., 2017).
Monensin acts as an ionophore that disrupts ion flux across microbial membranes (Clemmons et
al., 2019). Meanwhile, tylosin is a macrolide antibiotic and bacteriacidal feed additive that
inhibits the growth of Fusobacterium necrophorum in the rumen to reduce liver abscess
occurrence (Thomas et al., 2017). These additives have been proven to improve feed efficiency,
reduce liver abscess incidence, and control coccidiosis (Thomas et al., 2017). However, the
understanding of how they precisely influence the microbial dynamics of their environments is
incomplete.

In the rumen, use of these antibiotic feed additives monensin and tylosin did not result in a
significant difference in alpha diversity from animals that were not fed monensin/tylosin (Figure
2.2a). The only significant differences observed were seen on day 64 (p < 0.05) based on the
Shannon-Weiner diversity index. However, in fecal samples, significant differences were
detected at all timepoints according to the Shannon-Weiner diversity index. Loss of bacterial
community diverseness as a result of antibiotic treatment has been reported both in human

studies (Dethlefsen & Relman, 2011) and in the bovine rumen (Thomas et al., 2017) and feces
(Weinroth et al., 2019). As such, contrary to other published findings (Thomas et al., 2017;
Weinroth et al., 2019), we did not find that that antibiotic-fed animals had numerically lower
species diversity or richness. While the lack of significant changes in alpha diversity of the
rumen suggests that antibiotics have a subtle effect on the microbiome diversity, there are also
other putative explanations for this observation, such as the dosage of the antibiotics used and
possible lack of an effect of these antibiotics on the microbial community composition that
would be reflected by this analysis.

PERMANOVA analysis of rumen and fecal microbiome beta diversity (Fig. 2.4a, 2.4b)
displayed significant differences (p < 0.05) between treatments, timepoints, and an interaction
between time and treatment. These results suggest that tylosin and monensin does affect bacterial
community composition with changes in certain taxa such as increased Prevotella abundance in
rumen samples in antibiotic-fed animals and a lower abundance of Paeniclostridium In fecal
samples in antibiotic-fed animals. The distinct clustering patterns based on timepoints also
indicate that the period of time after antibiotic administration plays a larger role than previously
thought in “between-sample” diversity. Additionally, the day effect and the interaction suggests
that bacterial composition over time may be a result of selection of microbes due to monensin
and tylosin exposure over time.

The Firmicutes phylum dominates with the highest percent read abundance in all treatment
groups of the rumen and fecal samples (Supplementary Data 2.1, Supplementary Data 2.2). At
the genera level, Prevotella was the most common genus in the rumen, regardless of treatment.

This was in accordance with several studies that describe Prevotella as being the most abundant
Bacteroidetes member found in the rumen (Fernando et al., 2010; Henderson et al., 2015; Mao et
al., 2015; Thomas et al., 2017). However, we observe that the abundance of the Prevotella to be
higher in the antibiotic-fed samples, suggesting that the rumen is responsive to antibiotic use.
Furthermore, it is well-established that the most abundant phyla in the fecal microbiota of cattle
is Firmicutes (Lopes et al., 2019; Palumbo et al., 2021), corroborating our observation. At the
genus level, the Clostridium genus was most abundant in antibiotic-fed samples (Supplementary
Data 2.2), although past research indicates Clostridium sensu stricto 1 to be ubiquiotous in the
feces of cattle (Boukerb et al., 2021). We also observe greater abundance of Paeniclostridium,
Lachnospiraceae, and Clostridium sensu stricto 1 in fecal samples of control animals as opposed
to those fed monensin/tylosin, further highlighting the disproportionate changes in taxa
composition as a result of antimicrobial treatment.

Further analysis was performed to identify differential ASV based on monensin/tylosin feeding.
We observed monensin/tylosin feeding to increase Prevotella, Succinivibrionaceae UCG-001,
Ruminococcaceae NK4A214, and Roseburia while Corynebacterium, Rikenellaceae, and
Lachnospiraceae were significantly more abundant in the antibiotic-free treatment group.
However, this was not consistent across day and may further support selection of microbes over
time during monensin/tylosin feeding (Figure 2.4a). The genus Ruminococcus is a core
component of the rumen microbial population (Thomas et al., 2017). We observe that monensin
and tylosin feeding to increases the abundance of the Ruminococcus genus in the rumen. This
could be beneficial to animals fed high-concentrate diet, as the increased fermentable substrates
in high concentrate diets are known to increase lactic acid production through fermentation by

members of the Ruminococcus genus (Thomas et al., 2017). Furthermore, this increase in
Ruminococcus abundance in antibiotic-fed cattle may aid the animal’s ability of inhibiting
pathogens by competitive exclusion, as studies in humans have reported the genus Ruminococcus
(along with Erysipelotrichaceae and Lachanospira) to play a critical role in limiting the growth
of enteric pathogens in the gut (Buffie & Pamer, 2013; Pamer, 2016). Increased abundances of
Prevotellaceae UCG-001, Prevotella, and Succinovibrionaceae were observed in antibiotic-fed
rumen samples. Prevotella can utilize lactic acid and convert it into propionic acid, as such could
have beneficial effects for the ruminant animal for energy as propionate is the only
gluconeogenic VFA produced by rumen microbes (Thomas et al., 2017). Additionally, the
decrease of lactic acid could lead to better ruminal conditions and may provide some insight into
how monensin/tylosin mechanistically help improve animal health and productivity. Higher
abundances of ASV belonging to the genera Lachnospiraceae, Solobacterium, and Turicibacter
were observed in the fecal microbiota of antibiotic-free animals (Figure 2.4b). Lachnospiraceae
and Solobacterium have been detailed to be members of the core rumen microbiome, but limited
information exists on their role in the fecal microbial community.

The network analysis of rumen samples displayed similar clustering in both treatment groups,
with Lactobacillaceae being identified as a common hub between the two treatment groups
(Figure 2.5). However, different hubs were identified in control animals (Erysipelotrichaceae,
Corynebacteriaceae, and Peptostreptococcaceae) compared to monensin/tylosin-fed animals
(Lachnospiraceae, Bacteroidaceae, and Muribaculaceae). The fact that members of the core
microbiome (in both sample types) did not co-occur or strongly associate with one another
suggests changes in bacterial community composition due to antibiotic feeding, with changes in

interactions within each community. This suggests selection to occur during monensin and
tylosin feeding and the selection to result in changes in the interactions between bacterial
populations.

SPECIES INTERACTIONS IN THE RUMEN AND FECES ARE ALTERED BY
ANTIBIOTIC TREATMENTS
In the beef industry, high-risk cattle are administered long-acting antibiotics as prophylactics to
reduce disease susceptibility and morbidity while improving rate of gain (Griffin et al., 2010). To
investigate the effects of injectable antibiotics on rumen and fecal microbiomes, we evaluated
bacterial community differences using amplicon sequencing in animals injected with ceftiofur
(Excede), tulathromycin (Draxxin), enrofloxacin (Baytril), florfenicol (Nuflor). Alpha-diversity
metrics with Observed and Shannon-Weiner indices showed no significant differences (p < 0.05)
in bacterial community composition between control and treated animals (Figure 2.7). However,
a decrease in diversity was observed between the two timepoints (day 0 vs. day 42) indicating
changes in alpha-diversity over time. No significant difference between treatment groups were
seen in fecal microbial composition for alpha-diversity. This lack of difference in alpha diversity
can be attributed to potential environmental effects or to the fact that injectable antibiotics may
have limited effect on the rumen and fecal microbiome diversity. However, PERMANOVA
analysis identified significant differences in bacterial community composition between
antibiotic-free and antibiotic-injected animals. Still, the effect of one specific antibiotic versus
another (i.e. Baytril versus Draxxin) were not statistically significant. Also, Draxxin was the only
antibiotic administered that did not have a significant influence over the antibiotic-free rumen

microbial community. This may be due to the fact that the antibiotics administered are broad
spectrum antibiotics that have a similar effect on the microbiome.

The differences in microbial communities between fecal samples from antibiotic-free and
antibiotic-treated samples were found to be statistically significant when accounting for
treatment and timepoint. While the post-hoc pairwise comparison for timepoints (i.e. day 0 vs
day 42, day 0 vs day 7, day 7 vs day 42) revealed significant results, pairwise comparison using
the ‘pairwise.adonis’ function for treatments did not, which begs the question of how a
significant PERMANOVA result could to lead to insignificant post-hoc results. While
uncommon, this situation can occur due to i) lack of statistical power (small number of groups),
ii) a weakly significant global effect (p-value is close to the significance level) or iii) having a
high number of factor levels.

Consistent with results from the earlier “antibiotic-feeding” study, Prevotella was the most
common genus in the rumen, regardless of antibiotic treatment, in agreement with past research
(Fernando et al., 2010; Henderson et al., 2015; Mao et al., 2015; Thomas et al., 2017). Prevotella
percent read abundance increased with antibiotic treatment. We observe the Clostridium genus to
be the most abundant in fecal samples, consistent with our previous results. However, abundance
decreased with antibiotic treatment. Clostridium spp. produce butyrate, a short chain fatty acid
(SCFA) that is used by epithelial cells in the GI tract of mammals as an energy source (Pryde et
al., 2002; Holman & Gzyl, 2019). In our network analysis, the Clostridium sensu stricto cluster
was predominant. Furthermore, it has been suggested that members of this cluster are the only
true representatives of the Clostridium genus (Holman & Gzyl, 2019). In comparison to fecal

samples, rumen samples also had a higher relative abundance of Lachnospiraceae NK3A20
(Kenters et al., 2011). As a close relative of Butyvibrio, its role is suspected to be in degrading
hemicelluloses in plant cell walls into SCFAs to promote the growth of rumen epithelial cells
(Mentschel et al., 2001).

Differentially abundant ASVs in both sample types were investigated to identify specific effects
of antibiotic administration on rumen and fecal bacterial communities. In the rumen, we
determined 279 ASVs as differential. Ruminococcaceae NK4A214 group, Prevotella,
Prevotellaceae UCG-004, Prevotellaceae UCG-001, and Rikenellaceae U-29 B03 were high in
abundance (Figure 2.11a). Higher abundance of ASV_182 and ASV_645 (belonging to the
Roseburia and Mogibacteirum genera, respectively) were recognized in antibiotic-treated
samples while higher abundance of ASV_289 (Prevotella) and ASV_76 (Olsenella) were seen in
the antibiotic-free samples at both timepoints. Lower abundance of Ruminococcaceae NK4A214
were observed in the injectible treatment groups at both timepoints. The Ruminococcaceae
NK4A214 group has been identified as part of the core microbiome and has been reported to be
present in the entire gastrointestinal tract of cattle (Pacifico et al., 2021). This taxon was only
recently added to the SILVA SSU database and its functional role in the rumen remains unclear
(Pacifico et al., 2021). However, members of this taxa are cellulolytic and produce acetate,
formate, and succinate from cellulose (Flint et al., 2008). Due to the functional and genetic
diversity of Prevotella spp., it is unsurprising that they are ubiquitous throughout the bovine gut
(Holman & Gzyl, 2019) as they carry hemicellulose-degrading enzymes that convert
hemicellulose into the short chain fatty acids (SCFAs) acetate, propionate, or succinate (Flint et
al., 2008; Holman & Gzyl, 2019).

In the fecal samples, distinct hierarchical clustering was observed in 3 groups, with ASV
belonging to the genera Caviibacterium, Enterococcus, Erysipelatoclostridium, Hungatella,
Mycoplasma, Roseomonas, Treponema, and Tuzzurella. We observe that certain ASVs belonging
to Mycoplasma, Hungatella, Enterococcus, Erysipelatoclostridium, and Cetobacterium to be
more abundant in Excede-treated animals. Excede, also known as ceftiofur, is a third-generation
cephalosporin that is commonly administered to feedlot cattle and lactating dairy cows for BRD
treatment, mastitis and “off-label” use to treat enteric diseases (Foster et al., 2019). It exerts its
antibacterial action by inhibiting cell wall synthesis and thus, Mycoplasma, lacking a cell wall, is
not affected by its administration. Furthermore, the Enterococcus genus possesses intrinsic
resistance to beta-lactam and cephalosporin drug classes, due to their low-affinity penicillinbinding proteins (PCPs) (Hollenbeck & Rice, 2012), explaining some of our observations in the
microbial community of Excede/ceftiofur-treated samples. While this antibiotic has been shown
to have significant and sustained effects on bacterial community (Foster et al., 2019), these
studies are limited to highlighting the reduction of the Firmicutes and increase in the
Bacteroidetes phyla, with no information on differential effects on specific taxa within this
phylum. Here we report the possible changes that occur within this taxon with antibiotic
treatment.

Finally, network analysis was performed to determine co-occurrences between bacterial taxa due
to the various antibiotic treatments on the last day of sample collection. Network comparison in
rumen samples showed that, antibiotic-free animals had numerically more clusters (as indicated
by the different cluster colors, Figure 2.12) when compared to each treatment group suggesting

functional variations within the microbial community. Furthermore, despite network analysis for
all treatment groups following the exact same filtration parameters, the antibiotic-free group
showed weaker repulsion between clusters, indicating that antibiotic treatment may reduce
interaction between groups that may be due to selection.

SOIL MICROBIOME UNDERGOES SELECTION DUE TO ANTIBIOTIC
TREATMENT
No significant alpha diversity changes were observed in treatment groups of soil samples. In
contrast, beta-diversity results showed clustering by treatment and timepoint, with timepoint
displaying very apparent separation. This observation was supported by post-hoc analysis that
confirmed statistically significant differences (p < 0.05) between all pairs of timepoints
(Supplementary 2.11). This suggests, like the rumen and fecal microbiomes, the soil microbiome
may be undergoing selection.

Our observation of the phyla Actinobacteria, Firmicutes, and Proteobacteria dominating all
observed taxa is supported by the literature (Jiao et al., 2019) which states Proteobacteria,
Acidobacteria, Actinobacteria, and Chloroflexi to be core taxa in the soil microbiome.
Furthermore, the Corynebacterium genus possessed higher relative abundance in antibiotic-free,
antibiotic-treated, and no animal control pens, in comparison with baseline samples suggesting
enrichment of genus Corynebacterium during antibiotic treatment and animal inhabitance.

Many published works focus on the application of manure or antibiotics directly onto soil
surfaces, finding that the community composition changes resulting from antibiotic use often last

throughout the experimental periods (Ding & He, 2010). However, diversity can recover quickly
once antimicrobial use is stopped (Westergaard et al., 2001; Zielezny et al., 2006). This is
supported by Westergaard et al. (2001) and Demoling & Baath (2008) who found that tylosin
addition to soil did not persist beyond 15 days when the selective pressure of the macrolide
antibiotic is removed. We observe certain differential taxa to be of higher abundance earlier in
the study (Comamonas, Fermentimonas) and certain taxa (Corynebacterium, Dietzia,
Luteimonas, Prevotellaceae) to be more abundant later in the study, regardless of whether soil
collection was from an antibiotic-free versus antibiotic-treated pen, leading us to speculate that
animal excretion is a primary factor affecting soil microbial community and that this effect
persists long-term.

2.8 CONCLUSION
Analysis of 16s rRNA gene datasets across 72 animals revealed that antimicrobial administration
leads to changes in the bacterial community composition. Such disturbances are likely critical in
animals like cattle, where it is thought the intestinal microbial community plays a large role in
the degradation of feedstuff. In addition to showing differences in antibiotic treated and untreated
animals, we were able to determine the effects of feed additives such as monensin/tylosin and
injectible antibiotics (i.e. Baytril, Draxxin, Excede, Nuflor) on the rumen, fecal and soil
microbial communities. In general, we found differences in microbial composition and
abundance (beta diversity) as opposed to species richness and evenness (alpha diversity). Also,
we found that the relative abundance of certain key species to be influenced by antibiotic
treatment such as i) increased Prevotella abundance in the rumen following monensin/tylosin
feeding and injectible treatment, ii) decreased Ruminococcus abundance, a key player in rumen

degradation, iii) reduced presence of Clostridium and Lachnospiraceae in fecal samples, and iv)
changes in interactions of different taxa as a result of selection due to antibiotic treatment.
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2.10 TABLES AND FIGURES
Antibiotic
Excede

Class
Cephalosporin

Compound
Ceftiofur
crystalline-free
acid

Mode of Action
Inhibition of cell wall
synthesis by binding
to penicillin-binding
proteins (Bui &
Preuss, 2022)

Use in Industry
Treatment of
bovine respiratory
disease (eBRD)

Draxxin

Macrolide

Tulathromycin

Inhibition of protein
synthesis by binding
to the 50S ribosomal
subunit (Kanoh &
Rubin, 2010)

Baytril

Fluoroquinolone

Enrofloxacin

Treatment of
bovine respiratory
disease (BRD) and
infectious bovine
keratoconjunctivitis
(IBK)
Treatment of
bovine respiratory
disease (BRD)

Inhibition of
replication and
transcription of DNA
by inhibiting DNA
gyrase (Ezelarab et
al., 2018)
Nuflor
Amphenicol
Florfenicol
Inhibition of protein
synthesis by binding
to 50S ribosomal
subunit (Wei et al.,
2016)
Table 2.1. Antibiotics administered to the animals in this study.

Treatment of
bovine respiratory
disease (BRD) and
bovine interdigital
phlegmon

A

B

C

Figure 2.1. Timepoint of sample collection based on the time period when animals were a) fed
antibiotics (Monensin/Tylosin) (Phase I), b) injected 1 of 4 antibiotic treatments (Excede,
Draxxin, Baytril, Nuflor) (Phase II), and c) when soil samples were collected.

Sample Type

Rumen
Fecal

Phase 1: Antibiotic-Fed Study
Reads retained Total ASVs
identified
1, 430, 437
621
(90.8% retained)
6, 619, 827
1216
(86.6% retained)

Phase 2: Antibiotic-Injected Study
Reads retained
Total ASVs
identified
1, 716, 342
640
(91.2% retained)
5, 769, 463
1203
(83.7% retained)

Table 2.2. Number of reads retained and total ASVs following all filtration steps for
fecal and rumen samples for each experiment timeline.
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Figure 2.2a. Boxplots showing Observed and Shannon-Weiner’s α-diversity indices of bacterial
communities in rumen samples of antibiotic-free and antibiotic-fed cattle between two
timepoints. Treatment means were compared using Kruskal-Wallis test to identify differences in
species richness and evenness between treatment groups. A significant difference between
treatment groups was detected (p < 0.05) at day 64 according to the Shannon-Weiner index.
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Figure 2.2b. Boxplots showing Observed and Shannon-Weiner’s α-diversity indices of bacterial
communities in fecal samples of antibiotic-free and antibiotic-fed cattle at three timepoints.
Treatment means were compared using Kruskal-Wallis test to identify differences in species
richness and evenness between treatment groups. Significant differences between treatment
groups were detected (p < 0.05) at all timepoints according to the Shannon-Weiner index.
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Figure 2.3.a. Beta-diversity metrics of bacterial communities in rumen samples from
cattle that had been treated with oral antibiotics. No significant clustering was seen in
samples between treatments and timepoints except for the stratification of points
between days 64 and 134. Principal coordinate plot using Bray-Curtis distances are
shown, with each point representing a bacterial community of a rumen sample.
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Figure 2.3.b. Beta-diversity metrics of bacterial communities in fecal samples from
cattle that had been treated with oral antibiotics. Significant clustering was seen on day
0 and days 64 and 134. Principal coordinate plot using Bray-Curtis distances are shown,
with each point representing a bacterial community of a rumen sample.
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Figure 2.4.a. Heatmap of all differentially abundant ASV between antibiotic free and antibiotic-fed cattle in rumen samples.
Differential ASV were identified using DESeq2. Tiles in the heatmap are colored by variance stabilized transformations of read
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counts, with deeper colors indicating a higher abundance of the organism within a sample. Hierarchical clustering of variance
stabilized read count data was performed.
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Figure 2.4.b. Heatmap of all differentially abundant ASV between antibiotic free and antibiotic-fed cattle in fecal samples.
Differential ASV were identified using DESeq2. Tiles in the heatmap are colored by variance stabilized transformations of read
counts, with deeper colors indicating a higher abundance of the organism within a sample. Hierarchical clustering of variance
stabilized read count data was performed.
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Figure 2.5. Network analysis of rumen bacterial community at family level using SparCC
associations. Correlations below a threshold of 0.3 were considered as zero for the SparCC
loop. Clusters indicate close associations between taxa. Green edges correspond to positive
estimated associations and red edges to negative ones. Eigenvector centrality is used for
defining hubs (nodes with a centrality value above the empirical 95% quantile) and scaling
node sizes. Hubs are highlighted by bold text and borders, while node colors are classified by
phyla using greedy modularity optimization. Networks are reduced, where only the top 50 taxa
with the highest variance are shown. Unconnected nodes in both networks are removed.
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Figure 2.6. Network analysis of fecal bacterial community at family level using SparCC
associations. Correlations below a threshold of 0.3 were considered as zero for the SparCC loop.
Clusters indicate close associations between taxa. Green edges correspond to positive estimated
associations and red edges to negative ones. Eigenvector centrality is used for defining hubs
(nodes with a centrality value above the empirical 95% quantile) and scaling node sizes. Hubs
are highlighted by bold text and borders, while node colors are classified by phyla using greedy
modularity optimization. Networks are reduced, where only the top 50 taxa with the highest
variance are shown. Unconnected nodes in both networks are removed.

A

Treatment

AbxFree

Baytril

Draxxin

Kruskal−Wallis, p = 0.94

Excede

Nuflor

Kruskal−Wallis, p = 0.52

Observed

300

200

100

0
Day_0

Day_42

DayOfStudy

B

Treatment

AbxFree

Baytril

Draxxin

Kruskal−Wallis, p = 0.79

Excede

Nuflor

Kruskal−Wallis, p = 0.32

Shannon

4

3

2

Day_0

Day_42

DayOfStudy

Figure 2.7. Boxplots showing Observed (A) and Shannon-Weiner’s (B) α-diversity indices of
bacterial communities in rumen samples from antibiotic-free and antibiotic-injected cattle at the
day of injection and 42 days post-injection. Treatment means were compared using KruskalWallis to identify differences in species richness and evenness between treatment groups. No
significant differences between treatment groups were detected (p > 0.05).
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Figure 2.8. Boxplots showing Observed (A) and Shannon-Weiner’s (B) α-diversity indices of
bacterial communities in fecal samples from antibiotic-free and antibiotic-injected cattle at the
day of injection, 7 days post-injection and 42 days post-injection. Treatment means were
compared using Kruskal-Wallis to identify differences in species richness and evenness
between treatment groups. No significant differences between treatment groups were detected
(p > 0.05).
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Figure 2.9. Beta-diversity metrics of bacterial communities in rumen samples from cattle that
had been injected with antibiotics. No significant clustering was seen in samples according to
timepoint (A) or treatment (B). Principle coordinate plots using Bray-Curtis distances are shown,
with each point representing a bacterial community of a rumen sample.
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Figure 2.10. Beta-diversity metrics of bacterial communities in fecal samples from cattle that
had been injected with antibiotics. No significant clustering was seen in samples according to
timepoint (A) or treatment (B). Principle coordinate plots using Bray-Curtis distances are shown,
with each point representing a bacterial community of a rumen sample
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Figure 2.11.a. Heatmap of top 50 differentially abundant ASV between antibiotic free and antibiotic- injected rumen samples.
Differential ASV were identified using DESeq2. Tiles in the heatmap are colored by variance stabilized transformations of read
counts, with deeper colors indicating a higher abundance of the organism within a sample. Hierarchical clustering of variance
stabilized read count data was performed.
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Figure 2.11.b. Heatmap of differentially abundant ASV between antibiotic free and antibiotic-injected fecal samples. Differential
ASV were identified using DESeq2. Tiles in the heatmap are colored by variance stabilized transformations of read counts, with
deeper colors indicating a higher abundance of the organism within a sample. Hierarchical clustering of variance stabilized read count
data was performed.
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Figure 2.12. Network analysis of rumen bacterial community for (A) antibiotic-free, (B) Baytrilinjected, (C) Draxxin-injected, (D) Excede-injected, and (E) Nuflor-injected animals at family
level on the last day of sample collection using SparCC associations. Correlations below a
threshold of 0.3 were considered as zero for the SparCC loop. Clusters are shown by the same
colors and indicate close associations between taxa. Nodes are labelled as family level taxonomic
classification. Green edges correspond to positive estimated associations and red edges to
negative ones. Eigenvector centrality is used for defining hubs (nodes with a centrality value
above the empirical 95% quantile) and scaling node sizes. Hubs are highlighted by bold text and
borders, while node colors are classified by phyla using greedy modularity optimization.
Networks are reduced, where only the top 50 taxa with the highest variance are shown.

A

Coriobacteriaceae

Lactobacillaceae
Ruminococcaceae Eubacteriaceae

Lachnospiraceae

[Eubacterium] coprostanoligenes group

Eggerthellaceae
Clostridiaceae

Bifidobacteriaceae

Tannerellaceae

Anaerovoracaceae

Enterobacteriaceae

Corynebacteriaceae
Erysipelatoclostridiaceae

Oscillospiraceae
Erysipelotrichaceae

Bacteroidaceae
Atopobiaceae

Saccharimonadaceae

Peptostreptococcaceae
Streptococcaceae

Muribaculaceae
Monoglobaceae
Dietziaceae
Spirochaetaceae

UCG−010

Steroidobacteraceae
Microbacteriaceae

Bacteroidales UCG−001
Burkholderiaceae

Rikenellaceae
Prevotellaceae

Moraxellaceae

Oxalobacteraceae
Rubritaleaceae
Bacteroidales RF16 group

Fibrobacteraceae

Acidaminococcaceae

Rhodobacteraceae

Selenomonadaceae
Veillonellaceae

Beijerinckiaceae
Comamonadaceae

Hungateiclostridiaceae

Bacteroidales BS11 gut group
Succinivibrionaceae
p−251−o5
Flavobacteriaceae

B

F082

Acidaminococcaceae
Succinivibrionaceae
Hungateiclostridiaceae
Fibrobacteraceae
Moraxellaceae

Selenomonadaceae
F082
Pasteurellaceae

p−251−o5
Flavobacteriaceae

Oxalobacteraceae
Bacteroidales BS11 gut group

vadinBE97

Prevotellaceae

Veillonellaceae

Bacteroidales RF16 group
Sphingomonadaceae

Comamonadaceae
Rhodobacteraceae

Microbacteriaceae

Xanthomonadaceae
Bacteroidales UCG−001

Rubritaleaceae

Steroidobacteraceae

Burkholderiaceae
Christensenellaceae

Methylophilaceae

UCG−010

Erysipelatoclostridiaceae

Corynebacteriaceae
Erysipelotrichaceae

Eubacteriaceae

Atopobiaceae

Spirochaetaceae
Monoglobaceae
Rikenellaceae
Oscillospiraceae

Lactobacillaceae
Ruminococcaceae

Clostridiaceae

Peptostreptococcaceae

Saccharimonadaceae
Anaerovoracaceae
Muribaculaceae

Streptococcaceae

[Eubacterium] coprostanoligenes group
Lachnospiraceae

Bifidobacteriaceae
Eggerthellaceae
Enterobacteriaceae

C

Bacteroidales UCG−001

Erysipelatoclostridiaceae
Steroidobacteraceae

Methylophilaceae

Burkholderiaceae

Ruminococcaceae
[Eubacterium] coprostanoligenes group

Pseudomonadaceae

Rhodobacteraceae

Atopobiaceae
Oscillospiraceae
Anaerovoracaceae

Eggerthellaceae
Veillonellaceae

Lactobacillaceae
Lachnospiraceae

Bifidobacteriaceae
Beijerinckiaceae
Sporichthyaceae
Saccharimonadaceae

Dietziaceae

Monoglobaceae

Erysipelotrichaceae

Oxalobacteraceae

Microbacteriaceae

Clostridiaceae

Muribaculaceae
Corynebacteriaceae

Enterobacteriaceae

F082

Xanthomonadaceae

Sphingomonadaceae

Selenomonadaceae
p−251−o5
Rubritaleaceae
Bacteroidales RF16 group

Peptostreptococcaceae

Christensenellaceae

Succinivibrionaceae

Prevotellaceae

Fibrobacteraceae

Spirochaetaceae

Comamonadaceae

Acidaminococcaceae
Flavobacteriaceae
Rikenellaceae
UCG−010
Moraxellaceae

D

Hungateiclostridiaceae
Bacteroidales BS11 gut group

Christensenellaceae
Saccharimonadaceae

Enterobacteriaceae
Veillonellaceae
Rhodobacteraceae

Bacteroidaceae

Rhodocyclaceae

Hungateiclostridiaceae
Spirochaetaceae

Comamonadaceae

Erysipelatoclostridiaceae

Oscillospiraceae
Bacteroidales RF16 group

Xanthomonadaceae

F082
Muribaculaceae

Flavobacteriaceae

Lachnospiraceae

Ruminococcaceae

Oxalobacteraceae
Microbacteriaceae

Bacteroidales BS11 gut group
[Eubacterium] coprostanoligenes group

Lactobacillaceae

Prevotellaceae

Monoglobaceae

Pasteurellaceae
Burkholderiaceae

Atopobiaceae
Tannerellaceae
Anaerovoracaceae

p−251−o5

Selenomonadaceae

Clostridiaceae

Bacteroidales UCG−001
Eubacteriaceae

Eggerthellaceae

Corynebacteriaceae Peptostreptococcaceae

Fibrobacteraceae

Rubritaleaceae

Acidaminococcaceae

Bifidobacteriaceae

Succinivibrionaceae
Dietziaceae

Erysipelotrichaceae
Rikenellaceae
Moraxellaceae
UCG−010

Sphingomonadaceae

E

Tannerellaceae
Muribaculaceae

Erysipelatoclostridiaceae

Eubacteriaceae

UCG−010

Bacteroidaceae

Monoglobaceae

Ruminococcaceae

Atopobiaceae

Prevotellaceae

Oscillospiraceae

Bifidobacteriaceae
Lachnospiraceae

Rhodobacteraceae

Enterobacteriaceae
Clostridiaceae

Erysipelotrichaceae
Corynebacteriaceae

Microbacteriaceae
Coriobacteriales Incertae Sedis

[Eubacterium] coprostanoligenes group

Sporichthyaceae

Anaerovoracaceae
Peptostreptococcaceae
Eggerthellaceae

Xanthomonadaceae
Moraxellaceae

Lactobacillaceae
Oxalobacteraceae

Bacteroidales BS11 gut group

Dietziaceae
Christensenellaceae

Sphingomonadaceae
Selenomonadaceae

Coriobacteriaceae

Rubritaleaceae

Bacteroidales RF16 group

Beijerinckiaceae
Fibrobacteraceae
Comamonadaceae

Saccharimonadaceae
Flavobacteriaceae
Streptococcaceae

p−251−o5

Acidaminococcaceae

Hungateiclostridiaceae
Succinivibrionaceae

F082

Spirochaetaceae

Rikenellaceae

Figure 2.13. Network analysis of fecal bacterial community for (A) antibiotic-free, (B) Baytrilinjected, (C) Draxxin-injected, (D) Excede-injected, and (E) Nuflor-injected animals at family
level on the last day of sample collection using SparCC associations. Correlations below a
threshold of 0.3 were considered as zero for the SparCC loop. Clusters are shown by the same
colors and indicate close associations between taxa. Nodes are labelled as family level taxonomic
classification. Green edges correspond to positive estimated associations and red edges to
negative ones. Eigenvector centrality is used for defining hubs (nodes with a centrality value
above the empirical 95% quantile) and scaling node sizes. Hubs are highlighted by bold text and
borders, while node colors are classified by phyla using greedy modularity optimization.
Networks are reduced, where only the top 50 taxa with the highest variance are shown.
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Figure 2.14. Boxplots showing Observed (A) and Shannon-Weiner’s (B) α-diversity indices of
baseline soil bacterial communities.
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Figure 2.15. Boxplots showing Observed (A) and Shannon-Weiner’s (B) α-diversity indices of
soil bacterial communities between control, antibiotic-treated, and no animal control groups.
Treatment means were compared using Kruskal-Wallis to identify differences in species
richness and evenness between treatment groups. No significant differences between treatment
groups were detected (p > 0.05) except on day 226 according to the Shannon-Weiner index.
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Figure 2.16. Beta-diversity metrics of bacterial communities in soil/runoff samples. No
significant clustering was seen in samples according to timepoint (A) or treatment (B). Principle
coordinate plots using Bray-Curtis distances are shown, with each point representing a bacterial
community of a soil sample.
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Figure 2.17 Heatmap of top 50 differentially abundant ASV between antibiotic free and treatment groups of soil samples.
Differential ASV were identified using DESeq2. Tiles in the heatmap are colored by variance stabilized transformations of read
counts, with deeper colors indicating a higher abundance of the organism within a sample. Hierarchical clustering of variance
stabilized read count data was performed.

2.11 SUPPLEMENTARY DATA
Supplementary Data 2.1. Heatmap of relative abundance, based on read counts at the a)
phylum and b) genus level in rumen samples of animals that were fed Monensin/Tylosin
(AbxFed) and control animals (AbxFree).
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Supplementary Data 2.2. Heatmap of relative abundance, based on read counts at the a)
phylum and b) genus level in fecal samples of animals that were fed Monensin/Tylosin
(AbxFed) and control animals (AbxFree).
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Supplementary Data 2.3. Permutational multivariate analysis of variance (PERMANOVA)
based on Bray-Curtis distances between rumen and fecal microbiome samples (999)
permutations from control animals and animals that were fed Monensin/Tylosin. The statistical
model takes into account timepoint, treatment, and the interaction between them. Significance
is determined at p < 0.05.
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16s Rumen Antibiotic-Fed PERMANOVA using a Bray-Curtis dissimilarity matrix
Permutational multivariate analysis of variance based on Bray-Curtis distances between rumen microbiome samples (999 permutations) from animals that were antibioticfree versus animals fed Monensin/Tylosin The statistical model takes into account day of study, treatment, and the interaction between them. Significance is determined at
p < 0.05.
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16s Fecal Antibiotic-Fed PERMANOVA using a Bray-Curtis dissimilarity matrix
Permutational multivariate analysis of variance based on Bray-Curtis distances between fecal microbiome samples (999 permutations) from animals that were antibioticfree versus animals orally fed tylosin/monensin. The statistical model takes into account day of study, treatment, and the interaction between them. Significance is
determined at p < 0.05.

Supplementary Data 2.4. Results from testing centralities of the networks of rumen samples
in Figure 2.5 in the main text for group differences. Shown are respectively the computed
measure for antibiotic-free and antibiotic-fed treatment groups, the absolute differences, and
the adjusted p-value according to the Benjamini-Hochberg method. For all four measures, the
values are normalized.
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Supplementary Data 2.5. Results from testing centralities of the networks of fecal samples in
Figure 2.6 in the main text for group differences. Shown are respectively the computed
measure for antibiotic-free and antibiotic-fed treatment groups, the absolute differences, and
the adjusted p-value according to the Benjamini-Hochberg method. For all four measures, the
values are normalized.
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Supplementary Data 2.6. Heatmap of relative abundance, based on read counts at the a) phylum
and b) genus level in rumen samples of animals that were administered 1 of 4 antibiotic
injections: Baytril, Draxxin, Excede, Nuflor and control animals (AbxFree).
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Supplementary Data 2.7. Heatmap of relative abundance, based on read counts at the a) phylum
and b) genus level in fecal samples of animals that were administered 1 of 4 antibiotic injections:
Baytril, Draxxin, Excede, Nuflor and control animals (AbxFree).
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Supplementary Data 2.8a. PERMANOVA of Antibiotic-Injected Rumen Samples.
Df
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F.Model

R2

Pr(>F)

Treatment

4

1.3324304

0.3331076

1.562701

0.0417667

0.005

DayOfStudy

1
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143

31.9017148
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1.0000000
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16s Rumen Antibiotic-Injected PERMANOVA using a Bray-Curtis dissimilarity matrix
Permutational multivariate analysis of variance based on Bray-Curtis distances between rumen microbiome samples (999 permutations) from animals that were antibioticfree versus animals injected with antibiotics. The statistical model takes into account day of study, treatment, and the interaction between them. Significance is determined
at p < 0.05.

Supplementary Data 2.8b. Pairwise Comparison of Antibiotic Treatments in Rumen Samples.
pairs
Df
SumsOfSqs
F.Model
R2
p.value
p.adjusted sig
AbxFree vs Excede
1
0.5110204
2.4144498
0.0267042
0.006
0.0433333 .
AbxFree vs Baytril
1
0.4121210
1.9108465
0.0212527
0.013
0.0433333 .
AbxFree vs Nuflor
1
0.4610480
2.1510048
0.0238600
0.010
0.0433333 .
AbxFree vs Draxxin
1
0.4196970
1.9483431
0.0216607
0.021
0.0525000
Excede vs Baytril
1
0.1664902
0.7349394
0.0211585
0.805
0.9950000
Excede vs Nuflor
1
0.1444659
0.6475856
0.0186906
0.930
0.9950000
Excede vs Draxxin
1
0.1212903
0.5370225
0.0155492
0.970
0.9950000
Baytril vs Nuflor
1
0.1477986
0.6329758
0.0182767
0.947
0.9950000
Baytril vs Draxxin
1
0.1248386
0.5283696
0.0153025
0.982
0.9950000
Nuflor vs Draxxin
1
0.1151215
0.4944672
0.0143347
0.995
0.9950000
16s Rumen Treatments - Pairwise PERMANOVA
Permutational multivariate analysis of variance based on Bray-Curtis distances between timepoints of 16s rumen microbiome samples (999 permutations). The statistical
model performs a pairwise comparison between treatments. Significance is determined at p < 0.05.

Supplementary Data 2.9a. PERMANOVA of Antibiotic-Injected Fecal Samples.
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16s Fecal Antibiotic-Injected PERMANOVA using a Bray-Curtis dissimilarity matrix
Permutational multivariate analysis of variance based on Bray-Curtis distances between fecal microbiome samples (999 permutations) from animals that were antibioticfree versus animals injected with antibiotics. The statistical model takes into account day of study, treatment, and the interaction between them. Significance is determined
at p < 0.05.

Supplementary Data 2.9b. Pairwise Comparison of Antibiotic Treatments in Fecal Samples.
pairs
Df
SumsOfSqs
F.Model
R2
p.value
p.adjusted sig
AbxFree vs Excede
1
0.7176647
2.7095447
0.0208893
0.023
0.1150000
AbxFree vs Draxxin
1
0.7716589
2.9108915
0.0225806
0.014
0.1150000
AbxFree vs Nuflor
1
0.4995843
1.9524750
0.0152594
0.050
0.1375000
AbxFree vs Baytril
1
0.5224305
2.0091168
0.0155734
0.055
0.1375000
Excede vs Draxxin
1
0.3621223
1.0878283
0.0217184
0.310
0.3755556
Excede vs Nuflor
1
0.2566699
0.8301812
0.0166602
0.621
0.6210000
Excede vs Baytril
1
0.3289257
1.0321902
0.0202263
0.338
0.3755556
Draxxin vs Nuflor
1
0.4755334
1.5305444
0.0309010
0.108
0.2160000
Draxxin vs Baytril
1
0.3963257
1.2371543
0.0246263
0.212
0.3533333
Nuflor vs Baytril
1
0.3388704
1.1423604
0.0227823
0.270
0.3755556
16s Fecal Treatments - Pairwise PERMANOVA
Permutational multivariate analysis of variance based on Bray-Curtis distances between treatments of 16s fecal microbiome samples (999 permutations). The statistical
model performs a pairwise comparison between treatments. Significance is determined at p < 0.05.

Supplementary Data 2.9c. Pairwise Comparison of Timepoints in Fecal Samples.
pairs
Df
SumsOfSqs
F.Model
R2
p.value
p.adjusted sig
Day_0 vs Day_42
1
1.899621
8.840582
0.0618913
0.001
0.001 **
Day_0 vs Day_7
1
5.100047
19.694541
0.1273125
0.001
0.001 **
Day_42 vs Day_7
1
1.726888
5.652340
0.0401866
0.001
0.001 **
16s Fecal Timepoints - Pairwise PERMANOVA
Permutational multivariate analysis of variance based on Bray-Curtis distances between timepoints of 16s fecal microbiome samples (999 permutations). The statistical
model performs a pairwise comparison between timepoints. Significance is determined at p < 0.05.

Supplementary Data 2.10. Heatmap of relative abundance, based on read counts at the a)
phylum and b) genus level in soil samples of animals that were administered 1 of 4 antibiotic
injections: Baytril, Draxxin, Excede, Nuflor and control animals (AbxFree).
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Supplementary Data 2.11a. PERMANOVA of Baseline, Antibiotic-Free, AntibioticTreated, and No-Animal Control soil samples.
Df
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F.Model
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Pr(>F)

Treatment

3

6.6239984
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0.001
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Note:
Permutational multivariate analysis of variance based on Bray-Curtis distances between soil/runoff microbiome samples (999 permutations) from pens of animals that were
antibiotic-free versus animals treated witha antibiotics. The statistical model takes into account day of study, treatment, and the interaction between them. Significance is
determined at p < 0.05.

Supplementary Data 2.11b. Pairwise Comparison of Antibiotic Treatments in Soil Samples.
pairs

Df

SumsOfSqs

F.Model

R2

p.value

p.adjusted

sig

AbxFree vs Baseline

1

4.4615463

20.906881

0.3489896

0.001

0.0015

AbxFree vs AbxTreated

1

0.3760388
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0.0448861
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*
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1
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0.1541281
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*

*

16s Soil Treatments - Pairwise PERMANOVA
Permutational multivariate analysis of variance based on Bray-Curtis distances between treatments of 16s soil microbiome samples (999 permutations). The statistical
model performs a pairwise comparison between treatments. Significance is determined at p < 0.05.

Supplementary Data 2.11c. Pairwise Comparison of Timepoints of Soil Samples.
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0.0014286

*

Day_172 vs Day_226

1

2.8816145

31.787400
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*

Day_172 vs Day_42

1

0.6005940
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0.2952100
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*

Day_195 vs Day_0

1

5.3961786

33.396469

0.4550147
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0.0014286

*

Day_195 vs Day_226

1
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32.885212

0.5147547

0.001

0.0014286

*

Day_195 vs Day_42

1
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0.2552502
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0.0025000
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Day_0 vs Day_226

1

4.9170682

31.050364

0.5004058

0.001

0.0014286

*

Day_0 vs Day_42

1

0.7436722

3.407173

0.1341028

0.001

0.0014286

*

Day_226 vs Day_42

1
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17.100622

0.5681152

0.004

0.0044444

*

16s Soil Timepoints - Pairwise PERMANOVA
Permutational multivariate analysis of variance based on Bray-Curtis distances between timepoints of 16s soil microbiome samples (999 permutations). The statistical
model performs a pairwise comparison between timepoints. Significance is determined at p < 0.05.

CHAPTER 3: AMPLICON-BASED SEQUENCING OF AMR GENE
VARIANTS

3.1 ABSTRACT
Antimicrobial resistance (AMR) is recognized as a significant and inevitable threat to human and
animal health, with trends in global AMR showing no signs of slowing down (Dadgostar, 2019).
In the year 2010, 63,200 tons of antibiotics were used in livestock production globally, far
surpassing what is used for human consumption (Dadgostar, 2019). Despite its importance, little
is known regarding the emergence and spread of AMR. Current explorations of AMR genes and
their abundance have utilized real-time or conventional PCR-based analyses of AMR genes.
However, such approaches fail to identify variants within AMR genes and whether certain
variants are transmitted faster or are fixed in a given environment. As such, to identify AMR
gene diversity within most abundant AMR genes identified, we developed an amplicon-based
sequencing strategy to evaluate AMR genes and their variants. Such AMR gene variants can be
informative in identifying functional and nonfunctional variants, as well as to identify variants
that are most abundant. Additionally, correlating with 16S rDNA-based community profiling
could help predict potential carriers of AMR genes. As such, this strategy provides novel
opportunities for linking AMR genes to taxonomy.

As a proof of concept, in this study, we targeted AMR genes that confer resistance to macrolides
(ermB), sulfonamides (sul1), and tetracyclines (tetW), which represent the most utilized
antimicrobial classes in the American beef production system (Agga et al., 2019). Therefore, we
evaluated AMR genes belonging to these broad AMR groups by targeting TetW, ermB, sul1
gene variants in rumen and fecal samples of 72 beef animals, as well as soil samples from their
pens across multiple time points. We identified no differences in in AMR richness across the
AMR genes detected. However, AMR gene abundance was different across treatments and day.
Very few differential ASV were identified in the TetW and sul1 gene, with a much higher

abundance of differential ASV observed in the ermB gene, suggesting gene enrichment and
selection based on antimicrobial used. Furthermore, we show that amplicon-sequencing of AMR
genes expands the information that can be gathered when compared to traditional real-time PCR
analysis and can be used as a valuable tool to predict taxonomy and gene variants that are
abundant and important to each environment.

3.2 INTRODUCTION
Antimicrobials have historically been essential drugs that have helped drastically reduce the
mortality of infectious diseases. However, in recent years, antimicrobial resistance (AMR)
resulting from overuse of antimicrobials has been recognized as a significant and inevitable
threat to human and animal health. Infections stemming from antimicrobial-resistant pathogens
have been correlated with severe morbidity, mortality, and healthcare costs (Weis et al., 2022).
According to estimates by the US Center for Disease Control and Prevention (CDC), more than
2.9 million people experience antibiotic-resistant infections, with almost 36,000 deaths due to
infection each year (CDC, 2019).

Emergence and spread of AMR is believed to be the result of overuse and misuse of antibiotics
of clinical importance in human health, as well as agriculture, including livestock and poultry
(Canica et al., 2015). In food animals, antimicrobial drugs are used for one of four purposes:
treatment, metaphylaxis, prophylaxis, and growth promotion, making up 73% of all
antimicrobial use (Innes et al., 2020; Criscuolo et al., 2021). Additionally, beef cattle are often
administered antibiotics for the treatment of bovine respiratory disease (BRD) and liver abscess
prevention (Weinroth et al., 2019). Direct correlation exists between antimicrobial use and

resistance in countries with high levels of antibiotic use (van der Velden et al., 2013). The rise of
antimicrobial use and resistance in food animals is concerning for not only the future of animal
health, but also for the large global population that relies on these animals for subsistence
(Criscuolo et al., 2021). There exists an expanding body of literature suggesting that resistant
bacteria can transfer between animals to humans, thus causing drug-resistant zoonotic infections
in humans (Tang et al., 2017).

Spread of AMR is a complex phenomenon, and its mechanisms beyond horizontal gene transfer
(HGT) are not well-understood. In the past, approaches for AMR detection relied upon culturing
of microbes under the presence of specific antimicrobial compounds to determine resistance and
to identify biochemical characteristics (Galhano et al., 2021). These methods are targeted
towards a specific microbial culture and allow for determination of minimum inhibitory
concentrations (MIC) and fractional inhibitory concentrations (FIC) that act as metrics to
characterize AMR gene activity. However, not only are these methods tedious, they are also
restricted to bacterial species that are culturable, and provide little information about resistance
mechanisms (Galhano et al., 2021). As a result, culture-independent molecular methods based on
amplification of target genes (i.e. PCR, real-time PCR, multiplex PCR, random amplified
polymorphic DNA (RAPD), and next-generation metagenome sequencing have become popular
to surpass the problem of culturing unculturable microbes (Galhano et al., 2021). While these
methods have improved AMR detection capabilities, these methods fail to identify the ecology,
gene diversity, and functionality of AMR gene populations.

In this study, we propose amplicon-based sequencing of AMR genes built on the same
foundation as high-throughput sequencing of 16s rRNA gene fragments to identify AMR gene
diversity and ecology. By using a sequence-based approach and multiplexing a large number of
samples, this approach allows a low-cost approach to identify AMR gene variants, diversity,
functionality and ecology in a given ecosystem. Here, we show the application of this approach
to identify AMR genes in a beef cattle production system to i) identify the effect of antibiotic
exposure on AMR gene ecology, ii) evaluate changes/enrichment of AMR genes due to selection
pressures caused by antibiotic use, and iii) to identify functional variants that are fixed in the
environment.

3.3 MATERIALS AND METHODS
3.3.1 EXPERIMENTAL DESIGN
All animal handling treatment procedures, protocols, and husbandry practices were conducted in
accordance with regulations by the Institutional Animal Care and Use Committee (IACUC).
Briefly, 72 steers (18 pens with 4 head per pen) were utilized at a feedlot facility at U.S. Meat
Animal Research Center (USMARC) where the cattle population had never received antibiotics
(including in-utero). Following weaning, the 72 steers were sorted into 9 replicate pens of 4
steers per treatment at the USMARC facility, with antibiotic-free steers housed on the east side
of the building and conventional steers on the west side with 3 empty pens separating the two
treatment groups. Conventional steers were fed a growing diet supplemented with Monensin and
Tylosin while antibiotic-free steers were fed the same diet without supplementation of Monensin
and Tylosin.

This study was conducted in two phases with “Phase 1: Antibiotic-Fed Study” referring to the
growing phase in which animals were fed Monensin and Tylosin with no further antibiotic
treatment while “Phase 2: Antibiotic-Injected Study” referes to the finishing phase. In this phase,
each animal in the conventional pen was treated with 1 of 5 injectable antibiotics (Baytril,
Draxxin, Excede, Nuflor - Table 3.1) with one animal per pen left untreated and acting as the
negative control. This publication focuses on the effect of administering these injectable
antibiotics and thus, is limited to the finishing phase.

Rumen and fecal samples were collected on the first day of antibiotic administration (day 0) and
42 days after (day 42). Soil/runoff samples were collected prior to any animal entry into the pen
(day 0), followed by collection on days 172, 196, and 226. Soil and runoff samples were
analyzed as one sample type. Floor surface material (FSM) samples were collected at baseline
(day 0), followed by collection at days 141 and 154. Pen surface samples were collected by
randomly sampling 10 locations within each pen and pooled to obtain a representative sample.
Rumen samples were collected from each animal using esophageal tubing as described by Paz et
al., 2016. All samples were snap frozen in liquid nitrogen until used for microbial community
analysis.

3.3.2 DNA EXTRACTION
DNA was extracted from all samples collected using the Mag-Bind® Stool DNA 96 Kit (Omega
Bio-tek Inc., Norcross, GA, USA) according to the manufacturer’s protocol with some
modifications. To lyse and homogenize samples, a bead-beating step was added using a
TissueLyser (Qiagen Inc., Valencia, CA, USA) for 10 minutes at 20 Hz. Following lysis and

inhibitor removal, nucleic acids were precipitated using isopropanol as described by Yu and
Morrison (2004). The resulting DNA pellets were further purified using magnetic bead-based
purification using the KingFisher™ Flex Purification System (ThermoFisher Scientific, Lenexa,
KS). The resulting DNA was stored at −20°C until used for library preparation for ampliconbased sequencing of the AMR genes.

3.3.3 PRIMER DESIGN OF TARGET GENES
Barcoded AMR gene sequencing assays were prepared similar to the 16s rRNA-based
sequencing strategy described by Kozich et al. (2013), where the universal 16S primers were
replaced by universal AMR primers. Additionally, the corresponding sequencing and index
primers were also synthesized for custom sequencing. The modified forward primer design
included <Illumina adaptor sequence sequence><8bp index><10bp pad><2bp linker><universal
resistance gene forward primer>. Similarly, the reverse primer will include <Illumina adaptor
sequence><8bp index><10bp pad><2bp linker><universal resistance gene reverse primer>
(Figure 3.1). The assays included barcoded regions to allow multiplexing 384 sample-gene
combinations in each Illumina Miseq run.

3.3.4 AMPLIFICATION OF TARGETED AMR GENES
Following DNA extraction, the resulting DNA was used to identify a variety of AMR genes to
assess how antibiotic treatment affected diversity and ecology of resistance genes in beef cattle.
The primers used are summarized in Table 3.1, and include sul1, ermB, and TetW. These
targeted genes included “highly” and “critically important” resistance genes conferring resistance
to antibiotics used in animal production. Briefly, the PCR reactions contained 0.75 units of Terra

PCR Direct Polymerase Mix (Clontech Laboratories Inc., Mountain View, CA, USA), 1X Terra
PCR Direct Buffer (Clontech Laboratories Inc., Mountain View, CA, USA), 0.4 uM indexed
primers, and 20-50 ng of extracted DNA. Amplifications of each gene were performed on a
Veriti 96-Well Thermocycler (Life Technologies, Carlsbad, CA, USA) according to
thermocycler conditions described in Table 3.2. Negative controls were included in each PCR
run and the PCR product was separated using 1.5% agarose gel, stained (ethidium bromide), and
photographed to visualize PCR amplification products and confirm PCR product sizes.

3.3.5 LIBRARY PREPARATION AND SEQUENCING ON THE ILLUMINA MISEQ
Following amplification of the targeted genes, the resulting amplicons were normalized (NGS
Normalization 96-Well Kit, ON, Canada) and pooled (10 uL/sample). DNA Clean &
Concentrator (Zymo Research, CA, USA) was used for PCR product purification. QIAquick Gel
Extraction Kit (Qiagen, MD, USA) was used for gel extraction to remove unwanted fragments
according to the manufacturer’s protocols. Libraries were quality controlled using the
BioAnalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA) using the Agilent High
Sensitivity DNA kit. The resulting libraries were quantified using the KAPA Library
Quantification Kit (Roche, Basel, Germany) to determine library loading concentration and
sequenced using a 201/101 bp paired end sequencing strategy on the Illumina MiSeq platform.
The ermB gene utilized the V2 500 cycle sequencing kit while the TetW and sul1 genes utilized
the V2 300 cycle sequencing kit as described by the manufacturer (Illumina, San Diego, CA,
USA).

3.3.6 DATA PROCESSING PIPELINES

Detailed information regarding the bioinformatic analyses conducted including the mapping file,
scripts, and commands can be found on the Fernando Lab’s GitHub repository
(https://github.com/FernandoLab/See_2022_AMR). All analysis steps were performed using R
(R Core Team, 2019). In brief, the ‘DADA2’ pipeline (Callahan et al., 2016) was used for
preprocessing, quality filtering, denoising and processing raw fastq files. The DADA2 process
filters low quality scores with a Q score < 30 and crops sequences to contain bases with a score
Q30 or higher quality. Standard filtering parameters and a set maximum number of “expected
errors” were used to filter forward and reverse reads. After error rates were estimated to evaluate
read quality, forward and reverse reads were merged to obtain full denoised contig reads.
Subsequent filtering was conducted to remove sequences with ambiguous bases and chimeras
and the resulting reads were used to pick unique amplicon sequence variants (ASV).
Contaminants in ASVs were identified and removed using the ‘decontam’ package (Davis et al.,
2018). Using the ‘genefilter’ package (Gentleman et al., 2022), filtering was performed based on
prevalence and abundance, with function parameters set to 0.15% abundance within a sample
with the criteria in a minimum of 2 samples.

Complete lists of ermB, TetW, and sul1 gene sequences were drawn up from the MEGARes
database (Doster et al., 2020). Amplicon sequence variant (ASV) sequences were compared
against these MEGARes sequences using BLAST (Zhang et al., 2004) to confirm annotations
(i.e. if they belonged to the correct gene family). ASVs with a percent identity greater than 90%
were kept for further analysis.

3.3.7 STATISTICS

Phyloseq objects (McMurdie & Holmes, 2013) were created using the ASV sequences and
metadata for subsequent analysis using the adonis function within the R package ‘vegan’
(Oksanen et al., 2022). PERMANOVA analysis was performed using 999 permutations
(Anderson, 2017) to identify whether the effect of antibiotic treatment, timepoint, and the
interaction between them were significant. A nonparametric Kruskal-Wallis equality of
population rank test was performed to determine significant differences between the different
treatment groups. Statistical significance was determined at p < 0.05. Read count data (ASV
table) were normalized by proportions prior to statistical analyses of β-diversity and “betweensample” comparisons. Bray-Curtis distance matrix was used to perform principal coordinate
analysis (PCoA) to estimate variation between treatment groups.

To determine functionality of ASVs, 6-frame translations were performed on unique DNA
sequence variants obtained for each gene using a custom Python script. Resulting amino acid
sequences that possessed stop codons mid-sequence were assumed to be non-functional.
“Functional” sequences were further analyzed using multiple-sequence alignment using MAFFT
(Katoh et al., 2002) to identify sequence similarity between the functional ASVs and to identify
potential host.

3.4 RESULTS
TetW SEQUENCE ANALYSIS AND GENE DIVERSITY
The original dataset contained 10,518,524 reads that were binned into 167 ASVs after quality
filtering. Following chimera removal, decontamination, and prevalence filtration (0.15%
abundance within a sample with the prevalence of >2 samples), 44 ASVs were retained. To

ensure that the ASVs retained belonged to the TetW gene, the resulting ASVs were compared to
the MEGARes (Doster et al., 2020) database to confirm AMR gene annotation. All ASVs were
identified as being true TetW variants. As illustrated on the heatmap of ASV abundance (Figure
3.2), only ASV_1 and ASV_2 were present across all samples whereas the remainder of the
ASVs were randomly distributed across samples.

To evaluate global changes in TetW AMR gene diversity, a principal component analysis was
performed using a Bray-Curtis dissimilarity matrix (β-diversity). PERMANOVA analysis
revealed significant differences in the TetW AMR gene diversity between treatment groups and
sample types. Additionally, an interaction between treatment and sample type was observed
(Figure 3.3, Table 3.3). Differential analysis across all treatment groups resulted in only ASV_21
and ASV_27 to be statistically different (p < 0.05) between the Nuflor-treated and antibiotic-free
treatment groups. Interestingly, when differential analysis was performed using sample type as a
comparison, only 4 ASVs (ASV_1, ASV_5, ASV_7, ASV_48) were deemed significant.

In the rumen, diversity estimates only showed a significant difference on day 42 with the
Shannon index (Figure 3.4). Principal coordinate analysis using all pairwise Bray-Curtis
distances did not show obvious clustering of TetW gene ASVs by treatment group. However,
clustering was observed by timepoint (Figure 3.5). This observation was supported by
PERMANOVA (999 permutations) analysis using the Bray-Curtis dissimilarity matrix
considering a model containing treatment, timepoint, and the treatment and timepoint interaction.
This analysis identified treatment and timepoint to significantly affect TetW gene composition.
While post-hoc analysis of pairs of treatments showed a difference, this difference was not

significant between any pairs off treatments (Table 3.5). Differential ASV analysis conducted
with DESEQ identified only 1 statistically significant ASV, ASV_5, after p-value adjustment.

Similar patterns were observed in the fecal samples, where a significant difference in α-diversity
was mainly observed on day 42 according to the Shannon-Weiner index (Figure 3.7).
Furthermore, while PERMANOVA (999 permutations) analysis indicated significant differences
(p < 0.05) between treatments and timepoints, obvious clustering patterns in the PCoA plot were
not observed for this analysis (Figure 3.8, Table 3.6). Differential ASV analysis identified only 1
statistically significant ASV, ASV_15, after p-value adjustment.

Meanwhile, in the floor surface material (FSM) samples, significant differences in β-diversity
were only found between timepoints, and not treatments (Figure 3.8, Table 3.8). Numeric
differences in Observed and Shannon-Weiner indices for baseline (day 0) samples in comparison
to post-treatment samples were observed (Figure 3.9). However, comparisons between days 141
and 152 showed a significant difference in richness when considering Observed counts (p =
0.0069) (Figure 3.9). Also, no differential ASVs were identified between treatment groups.

Contrary to what was seen in the floor surface material (FSM) samples, significant differences in
β-diversity of soil samples were found between treatments (Figure 3.10, Table 3.9), with
PERMANOVA analysis confirming a p-value < 0.05. A more in-depth look into pairwise
comparisons between treatments (Table 3.10) highlight that the only significant pairs were
“AbxFree vs Baseline” and “AbxTreated vs Baseline”, indicating that the soil community is
affected by antibiotic administration and animal entry into the pens (Figure 3.11).

Sul1 SEQUENCE ANALYSIS AND GENE DIVERSITY
For the sul1 gene, the original dataset possessed 12,648,507 reads, resulting in 344 ASVs after
the quality filtration step. However, only 25 ASVs remained after chimera removal,
decontamination, and prevalence filtration (0.15% abundance within a sample with this criterion
in 2 samples). Again, these ASVs were BLASTed against the MEGARes (Doster et al., 2020)
database to confirm Sul1 annotations, with all 25 ASVs remaining as true variants. Similar to
what we observe with the TetW gene, our dataset appears to be very sparse when considering
ASV abundance (Figure 3.12), with ASV_1, ASV_2, and ASV_5 appearing to be the most
consistent across all samples. No significantly differential ASV were identified with treatment
group as a comparison, while ASV_4 was identified when comparing sample types. This was
observed in the comparison between soil/runoff and fecal samples.

Changes in Sul1 gene β-diversity was determined by performing a principal component analysis
on proportional data using the Bray-Curtis distance matrix. This is illustrated by Figure 3.13,
where obvious clustering patterns were observed among the different sample types as opposed to
treatments. In support, PERMANOVA analysis at 999 permutations with a model considering
treatment, sample type, and the treatment and sample type interaction identified a significant
difference between sample types (p = 0.001) (Table 3.11). Further post-hoc analysis confirmed
that all pairs of sample types were deemed significantly different from one another (Table 3.12).

In the rumen, Observed and Shannon-Weiner indices displayed no significant difference between
treatment groups on both days of sample collection (Figure 3.14), following a similar pattern to
the TetW gene in rumen samples. Principal coordinate analysis using the Bray-Curtis distance

matrix showed some clustering, however, PERMANOVA analysis identified a significant
interaction between treatment and day of study (Figure 3.15, Table 3.13). Similar patterns were
observed for the fecal samples, where no significant differences were seen in α-diversity, as
shown on Figure 3.16. However, for β-diversity metrics, grouping by day of study was observed
(Figure 3.17). This observation is supported by PERMANOVA analysis where timepoint showed
a greater difference than treatment (Table 3.14). As expected, no differential ASV were detected
between treatments in both the rumen and fecal sample types.

We found significant differences in β-diversity of floor surface material (FSM) samples.
Specifically, between treatments and timepoints, despite unclear groupings in the PCoA plot
(Figure 3.18, Table 3.15). As mentioned previously, baseline (day 0) samples were analyzed as
their own treatment group when performing α-diversity calculations in both FSM and soil
samples. Through Kruskal-Wallis testing, we found significant differences on day 154 (p = 0.03)
using both Observed and Shannon indices between the AbxFree, AbxTreated, and
NoAnimal_Control treatment groups (Figure 3.19).

In soil samples, no significant differences in α-diversity were observed between treatments at all
timepoints (Figure 3.20). In terms of PCoA plot of β-diversity, we did not observe distinct
clusterings (Figure 3.10), which corroborates with PERMANOVA analysis confirming no
significant differences between treatments and timepoints (Table 3.16).

ErmB SEQUENCE ANALYSIS AND GENE DIVERSITY
Ensuing quality filtration, the original dataset composed of 14, 045 ,553 reads resulting in 719
ASVs. After steps for chimera removal, decontamination, and prevalence filtration (with the
same parameters as TetW and sul1 genes), we observe only 168 ASVs remaining. These ASVs
were BLASTed against the MEGARes (Doster et al., 2020) database to confirm ermB
annotations. Corroborating with what we observe in the TetW and sul1 ASV abundance, our
dataset is very sparse (Figure 3.22). However, unlike those genes, there appears to be no ASVs
that are common across all samples, likely affecting microbial estimators like α- and β-diversity
and how they are visualized. For example, in Figure 3.23, β-diversity estimates based for the
Bray-Curtis distance matrix between treatments and timepoints are difficult to discern, due to the
lack of commonality. However, PERMANOVA analysis reveals significant differences between
both treatments and timepoints (Table 3.17), and significant differences between all pairs of
sample types (Table 3.18). Differential abundance analysis identified 66 ASVs that were
statistically significant (Supplementary Data 3.1), a higher number compared to what was
observed in the TetW and sul1 genes, as illustrated in the heatmap in Figure 3.24. For clarity and
illustration purposes, only the top 20 most statistically significant ASV are shown.

Observed and Shannon diversity estimates were significantly different on day 42 in the rumen
sample collected (Figure 3.25), indicating that antibiotic treatment plays a role in richness and
evenness of the ermB gene. Principal coordinate analysis did not show distinct clustering
patterns by treatment group or timepoint (Figure 3.26). However, PERMANOVA analysis in a
model accounting for treatment, timepoint, and the treatment and timepoint interaction, identified
significant differences between treatments and timepoints, with post-hoc investigation revealing

that all pairs of antibiotic-free and injectable antibiotics were significantly different, while pairs
of antibiotics were not (Table 3.19). Differential abundance analysis between antibiotic
treatments identified 39 ASVs, with the top 20 ASVs being illustrated (Supplementary Data 3.2,
Figure 3.27). Certain ASV were more prevalent in a particular treatment group or timepoint. For
example, ASV_80 was more abundant in Draxxin, Excede, and Nuflor-treated groups while
ASV_25 and ASV_73 were most abundant at the day 0 timepoint.

In contrast to what we observe in the rumen samples, evenness, and richness of ErmB in fecal
samples were significantly different on day 0 as opposed to the later timepoints (Figure 3.28).
Principal component analysis was unable to discern distinct groupings based on treatment or
timepoint (Figure 3.29). However, PERMANOVA analysis identified significant differences in
both treatment and timepoint (Table 3.20). Post-hoc analysis indicated significant differences
between all pairs of antibiotic-free and antibiotic treatment groups, while pairs of antibiotics
were not massively different from one another. Differential abundance analysis revealed 31
differential ASVs (Supplementary Data 3.3), with the top 20 most significant ASVs being
illustrated in Figure 3.30. ASV_5, ASV_34, and ASV_55 follow the same pattern of being more
abundant in the AbxFree treatment groups on day 42. However, ASV_3, ASV_32, ASV_54,
ASV_12, ASV_61 were more prevalent at day 0 in various antibiotic-treated groups.

In the case of floor surface and soil samples, Observed and Shannon-Weiner α-diversity indices
reveal no significant differences between treatments at all timepoints for both sample types
(Figure 3.31, Figure 3.33). Principal coordinate plot on all pairwise Bray-Curtis distances for
these samples displayed no clustering. However, PERMANOVA analysis in a model considering

treatment, timepoint, and their interaction that resulted in p = 0.001 for treatments and timepoints
in both floor surface and soil samples, indicating significance despite the lack of clustering seen
in the PCoA plot. Pairwise post-hoc testing for floor surface samples displayed statistically
significant differences between all pairs of timepoints, while only AbxTreated vs AbxFree,
AbxTreated vs Baseline, Baseline vs NoAnimal_Control treatment pairs were significant (Table
3.21). Post-hoc testing for soil samples followed the same pattern of significance for all pairs of
timepoints while highlighting that only the AbxFree vs Baseline and AbxTreated vs Baseline
pairs were significantly different (Table 3.22).

3.5 DISCUSSION
While antimicrobial therapies have been critical in disease prevention, growth promotion, and
treatment of infection, antimicrobial resistance continues to be a major health and economic
concern in both human and animal health. The main risk factor for emergence and spread of
antimicrobial resistance is the overuse and misuse of antibiotics (Canica et al., 2015). While
AMR gene reservoirs are found in humans, animals, and environmental samples with complex
transmission pathways between them, little is known how they occur and what triggers drive the
emergence of AMR. The resistome, composed of all types of AMR genes, their precursors, and
potential resistance mechanisms, is identified in most cases using culture-based, PCR-based, or
sequence-based analysis methods. However, these methods are either very labor intensive with
low throughput, insensitive to the different variants of the same gene or hard to identify by
metagenome sequencing due to low abundance. Therefore, in this study, we developed a new
strategy of AMR gene detection using amplicon-based sequencing to investigate AMR gene
variants, spread, and gain and understanding of their functional traits.

We targeted AMR genes that are commonly found in the beef production system to validate the
applicability of the approach and to identify AMR gene variants and their persistence and spread.
To this end, we investigated resistance to macrolides (ermB), sulfonamides (sul1), and
tetracyclines (tetW), which are the most used antimicrobial classes in the American beef
production system (Agga et al., 2019). Between the 3 AMR genes (TetW, Sul1, ErmB) that were
amplified and sequenced, we identified a total of 44, 25, and 168 ASVs, respectively, from
rumen, fecal, soil, and floor surface samples of 36 animals that had been antibiotic-treated and 36
animals that remained antibiotic-free. Sampling of soil and floor surface material was conducted
for each pen to explore whether AMR genes were capable of being transmitted from fecal to
soil/floor surface material. All gene datasets were sparse (i.e, most ASVs not found in most
samples), as highlighted by heatmaps in Figures 3.2 (TetW), 3.12 (Sul1), and 3.22 (ErmB). In
general, there exists a lack of common ASVs between samples for all AMR genes of interest,
with only a few ASVs at most being universally present across samples, suggesting that many of
the AMR gene variants identified are not selected within the environment. This may be because
many of the AMR gene variants identified are non-functional and therefore are not selected for
within the bacterial population as no advantage is provided to the host species. However, the few
stable AMR genes may be functional and therefore selected within the environment.

Tetracyclines are a commonly used class of antimicrobial agents in human and veterinary
medicine due to their broad-spectrum activity, affordability, route of administration, and minimal
side effects (Shin et al., 2015). However, widespread and misuse of these antibiotics has led to an
increase in tetracycline resistance (Shin et al., 2015). Tetracycline-resistant genes are believed to

be some of the most abundant and prevalent AMR genes in cattle and swine gut resistomes, with
a prevalence of almost 100% (Lim et al., 2020). Meanwhile, sulfonamides are known to be
highly mobile in soils. However, they are used less frequently in veterinary medicine (Conde-Cid
et al., 2020). Additionally, the ermB gene is the most common mode of resistance to macrolide
antibiotics in enterococci of animal origin (Jacob et al., 2008).

As an observation, enrofloxacin (Baytril), belongs to the floroquinolone class of antibiotics. Its
mode of action relies on disrupting DNA replication in bacterial cells by inhibiting the enzyme
gyrase (Tyson et al., 2019). Resistance to this drug class is mediated by point mutations in the
gyrase enzyme and topoisomerase genes, with gyrA mutations being the most common
mechanism in Gram-negative bacteria (Tyson et al., 2019). As such, we may not be able to
observe the selection or spread of a particular “fluoroquinolone-resistant” gene itself.

In this study, we fed Baytril, Draxxin, Excede, and Nuflor to cattle to identify how injectable
antibiotics would affect AMR gene diversity and stability. We observed common TetW (ASV_1,
ASV_2) and Sul1 ASVs (ASV_1, ASV_2) across all sample types suggesting that these AMR
ASVs may be functional variants that selected within the environment. Through qPCR
assessment, Kyselkova et al. (2015) identified a “core resistome” consisting of tetW, tetO, and
tetQ genes, which were found in almost all fecal samples from cattle at different ages and status
of antibiotic treatment. However, this study failed to identify the different variants or if the AMR
genes identified were functional. With the amplicon-based sequencing strategy developed in this
study, we can evaluate each variant bioinformatically to predict if the variant codes for a
functional gene, providing valuable new information to understanding AMR.

AMR GENE DIVERSITY ACROSS SAMPLES
In studies describing changes in community composition, microbial ecological estimators like αand β -diversity are routinely used. We evaluated alpha diversity to estimate the number of AMR
gene variants that could be present in each environment. We observed statistically significant
differences between treatment means at the later timepoint for rumen and fecal samples of the
TetW (Figure 3.5, Figure 3.7) and ermB gene (Figure 3.25, Figure 3.28), with no observed
differences in soil and floor surface samples. This suggests a selection for TetW and ErmB genes
in the gut environments within the animal but not in the soil. This may be due to the fact that
microbes carrying the AMR genes are adapted to the gut environment and when they enter the
soil environment they are outcompeted as the AMR gene only provides an advantage within the
host animal that is exposed to the antibiotic and not in the soil.

The sul1 gene diversity was only statistically different in the floor surface samples which differ
from soil samples due to the presence of cobs. The sul1 gene is usually located on the 3’
conserved region of a class 1 integron and is often identified with this mobile genetic element in
slurry and soil environments (Guerra et al., 2003; Byrne-Bailey et al., 2009. Additionally, several
studies have highlighted the predominance of AMR genes belonging to tetracycline and
macrolide-lincosamide streptogramin (MLS) classes in the rumen, irrespective of breeds and
antibiotic treatment (Auffrett et al., 2017; Ma et al., 2022). Our results indicate that antibiotic
treatment resulted in shifts in the evenness of these genes, suggesting the role of antimicrobials
in shaping the resistome.

PERMANOVA analysis identified statistically significant differences between treatment groups
for all three antibiotics evaluated, suggesting that AMR variants and abundance across sample
types are different. This could be due to different microbial populations present in each sample
type and thus, different microbes carry different variants of the same gene in different sample
types collected. This notion is supported by the fact that all genes reveal clear separations
between sample types.

Timepoint, or day of study, were significant explanatory variables for all 3 AMR genes
quantified in this study. However, the effect of timepoint was greater than treatments suggesting
selection to happen over time or community shifts over time changing AMR gene variants. A
cross-sectional study by Birkegard et al. (2017) highlighted that only 10-42% of the variation in
AMR gene levels could be explained by factors included in statistical models in the study. As
such, there could be variables that were not measured in this study that could influence AMR
variants and abundance.

In the soil communities, post-hoc analysis revealed that the baseline treatment group was
significantly different from the AbxFree and AbxTreated groups in both the TetW and ermB
genes. This suggests that entry of animals into the pen is also a key factor in shaping the
resistome. This phenomenon is not surprising as native microbial populations are known to carry
AMR genes and as such, even the AbxFree animal microbiomes are expected to carry AMR
genes.

DIFFERENTIAL ASV IDENTIFIED IN THE ERMB GENE AND STABILITY OF
FUNCTIONAL GENES
Investigation of differential ASVs based on treatments and sample types identified a very small
number of differential ASV in the TetW and Sul1 genes. However, differential ASV analysis of
the ErmB gene displayed a much higher abundance (66 ASVs) of differential ASVs as illustrated
in Figure 3.24. This is likely due to the lack of ASVs of universal presence and abundance
(Figure 3.22). This observation may be a reflection of the various ermB variants that may or may
not be functional or confer resistance as comparisons to the UniProtKB database indicate all of
our variants to be functional.

After performing six-frame translations on all ASVs of the three AMR genes, we found that each
ASV had at least 1 or 2 frames that did not possess stop codons and thus, we deemed those to be
functional. We found that apart from 1 or 2 ASVs in each gene, we speculate most of our ASVs
to be functional. It has been reported that there is widespread occurrence of tet(W) among
ruminal bacteria, corroborating our observation of persistent ASVs across timepoints and
regardless of treatment, and explains how its functionality leads to its persistence. Functionality
of our sul1 ASVs is predicted to be a result of dihydropteroate synthase activity (Hammoudeh et
al., 2014), as confirmed by comparing our sequences to the UniProtKB dataset. This activity
catalyzes a crucial step in the bacterial pathway of folic acid synthesis, which act as the targets
for sulfonamide antibiotics. It should be noted that we cannot confirm definitively into the
functionality of these genes without doing in-vitro testing, but this amplicon-based approach

enables us to make predictions, even though they may be limited by existing literature and
databases.

3.6 CONCLUSION
Our understanding of the emergence and spread of AMR is limited. To better assess the ecology
of AMR genes, we utilized targeted amplicon-sequencing of AMR genes to explore the diversity
and distribution of AMR genes in the beef cattle production system. Our results demonstrate that
only a few of the AMR variants identified might be functional and selected within the
gastrointestinal tract and the environment in beef cattle production systems. Furthermore, we
provide a novel approach to identify AMR gene ecology and a technique that provides valuable
information into diversity, stability, and functionality of AMR genes in any environment.
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BC
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Figure 3.1. Primer design of AMR genes, with “BC” referring to the barcoded primers, and i5 and
i7 referring to Illumina indices.

Target Gene
Sul(I)

Importance
Encodes for sulfonamide resistance. Commonly studied
resistant gene in environmental samples. Sulfonamides are
declared “Highly Important” (the second category) by the
World Health Organization (WHO, 2018).

erm(B)

Encodes for resistance to macrolide drugs such as
tulathromycin. These drugs are classified as “Critically
Important” (the top category) by the World Health
Organization (WHO, 2018). In cattle, tulathromycin is FDAapproved for treatment of BRD caused by M. haemolytica,
P. multicoda, and H. somni (FDA, 2021).

TetW

Encodes for resistance to tetracycline drugs, including
tetracycline, chlortetracycline, oxytetracycline, and
doxycycline. Tetracyclines are the most commonly
used drugs in food animal production globally (Miller
et al., 2020).

Table 3.1. List of targeted genes and their importance.

PCR
Primer
Target name
erm(B) erm(B)–F

Primer sequence
5’-GGTTGCTCTTGCACACTCAAG-3’

PCR
conditions
95°C (2 min),
30 cycles of
94°C (30 s),
63°C (30 s),
72°C (45 s),
72°C (7 min)

erm(B)–R 5’-CAGTTGACGATATTCTCGATTG-3’
Sul(I) Sul(I)–F
5’-CGCACCGGAAACATCGCTGCAC-3’ 95°C (2 min),
35 cycles of
95°C (15 s),
70°C (15 s),
72°C (30 s),
72°C (7 min)
Sul(I)–R 5’-TGAAGTTCCGCCGCAAGGCTCG-3’
TetW TetW – F 5’-GAGAGCCTGCTATATGCCAGC-3’
94°C (5 min),
35 cycles of
94°C (30 s),
60°C (30 s),
72°C (30 s),
72°C (7 min)
TetW – R 5’-GGGCGTATCCACAATGTTAAC-3’
Table 3.2. PCR conditions utilized for each AMR gene.

Amplicon Source
size (bp)
191
Koike et
al.
(2010)

163

Pei et al.
(2006)

169

Aminov
et al.
(2001)

ASV

ASV_13
ASV_44
ASV_22
ASV_7
ASV_12
ASV_30
ASV_20
ASV_31
ASV_5
ASV_53
ASV_28
ASV_34
ASV_59
ASV_43
ASV_15
ASV_26
ASV_60
ASV_37
ASV_45
ASV_14
ASV_55
ASV_47
ASV_11
ASV_8
ASV_57
ASV_46
ASV_17
ASV_25
ASV_2
ASV_21
ASV_18
ASV_27
ASV_3
ASV_1
ASV_38
ASV_6
ASV_10
ASV_4
ASV_33
ASV_16
ASV_24
ASV_19
ASV_32
ASV_29

Abundance
0.2500000000

0.0156250000

0.0009765625
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Figure 3.2. Heatmap showing ASV abundance in the TetW gene across all samples. Black color
indicates missing/NA data.
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Figure 3.3. Overall beta diversity (β-diversity) metrics of the TetW gene on all sample types and
treatment groups. Principal coordinate plot using Bray-Curtis distances are shown, with the plot
colored by A) treatment and B) sample type. Axes represent the amount of variation explained in
the first 2 principal components. Significant differences were observed between treatment groups
and sample types (p < 0.05).

Df
SumsOfSqs
MeanSqs
F.Model
R2
Pr(>F)
Treatment
7
0.2404748
0.0343535
7.549737
0.1131067
0.001
Sample_Type
3
0.2321125
0.0773708
17.003466
0.1091735
0.001
Treatment:Sample_Type
7
0.0381459
0.0054494
1.197594
0.0179418
0.268
Residuals
355
1.6153555
0.0045503
NA
0.7597781
NA
Total
372
2.1260887
NA
NA
1.0000000
NA
TetW All Samples Bray-Curtis Permanova
Permutational multivariate analysis of variance based on Bray-Curtis distances between all microbiome samples (999 permutations). The statistical model takes into account day of study,
treatment, and the interaction between them. Significance is determined at p < 0.05.

Table 3.3. Permutational multivariate analysis of variance (PERMANOVA) based on BrayCurtis distances between all samples (999 permutations) from control animals and animals that
were antibiotic-treated. The statistical model considers treatment, sample type, and the
interaction between them. Significance is determined at p < 0.05.

A

Treatment

AbxFree

Baytril

Draxxin

Kruskal−Wallis, p = 0.18

Excede

Nuflor

Kruskal−Wallis, p = 0.052

Observed

9

6

3

Day_0

Day_42

DayOfStudy

B

Treatment

AbxFree

Baytril

Draxxin

Kruskal−Wallis, p = 0.31

Excede

Nuflor

Kruskal−Wallis, p = 0.0099

Shannon

0.8

0.6

0.4

Day_0

Day_42

DayOfStudy

Figure 3.4. Boxplots showing Observed and Shannon-Weiner’s TetW α-diversity indices in the
rumen samples of animals with or without antibiotic treatment. Treatment means were compared
using Kruskal-Wallis test to identify differences in species richness and evenness between
treatment groups. A significant difference was observed on day 42 using the Shannon-Weiner
index.
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Figure 3.5. Overall beta diversity (β-diversity) metrics on TetW gene in rumen samples.
Principal coordinate plot using Bray-Curtis distances are shown, with the plot colored by A)
treatment and B) day of study. Axes represent the amount of variation explained in the first 2
principal components. Significant differences were observed between treatment groups and
timepoints (p < 0.05).

Df
SumsOfSqs
MeanSqs
F.Model
R2
Pr(>F)
Treatment
4
0.0580968
0.0145242
3.482882
0.0850339
0.001
DayOfStudy
1
0.0370655
0.0370655
8.888248
0.0542512
0.001
Treatment:DayOfStudy
4
0.0292545
0.0073136
1.753798
0.0428186
0.082
Residuals
134
0.5588025
0.0041702
NA
0.8178962
NA
Total
143
0.6832193
NA
NA
1.0000000
NA
tetw Rumen Bray-Curtis Permanova
Permutational multivariate analysis of variance based on Bray-Curtis distances between rumen microbiome samples (999 permutations). The statistical model takes into
account day of study, treatment, and the interaction between them. Significance is determined at p < 0.05.

Table 3.4. Permutational multivariate analysis of variance (PERMANOVA) based on BrayCurtis distances between rumen samples (999 permutations) from control animals and animals
that were antibiotic-treated. The statistical model considers treatment, day of study, and the
interaction between them. Significance is determined at p < 0.05.

pairs
Df
SumsOfSqs
F.Model
R2
p.value
p.adjusted sig
AbxFree vs Nuflor
1
0.0223103
4.1125231
0.0446467
0.024
0.0700000
AbxFree vs Excede
1
0.0250819
4.8097451
0.0518237
0.007
0.0700000
AbxFree vs Baytril
1
0.0215970
4.0495471
0.0439931
0.023
0.0700000
AbxFree vs Draxxin
1
0.0206766
3.7920589
0.0413114
0.028
0.0700000
Nuflor vs Excede
1
0.0031431
1.1122394
0.0316767
0.307
0.6140000
Nuflor vs Baytril
1
0.0025436
0.8120594
0.0233270
0.460
0.7666667
Nuflor vs Draxxin
1
0.0014160
0.4114521
0.0119568
0.689
0.9842857
Excede vs Baytril
1
0.0010044
0.3880282
0.0112838
0.871
0.9860000
Excede vs Draxxin
1
0.0002738
0.0945125
0.0027721
0.962
0.9860000
Baytril vs Draxxin
1
-0.0001584
-0.0494482
-0.0014565
0.986
0.9860000
tetw Rumen Treatments - Pairwise PERMANOVA
Permutational multivariate analysis of variance based on Bray-Curtis distances between treatments of rumen microbiome samples (999 permutations). The statistical
model performs a pairwise comparison between treatments. Significance is determined at p < 0.05.

Table 3.5. Pairwise comparisons (PERMANOVA) based on Bray-Curtis distances between
treatment groups of rumen samples (999 permutations). Significance is determined at p < 0.05.

A

Treatment

AbxFree

Baytril

Draxxin

Kruskal−Wallis, p = 0.79

Excede

Nuflor

Kruskal−Wallis, p = 0.063

Observed

9

6

3

Day_0

Day_42

DayOfStudy

B

Treatment

AbxFree

Baytril

Draxxin

Kruskal−Wallis, p = 0.07

Excede

Nuflor

Kruskal−Wallis, p = 0.034

Shannon
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0.4

Day_0
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Figure 3.6. Boxplots showing Observed and Shannon-Weiner’s TetW α-diversity indices in the
fecal samples of animals with or without antibiotic treatment. Treatment means were compared
using Kruskal-Wallis test to identify differences in species richness and evenness between
treatment groups. A significant difference was observed on day 42 using the Shannon-Weiner
index.
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Figure 3.7. Beta diversity (β-diversity) metrics on TetW gene in fecal samples. Principal
coordinate plot using Bray-Curtis distances are shown, with the plot colored by A) treatment and
B) day of study. Axes represent the amount of variation explained in the first 2 principal
components. Significant differences were observed between treatment groups and timepoints (p
< 0.05).

Df
SumsOfSqs
MeanSqs
F.Model
R2
Pr(>F)
Treatment
4
0.0488217
0.0122054
3.2798043
0.0866423
0.010
DayOfStudy
1
0.0398638
0.0398638
10.7120775
0.0707450
0.001
Treatment:DayOfStudy
4
0.0133480
0.0033370
0.8967082
0.0236883
0.512
Residuals
124
0.4614517
0.0037214
NA
0.8189244
NA
Total
133
0.5634851
NA
NA
1.0000000
NA
tetw Fecal Bray-Curtis Permanova
Permutational multivariate analysis of variance based on Bray-Curtis distances between fecal microbiome samples (999 permutations). The statistical model takes into account day of study,
treatment, and the interaction between them. Significance is determined at p < 0.05.

Table 3.6. Permutational multivariate analysis of variance (PERMANOVA) based on BrayCurtis distances between fecal samples (999 permutations) from control animals and animals that
were antibiotic-treated. The statistical model considers treatment, day of study, and the
interaction between them. Significance is determined at p < 0.05.

pairs
Df
SumsOfSqs
F.Model
R2
p.value
p.adjusted sig
AbxFree vs Baytril
1
0.0279058
6.8984846
0.0758922
0.007
0.0700000
AbxFree vs Draxxin
1
0.0149525
3.3871440
0.0387602
0.064
0.1600000
AbxFree vs Nuflor
1
0.0141028
3.3163952
0.0384214
0.047
0.1566667
AbxFree vs Excede
1
0.0165665
3.8567141
0.0449204
0.038
0.1566667
Baytril vs Draxxin
1
0.0026063
0.7591704
0.0231743
0.472
0.8340000
Baytril vs Nuflor
1
0.0016310
0.5496193
0.0174208
0.560
0.8340000
Baytril vs Excede
1
0.0011698
0.3844820
0.0126539
0.722
0.8340000
Draxxin vs Nuflor
1
0.0011690
0.2946062
0.0094140
0.761
0.8340000
Draxxin vs Excede
1
0.0007057
0.1731105
0.0057372
0.834
0.8340000
Nuflor vs Excede
1
0.0008045
0.2234234
0.0076454
0.821
0.8340000
TetW Fecal Treatments - Pairwise PERMANOVA
Permutational multivariate analysis of variance based on Bray-Curtis distances between treatments of fecal microbiome samples (999 permutations). The statistical model
performs a pairwise comparison between treatments. Significance is determined at p < 0.05.

Table 3.7. Pairwise comparisons (PERMANOVA) based on Bray-Curtis distances between
treatment groups of fecal samples (999 permutations). Significance is determined at p < 0.05.
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Figure 3.8. Beta diversity (β-diversity) metrics on TetW gene in floor surface material (FSM)
samples. Principal coordinate plot using Bray-Curtis distances are shown, with the plot colored
by A) treatment and B) day of study. Axes represent the amount of variation explained in the
first 2 principal components. Significant differences were observed between treatment groups
and timepoints (p < 0.05).

Df
SumsOfSqs
MeanSqs
F.Model
R2
Pr(>F)
Treatment
3
0.0272404
0.0090801
1.5558543
0.0762810
0.171
DayOfStudy
1
0.0393833
0.0393833
6.7482278
0.1102848
0.007
Treatment:DayOfStudy
2
0.0045131
0.0022565
0.3866531
0.0126380
0.728
Residuals
49
0.2859688
0.0058361
NA
0.8007963
NA
Total
55
0.3571056
NA
NA
1.0000000
NA
TetW FSM Bray-Curtis Permanova
Permutational multivariate analysis of variance based on Bray-Curtis distances between FSM microbiome samples (999 permutations). The statistical model takes into account day of study,
treatment, and the interaction between them. Significance is determined at p < 0.05.

Table 3.8. Permutational multivariate analysis of variance (PERMANOVA) based on BrayCurtis distances between FSM samples (999 permutations) from pens of antibiotic-free animals
and animals that were antibiotic-treated. The statistical model considers treatment, day of study,
and the interaction between them. Significance is determined at p < 0.05.
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Figure 3.9. Boxplots showing Observed and Shannon-Weiner’s TetW α-diversity indices in the
FSM samples of pens that had received antibiotic treatment, with A) Observed baseline samples,
B) Shannon-Weiner metric of baseline samples, C) Observed and D) Shannon indices for both
timepoints. Treatment means were compared using Kruskal-Wallis test to identify differences in
species richness and evenness between treatment groups. A significant difference was observed
on day 141 (p = 0.0069) of Observed diversity.

Axis.2 [13.5%]

A

0.00

Treatment
AbxFree
AbxTreated
Baseline
NoAnimal_Control

−0.05

−0.10

−0.05

0.00

0.05

0.10

Axis.1 [78.6%]

Axis.2 [13.5%]

B

0.00

DayOfStudy
Day_0
Day_172
Day_196
Day_226

−0.05

−0.10

−0.05

0.00

0.05

0.10

Axis.1 [78.6%]

Figure 3.10. Beta diversity (β-diversity) metrics of TetW gene in soil samples. Principal
coordinate plot using Bray-Curtis distances are shown, with the plot colored by A) treatment and
B) day of study. Axes represent the amount of variation explained in the first 2 principal
components. Significant differences were observed between treatment groups and timepoints (p
< 0.05).

Df
SumsOfSqs
MeanSqs
F.Model
R2
Pr(>F)
Treatment
3
0.0634500
0.0211500
5.131282
0.3033645
0.001
DayOfStudy
2
0.0084980
0.0042490
1.030866
0.0406303
0.368
Treatment:DayOfStudy
2
0.0094313
0.0047156
1.144076
0.0450923
0.324
Residuals
31
0.1277750
0.0041218
NA
0.6109129
NA
Total
38
0.2091543
NA
NA
1.0000000
NA
TetW Soil Bray-Curtis Permanova
Permutational multivariate analysis of variance based on Bray-Curtis distances between soil/runoff microbiome samples (999 permutations). The statistical model takes into account day of
study, treatment, and the interaction between them. Significance is determined at p < 0.05.

Table 3.9. Permutational multivariate analysis of variance (PERMANOVA) based on BrayCurtis distances between soil samples (999 permutations) from pens of antibiotic-free and
antibiotic-treated animals. The statistical model considers treatment, day of study, and the
interaction between them. Significance is determined at p < 0.05.

pairs
Df
SumsOfSqs
F.Model
R2
p.value
p.adjusted sig
AbxFree vs AbxTreated
1
0.0034738
0.9661157
0.0605104
0.400
0.600
AbxFree vs Baseline
1
0.0297700
6.2193170
0.1817487
0.007
0.021 .
AbxFree vs NoAnimal_Control
1
0.0007602
0.1439168
0.0176717
0.792
0.797
AbxTreated vs Baseline
1
0.0492316
12.8496130
0.3224526
0.001
0.006 *
AbxTreated vs NoAnimal_Control
1
0.0018370
1.1012737
0.1359383
0.340
0.600
Baseline vs NoAnimal_Control
1
0.0032064
0.6987976
0.0337603
0.797
0.797
TetW Soil Treatments - Pairwise PERMANOVA
Permutational multivariate analysis of variance based on Bray-Curtis distances between treatments of soil/runoff microbiome samples (999 permutations). The statistical
model performs a pairwise comparison between treatments. Significance is determined at p < 0.05.

Table 3.10. Pairwise comparisons (PERMANOVA) based on Bray-Curtis distances between
treatment groups of soil samples (999 permutations). Significance is determined at p < 0.05.
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Figure 3.11. Boxplots showing Observed and Shannon-Weiner’s TetW α-diversity indices in the
soil samples of pens with animals with or without antibiotic treatment, with A) Observed
baseline samples, B) Shannon-Weiner metric of baseline samples, C) Observed and D) Shannon
indices for all timepoints. Treatment means were compared using Kruskal-Wallis test to identify
differences in species richness and evenness between treatment groups. No significant
differences were observed.
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Figure 3.12. Heatmap showing ASV abundance in the sul1 gene across all samples. Black color
indicates missing/NA data.
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Figure 3.13. Overall beta diversity (β-diversity) metrics of the sul1 gene on all sample types and
treatment groups. Principal coordinate plot using Bray-Curtis distances are shown, with the plot
colored by A) treatment and B) sample type. Axes represent the amount of variation explained in
the first 2 principal components. Significant differences were observed between treatment groups
and sample types (p < 0.05).

Df SumsOfSqs MeanSqs
F.Model
R2 Pr(>F)
Treatment
7 0.0123392 0.0017627 1.4143043 0.0257019 0.140
Sample_Type
3 0.0227964 0.0075988 6.0967585 0.0474838 0.001
Treatment:Sample_Type
7 0.0024924 0.0003561 0.2856759 0.0051915 0.992
Residuals
355 0.4424601 0.0012464
NA 0.9216228
NA
Total
372 0.4800881
NA
NA 1.0000000
NA

Table 3.11. Permutational multivariate analysis of variance (PERMANOVA) based on BrayCurtis distances between all samples (999 permutations). The statistical model considers
treatment, sample type, and the interaction between them. Significance is determined at p <
0.05.

pairs
Df SumsOfSqs
F.Model
R2 p.value p.adjusted sig
FSM vs FECAL
1 0.0030458 6.148457 0.0316688
0.007
0.0105 .
FSM vs SOIL/RUNOFF
1 0.0033036 4.405018 0.0452237
0.001
0.0030 *
FSM vs RUMEN
1 0.0112648 6.681791 0.0326448
0.005
0.0100 *
FECAL vs SOIL/RUNOFF
1 0.0028802 4.173778 0.0238265
0.013
0.0130 .
FECAL vs RUMEN
1 0.0182712 13.198996 0.0456398
0.001
0.0030 *
SOIL/RUNOFF vs RUMEN 1 0.0099716 5.031949 0.0270488
0.011
0.0130 .

Table 3.12. Pairwise comparisons (PERMANOVA) of the sul1 gene based on Bray-Curtis
distances between different sample types (999 permutations). Significance is determined at p <
0.05.
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Figure 3.14. Boxplots showing Observed and Shannon-Weiner’s sul1 α-diversity indices in the
rumen samples of animals with or without antibiotic treatment. Treatment means were compared
using Kruskal-Wallis test to identify differences in species richness and evenness between
treatment groups. No significant differences were observed.
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Figure 3.15. Beta diversity (β-diversity) metrics of sul1 gene in rumen samples. Principal
coordinate plot using Bray-Curtis distances are shown, with the plot colored by A) treatment and
B) day of study. Axes represent the amount of variation explained in the first 2 principal
components.

Df
SumsOfSqs
MeanSqs
F.Model
R2
Pr(>F)
Treatment
4
0.0006646
0.0001661
0.0815140
0.0021344
0.990
DayOfStudy
1
0.0004782
0.0004782
0.2346175
0.0015358
0.681
Treatment:DayOfStudy
4
0.0370974
0.0092743
4.5500815
0.1191425
0.002
Residuals
134
0.2731295
0.0020383
NA
0.8771872
NA
Total
143
0.3113697
NA
NA
1.0000000
NA
sul1 Rumen Bray-Curtis Permanova
Permutational multivariate analysis of variance based on Bray-Curtis distances between rumen microbiome samples (999 permutations). The statistical model takes into
account day of study, treatment, and the interaction between them. Significance is determined at p < 0.05.

Table 3.13. Permutational multivariate analysis of variance (PERMANOVA) based on BrayCurtis distances between rumen samples (999 permutations). The statistical model considers
treatment, timepoint, and the interaction between them. Significance is determined at p <
0.05.
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Figure 3.16. Boxplots showing Observed and Shannon-Weiner’s sul1 α-diversity indices in the
fecal samples of animals with or without antibiotic treatment. Treatment means were compared
using Kruskal-Wallis test to identify differences in species richness and evenness between
treatment groups. No significant differences were observed.
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Figure 3.17. Beta diversity (β-diversity) metrics of sul1 gene in fecal samples. Principal
coordinate plot using Bray-Curtis distances are shown, with the plot colored by A) treatment and
B) day of study. Axes represent the amount of variation explained in the first 2 principal
components.

Df
SumsOfSqs
MeanSqs
F.Model
R2
Pr(>F)
Treatment
4
0.0028142
0.0007035
1.4920844
0.0398084
0.207
DayOfStudy
1
0.0081419
0.0081419
17.2675484
0.1151732
0.001
Treatment:DayOfStudy
4
0.0012688
0.0003172
0.6727143
0.0179478
0.600
Residuals
124
0.0584678
0.0004715
NA
0.8270706
NA
Total
133
0.0706926
NA
NA
1.0000000
NA
sul1 Fecal Bray-Curtis Permanova
Permutational multivariate analysis of variance based on Bray-Curtis distances between fecal microbiome samples (999 permutations). The statistical model takes into account day of study,
treatment, and the interaction between them. Significance is determined at p < 0.05.

Table 3.14. Permutational multivariate analysis of variance (PERMANOVA) based on BrayCurtis distances between fecal samples (999 permutations). The statistical model considers
treatment, timepoint, and the interaction between them. Significance is determined at p <
0.05.
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Figure 3.18. Beta diversity (β-diversity) metrics of sul1 gene in floor surface material (FSM)
samples. Principal coordinate plot using Bray-Curtis distances are shown, with the plot colored
by A) treatment and B) day of study. Axes represent the amount of variation explained in the
first 2 principal components.

Df
SumsOfSqs
MeanSqs
F.Model
R2
Pr(>F)
Treatment
3
0.0038309
0.0012770
3.962195
0.1707339
0.009
DayOfStudy
1
0.0012203
0.0012203
3.786205
0.0543835
0.031
Treatment:DayOfStudy
2
0.0015946
0.0007973
2.473871
0.0710673
0.081
Residuals
49
0.0157923
0.0003223
NA
0.7038154
NA
Total
55
0.0224381
NA
NA
1.0000000
NA
sul1 FSM Bray-Curtis Permanova
Permutational multivariate analysis of variance based on Bray-Curtis distances between FSM microbiome samples (999 permutations). The statistical model takes into account day of study,
treatment, and the interaction between them. Significance is determined at p < 0.05.

Table 3.15. Permutational multivariate analysis of variance (PERMANOVA) based on BrayCurtis distances between floor surface samples (999 permutations). The statistical model
considers treatment, timepoint, and the interaction between them. Significance is determined at
p < 0.05.
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Figure 3.19. Boxplots showing Observed and Shannon-Weiner’s sul1 α-diversity indices in the
floor surface samples of pens of animals with or without antibiotic treatment, with A) Observed
baseline samples, B) Shannon-Weiner metric of baseline samples, C) Observed and D) Shannon
indices for all timepoints. Treatment means were compared using Kruskal-Wallis test to identify
differences in species richness and evenness between treatment groups.
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Figure 3.20. Boxplots showing Observed and Shannon-Weiner’s sul1 α-diversity indices in the
soil samples of pens of animals with or without antibiotic treatment, with A) Observed baseline
samples, B) Shannon-Weiner metric of baseline samples, C) Observed and D) Shannon indices
for all timepoints. Treatment means were compared using Kruskal-Wallis test to identify
differences in species richness and evenness between treatment groups. No significant
differences were observed between treatments at all timepoints.
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Figure 3.21. Beta diversity (β-diversity) metrics of sul1 gene in soil samples. Principal
coordinate plot using Bray-Curtis distances are shown, with the plot colored by A) treatment
and B) day of study. Axes represent the amount of variation explained in the first 2 principal
components.

Df
SumsOfSqs
MeanSqs
F.Model
R2
Pr(>F)
Treatment
3
0.0020396
0.0006799
0.4697230
0.0431118
0.530
DayOfStudy
2
0.0002971
0.0001486
0.1026400
0.0062803
0.722
Treatment:DayOfStudy
2
0.0001041
0.0000520
0.0359606
0.0022003
0.929
Residuals
31
0.0448682
0.0014474
NA
0.9484075
NA
Total
38
0.0473090
NA
NA
1.0000000
NA
sul1 Soil Bray-Curtis PERMANOVA
Permutational multivariate analysis of variance based on Bray-Curtis distances between soil microbiome samples (999 permutations). The statistical model takes into account day of study,
treatment, and the interaction between them. Significance is determined at p < 0.05.

Table 3.16. Permutational multivariate analysis of variance (PERMANOVA) based on BrayCurtis distances between soil samples (999 permutations). The statistical model considers
treatment, timepoint, and the interaction between them. Significance is determined at p < 0.05.
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Figure 3.22. Heatmap showing ASV abundance in the ermB gene across all samples. Black
color indicates missing/NA data.
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Figure 3.23. Overall beta diversity (β-diversity) metrics of the ermB gene on all sample types
and treatment groups. Principal coordinate plot using Bray-Curtis distances are shown, with the
plot colored by A) treatment and B) sample type. Axes represent the amount of variation
explained in the first 2 principal components. Significant differences were observed between
treatment groups and sample types (p < 0.05).

Df
SumsOfSqs
MeanSqs
F.Model
R2
Pr(>F)
Treatment
7
9.382255
1.3403221
3.127417
0.0524191
0.001
Sample_Type
3
9.214665
3.0715550
7.166959
0.0514828
0.001
Treatment:Sample_Type
7
8.245636
1.1779481
2.748544
0.0460687
0.001
Residuals
355
152.142910
0.4285716
NA
0.8500294
NA
Total
372
178.985466
NA
NA
1.0000000
NA
ermB All Samples Bray-Curtis Permanova
Permutational multivariate analysis of variance based on Bray-Curtis distances between all microbiome samples (999 permutations). The statistical model takes into account treatment,
sample type, and the interaction between them. Significance is determined at p < 0.05.

Table 3.17. Permutational multivariate analysis of variance (PERMANOVA) based on BrayCurtis distances between all microbiome samples (999 permutations). The statistical model
considers treatment, sample type, and the interaction between them. Significance is determined
at p < 0.05.

pairs
Df SumsOfSqs
F.Model
R2 p.value p.adjusted sig
FSM vs FECAL
1
1.674073 3.600052 0.0187894
0.001
0.001 **
FSM vs SOIL/RUNOFF
1
3.723560 8.676726 0.0853364
0.001
0.001 **
FSM vs RUMEN
1
4.559437 10.066903 0.0483830
0.001
0.001 **
FECAL vs SOIL/RUNOFF
1
2.122183 4.598228 0.0261861
0.001
0.001 **
FECAL vs RUMEN
1
4.038663 8.661891 0.0304287
0.001
0.001 **
SOIL/RUNOFF vs RUMEN 1
4.378473 9.762955 0.0511785
0.001
0.001 **

Table 3.18. Pairwise comparisons (PERMANOVA) of the ermB gene based on Bray-Curtis
distances between different sample types (999 permutations). Significance is determined at p <
0.05.
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Figure 3.24. Heatmap of top 20 differentially abundant ASV between antibiotic free and antibiotic-fed
cattle in all samples. Differential ASV were identified using DESeq2. Tiles in the heatmap are colored by variance stabilized
transformations of read counts, with deeper colors indicating a higher abundance of the organism within a sample. Hierarchical
clustering of variance stabilized read count data was performed.
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Figure 3.25. Boxplots showing Observed and Shannon-Weiner’s ermB α-diversity indices in the
rumen samples of animals with or without antibiotic treatment. Treatment means were compared
using Kruskal-Wallis test to identify differences in species richness and evenness between
treatment groups. Significant differences were observed on day 42.
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Figure 3.26. Beta diversity (β-diversity) metrics of the ermB gene in rumen samples. Principal
coordinate plot using Bray-Curtis distances are shown, with the plot colored by A) treatment
and B) day of study. Axes represent the amount of variation explained in the first 2 principal
components.

Df
SumsOfSqs
MeanSqs
F.Model
R2
Pr(>F)
Treatment
4
4.172149
1.0430373
2.447778
0.0637256
0.001
DayOfStudy
1
0.979093
0.9790930
2.297715
0.0149547
0.010
Treatment:DayOfStudy
4
3.219775
0.8049437
1.889025
0.0491790
0.002
Residuals
134
57.099539
0.4261160
NA
0.8721407
NA
Total
143
65.470556
NA
NA
1.0000000
NA
ermB Rumen Bray-Curtis Permanova
Permutational multivariate analysis of variance based on Bray-Curtis distances between rumen microbiome samples (999 permutations). The statistical model takes into
account day of study, treatment, and the interaction between them. Significance is determined at p < 0.05.

Table 3.19a. Permutational multivariate analysis of variance (PERMANOVA) based on BrayCurtis distances between rumen microbiome samples (999 permutations). The statistical model
considers treatment, day of study, and the interaction between them. Significance is determined
at p < 0.05.
pairs
Df
SumsOfSqs
F.Model
R2
p.value
p.adjusted sig
AbxFree vs Nuflor
1
1.6777678
3.8467798
0.0418826
0.001
0.0025 *
AbxFree vs Excede
1
1.5583364
3.5650080
0.0389342
0.001
0.0025 *
AbxFree vs Baytril
1
1.6363341
3.7493282
0.0408649
0.001
0.0025 *
AbxFree vs Draxxin
1
1.6249737
3.7218440
0.0405775
0.001
0.0025 *
Nuflor vs Excede
1
0.1058490
0.2357867
0.0068871
0.993
0.9990
Nuflor vs Baytril
1
0.0546509
0.1222225
0.0035819
0.998
0.9990
Nuflor vs Draxxin
1
0.0558945
0.1248805
0.0036595
0.999
0.9990
Excede vs Baytril
1
0.0833581
0.1853815
0.0054228
0.997
0.9990
Excede vs Draxxin
1
0.1134937
0.2521531
0.0073617
0.983
0.9990
Baytril vs Draxxin
1
0.0318202
0.0709760
0.0020832
0.999
0.9990
ermB Rumen Treatments - Pairwise PERMANOVA
Permutational multivariate analysis of variance based on Bray-Curtis distances between treatments of rumen microbiome samples (999 permutations). The statistical
model performs a pairwise comparison between treatments. Significance is determined at p < 0.05.

Table 3.19b. Pairwise comparisons (PERMANOVA) of the ermB gene in rumen samples
based on Bray-Curtis distances between different treatment groups (999 permutations).
Significance is determined at p < 0.05.
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Figure 3.27. Heatmap of differentially abundant ASV between antibiotic free and antibiotic-fed cattle in rumen samples. Differential
ASV were identified using DESeq2. Tiles in the heatmap are colored by variance stabilized transformations of read counts, with
deeper colors indicating a higher abundance of the organism within a sample. Hierarchical clustering of variance stabilized read count
data was performed.
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Figure 3.28. Boxplots showing Observed and Shannon-Weiner’s ermB α-diversity indices in the
fecal samples of animals with or without antibiotic treatment. Treatment means were compared
using Kruskal-Wallis test to identify differences in species richness and evenness between
treatment groups. Significant differences were observed on day 0.
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Figure 3.29. Beta diversity (β-diversity) metrics of the ermB gene in fecal samples. Principal
coordinate plot using Bray-Curtis distances are shown, with the plot colored by A) treatment
and B) day of study. Axes represent the amount of variation explained in the first 2 principal
components.

Df
SumsOfSqs
MeanSqs
F.Model
R2
Pr(>F)
Treatment
4
3.856818
0.9642044
2.310597
0.0610099
0.001
DayOfStudy
1
3.548325
3.5483248
8.503122
0.0561300
0.001
Treatment:DayOfStudy
4
4.066312
1.0165779
2.436104
0.0643238
0.001
Residuals
124
51.744791
0.4172967
NA
0.8185363
NA
Total
133
63.216245
NA
NA
1.0000000
NA
ermB Fecal Bray-Curtis Permanova
Permutational multivariate analysis of variance based on Bray-Curtis distances between fecal microbiome samples (999 permutations). The statistical model takes into account day of study,
treatment, and the interaction between them. Significance is determined at p < 0.05.

Table 3.20a. Permutational multivariate analysis of variance (PERMANOVA) of the ermB
gene based on Bray-Curtis distances between fecal microbiome samples (999 permutations).
The statistical model considers treatment, day of study, and the interaction between them.
Significance is determined at p < 0.05.
pairs
Df
SumsOfSqs
F.Model
R2
p.value
p.adjusted sig
AbxFree vs Baytril
1
1.4622254
3.1997546
0.0366945
0.001
0.0025 *
AbxFree vs Draxxin
1
1.4686999
3.2182782
0.0368991
0.001
0.0025 *
AbxFree vs Nuflor
1
1.4459405
3.1651547
0.0367336
0.001
0.0025 *
AbxFree vs Excede
1
1.3251220
2.9017226
0.0341774
0.001
0.0025 *
Baytril vs Draxxin
1
0.2084994
0.4476613
0.0137964
0.927
0.9990
Baytril vs Nuflor
1
0.0485906
0.1039791
0.0033430
0.999
0.9990
Baytril vs Excede
1
0.1573056
0.3366892
0.0110984
0.973
0.9990
Draxxin vs Nuflor
1
0.1953427
0.4195187
0.0133522
0.950
0.9990
Draxxin vs Excede
1
0.1834090
0.3940198
0.0129637
0.958
0.9990
Nuflor vs Excede
1
0.1450704
0.3105514
0.0105952
0.986
0.9990
ermB Fecal Treatments - Pairwise PERMANOVA
Permutational multivariate analysis of variance based on Bray-Curtis distances between treatments of fecal microbiome samples (999 permutations). The statistical model performs a pairwise
comparison between treatments. Significance is determined at p < 0.05. * denotes significance at p < 0.01.

Table 3.20b. Pairwise comparisons (PERMANOVA) of the ermB gene in fecal samples based
on Bray-Curtis distances between treatments (999 permutations). Significance is determined at
p < 0.05.
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Figure 3.30. Heatmap of differentially abundant ASV between antibiotic free and antibiotic-fed cattle in fecal samples. Differential
ASV were identified using DESeq2. Tiles in the heatmap are colored by variance stabilized transformations of read counts, with
deeper colors indicating a higher abundance of the organism within a sample. Hierarchical clustering of variance stabilized read count
data was performed.
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Figure 3.31. Boxplots showing Observed and Shannon-Weiner’s ermB α-diversity indices in the
floor surface samples of pens of animals with or without antibiotic treatment, with A) Observed
baseline samples, B) Shannon-Weiner metric of baseline samples, C) Observed and D) Shannon
indices for all timepoints. Treatment means were compared using Kruskal-Wallis test to identify
differences in species richness and evenness between treatment groups.
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Figure 3.32. Beta diversity (β-diversity) metrics of ermB gene in floor surface material (FSM)
samples. Principal coordinate plot using Bray-Curtis distances are shown, with the plot colored
by A) treatment and B) day of study. Axes represent the amount of variation explained in the
first 2 principal components.
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Figure 3.33. Boxplots showing Observed and Shannon-Weiner’s ermB α-diversity indices in the
soil samples of pens of animals with or without antibiotic treatment, with A) Observed baseline
samples, B) Shannon-Weiner metric of baseline samples, C) Observed and D) Shannon indices
for all timepoints. Treatment means were compared using Kruskal-Wallis test to identify
differences in species richness and evenness between treatment groups.
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Figure 3.34. Beta diversity (β-diversity) metrics of ermB gene in soil samples. Principal
coordinate plot using Bray-Curtis distances are shown, with the plot colored by A) treatment and
B) day of study. Axes represent the amount of variation explained in the first 2 principal
components.

pairs
Df SumsOfSqs
F.Model
R2 p.value p.adjusted sig
Day_154 vs Day_141 1
2.827200 8.091797 0.1835216
0.001
0.001 **
Day_154 vs Day_0
1
3.077268 9.184821 0.2078728
0.001
0.001 **
Day_141 vs Day_0
1
3.395436 10.141588 0.2246617
0.001
0.001 **

Table 3.21a. Pairwise comparisons (PERMANOVA) of the ermB gene in floor surface samples
based on Bray-Curtis distances between timepoints (999 permutations). Significance is
determined at p < 0.05.

pairs
Df SumsOfSqs F.Model
R2 p.value p.adjusted sig
AbxTreated vs AbxFree
1 1.2456896 3.253473 0.0949823
0.015
0.0300 .
AbxTreated vs Baseline
1 3.0078601 8.666550 0.2079978
0.001
0.0030 *
AbxTreated vs NoAnimal_Control 1 0.7428684 1.898978 0.0867154
0.094
0.1128
AbxFree vs Baseline
1 2.5907919 7.348132 0.1867467
0.001
0.0030 *
AbxFree vs NoAnimal_Control
1 0.3984843 0.989283 0.0494907
0.455
0.4550
Baseline vs NoAnimal_Control
1 1.1485152 3.332662 0.1369625
0.026
0.0390 .

Table 3.21b. Pairwise comparisons (PERMANOVA) of the ermB gene in floor surface samples
based on Bray-Curtis distances between treatments (999 permutations). Significance is
determined at p < 0.05.

pairs
Df SumsOfSqs
F.Model
R2 p.value p.adjusted sig
Day_172 vs Day_196 1
3.127113 159.004267 0.9352957 0.002
0.0024 *
Day_172 vs Day_226 1
2.747101 81.192351 0.8903417 0.002
0.0024 *
Day_172 vs Day_0
1
3.324280 11.728639 0.3108683 0.001
0.0024 *
Day_196 vs Day_226 1
2.611201 106.313295 0.9219518 0.002
0.0024 *
Day_196 vs Day_0
1
2.591229
8.932858 0.2632510 0.001
0.0024 *
Day_226 vs Day_0
1
1.963486
6.390543 0.2102806 0.003
0.0030 *

Table 3.22a. Pairwise comparisons (PERMANOVA) of the ermB gene in soil samples based on
Bray-Curtis distances between timepoints (999 permutations). Significance is determined at p <
0.05.

pairs
Df SumsOfSqs
F.Model
R2 p.value p.adjusted sig
AbxFree vs Baseline
1 1.7076268 4.7159954 0.1358450 0.001
0.0030 *
AbxFree vs AbxTreated
1 0.5958307 1.7266265 0.1032262 0.220
0.3300
AbxFree vs NoAnimal_Control
1 0.3771284 1.0303100 0.0934072 0.509
0.6108
Baseline vs AbxTreated
1 1.6702169 4.7893702 0.1607745 0.001
0.0030 *
Baseline vs NoAnimal_Control
1 0.6271619 1.7415269 0.0801014 0.046
0.0920
AbxTreated vs NoAnimal_Control 1 0.2136031 0.7045346 0.1235043 0.862
0.8620

Table 3.22b. Pairwise comparisons (PERMANOVA) of the ermB gene in soil samples based on
Bray-Curtis distances between treatments (999 permutations). Significance is determined at p <
0.05.

3.9 SUPPLEMENTARY DATA
Supplementary Data 3.1. Significance table of differential ASVs in all samples of the ermB gene with treatment as a comparison.
baseMean

log2FoldChange

lfcSE

stat

pvalue

padj

ASV_18

409.579469813746

30

4.41210088499305

6.79948187541211

1.04996072556604E-11

1.0604603328217E-09

ASV_23

509.856239832969

-29.7251003710592

4.352737068482

-6.82905948679912

8.54731293739111E-12

1.0604603328217E-09

ASV_47

88.3075040873892

-29.103691841721

4.41788814764591

-6.58769323013054

4.46712417569377E-11

1.80471816698028E-09

ASV_56

40.5497199307874

-29.3303456056012

4.43229460439202

-6.61741788926606

3.65527124422189E-11

1.80471816698028E-09

ASV_64

146.344071320889

-28.4653440885664

4.31747899548154

-6.5930474979396

4.30888644088469E-11

1.80471816698028E-09

ASV_1

631.338376033073

-29.8697315243939

4.60686840494286

-6.48373882187424

8.94770618014591E-11

2.25951441111775E-09

ASV_33

82.5897776602978

-29.0331141363999

4.47784530894411

-6.48372423192216

8.94857192521881E-11

2.25951441111775E-09

ASV_69

50.2740197084828

-29.3927753808626

4.51660621033024

-6.50771265239736

7.63036941734786E-11

2.25951441111775E-09

ASV_24

232.179627578738

-29.1224063712776

4.57806526966502

-6.3612912127416

2.00064721950431E-10

4.49034153710967E-09

ASV_46

218.64322925796

-26.2953982758009

4.21996492147298

-6.23118882860819

4.62908724442222E-10

9.35075623373289E-09

ASV_38

244.272318028685

-28.6556378264007

4.61089870658312

-6.21476194770624

5.14025173123508E-10

9.43937136099532E-09

ASV_21

620.468604746796

-28.4902448724181

4.69473874152553

-6.06854746152719

1.29072274157505E-09

2.17271661498466E-08

ASV_42

406.221332759839

25.5928731786017

4.25544473644807

6.01414770103761

1.80835576528975E-09

2.80990665068099E-08

ASV_12

2135.42011659456

24.7594559578525

4.19253106789503

5.90561061012807

3.51342957081039E-09

5.06937695216928E-08

ASV_61

209.417559698914

25.6062263562309

4.36718486056205

5.86332550001911

4.53687606507562E-09

6.10965976763517E-08

ASV_58

157.104381311914

-26.3190255688659

4.51760013538144

-5.82588648400676

5.68102229399076E-09

7.17229064616334E-08

ASV_25

190.337820249411

29.1456139559646

5.06835113114873

5.75051199133452

8.89735925767947E-09

1.05721562944191E-07

ASV_8

45.6526697433397

-29.6303614328868

5.25127031288723

-5.64251308110543

1.67585799073047E-08

1.88068507848642E-07

ASV_29

8.47610431513324

-29.438455832843

5.251428316733

-5.60579980479619

2.07295458147472E-08

2.20387802872576E-07

ASV_11

253.653296816652

-29.3763977928952

5.25124996648304

-5.59417243140107

2.21676562473646E-08

2.23893328098383E-07

ASV_5

287.499082796904

-29.2170856727591

5.25125035315999

-5.56383407909269

2.63910888582663E-08

2.5385714044618E-07

ASV_6

184.021041926257

-29.097306754124

5.2512512560616

-5.54102352663787

3.00708809708522E-08

2.76105361641461E-07

ASV_4

181.84939254058

-28.7882668240931

5.25125131429965

-5.4821727434183

4.20133691922772E-08

3.66383776907286E-07

ASV_54

836.147196480254

24.460814688301

4.46699905008566

5.4758943116032

4.35307457711626E-08

3.66383776907286E-07

ASV_3

15529.4531558341

22.7937823307452

4.20171278609401

5.42487873187894

5.79938996264275E-08

4.68590708981534E-07

ASV_32

1700.9115024217

24.553499794679

4.53895180887663

5.40950880920586

6.31978423358955E-08

4.90998621225034E-07

ASV_17

82.7940787806534

28.3194962355245

5.24200828086819

5.40241348699934

6.57501710528588E-08

4.91908687136203E-07

ASV_27

81.264922478079

-27.6897625035667

5.25125720855114

-5.27297776587229

1.34227830478875E-07

9.03800725224424E-07

ASV_43

60.7624523956924

-27.7127816687147

5.25126080563186

-5.27735770407619

1.31059901838343E-07

9.03800725224424E-07

ASV_87

9.36005640397138

-27.2280855545642

5.15362048337091

-5.28329271478576

1.26882412903368E-07

9.03800725224424E-07

ASV_73

22.5023129556155

27.4777025693377

5.24207454051748

5.24176113043696

1.59051186091262E-07

1.03639805130435E-06

ASV_10

69.9173855422242

-27.4607024440236

5.2512589399104

-5.22935599981899

1.70101534386071E-07

1.07376593581207E-06

ASV_80

3.21063453380816

27.238847493516

5.24227491689177

5.19599752499558

2.03624967168034E-07

1.24643161721039E-06

ASV_14

120.197610386446

-26.8372506312751

5.25125376196836

-5.11063678271291

3.21074749473987E-07

1.81098953280398E-06

ASV_39

48.2933583655676

-26.6450902717097

5.25126448685324

-5.07403318541977

3.89471088251029E-07

1.81098953280398E-06

ASV_40

37.0750271983278

-26.6965828119033

5.2512699072027

-5.08383367902799

3.69891868548319E-07

1.81098953280398E-06

ASV_41

30.669477562115

26.8369322742078

5.2421357264755

5.11946536192633

3.06403037447638E-07

1.81098953280398E-06

ASV_44

43.414369825423

-26.7829556258422

5.25126649865865

-5.1002849755737

3.39142467902069E-07

1.81098953280398E-06

ASV_55

37.3163462971885

-26.3598492273632

5.19753516915101

-5.07160574570368

3.94472967541461E-07

1.81098953280398E-06

ASV_57

39.4755238142125

-26.784454796443

5.25126848360596

-5.10056853502386

3.38634730419218E-07

1.81098953280398E-06

ASV_59

22.6071112591768

-26.66164382996

5.25128482503864

-5.07716582098817

3.8310650435213E-07

1.81098953280398E-06

ASV_74

20.4075981403879

26.6896234356014

5.24216614116736

5.09133490180798

3.55551383882747E-07

1.81098953280398E-06

ASV_77

11.6282623616918

26.6369962116863

5.24216348172473

5.08129826636433

3.74863976241984E-07

1.81098953280398E-06

ASV_96

64.5771253816735

23.0807927352488

4.53245771433711

5.09233492951065

3.53680601851235E-07

1.81098953280398E-06

ASV_50

34.5305083060496

26.4252090001143

5.24220721277059

5.04085548845526

4.63455351158444E-07

2.08039957631124E-06

ASV_20

42.4132258861681

-26.297991874713

5.25126696570962

-5.00793276107212

5.50177465248521E-07

2.33874871559074E-06

ASV_31

28.4604280891639

-26.2955093132034

5.25127696862046

-5.00745046782619

5.51557389807241E-07

2.33874871559074E-06

ASV_34

68.0275316505175

-26.287777196784

5.25125927910353

-5.0059949051443

5.55742269051264E-07

2.33874871559074E-06

ASV_65

16.453822215452

-26.2385435400796

5.25129913201777

-4.9965813945163

5.83555511225279E-07

2.40567782178584E-06

ASV_7

39.7916633621495

-26.1429124279047

5.25127719380505

-4.97839124903664

6.41149512730617E-07

2.53945493277617E-06

ASV_94

4.77278006892082

-26.1594038559094

5.25141122248029

-4.98140456872354

6.31244123506491E-07

2.53945493277617E-06

ASV_37

32.9381207564977

-25.9062258056621

5.25127648101944

-4.93331971746284

8.08436609578777E-07

3.14046529105602E-06

ASV_60

11.0702950068775

25.8303417985598

5.24232790079643

4.92726557501974

8.33883784983758E-07

3.17819857673055E-06

ASV_35

20.5129974105398

-25.5232623532293

5.25128873628953

-4.86038068652527

1.17160238174067E-06

4.38266076132622E-06

ASV_53

14.8633852453253

-25.264464980039

5.25130481347519

-4.81108331689464

1.50114419746941E-06

5.51329323434221E-06

ASV_15

9.75169846115934

-24.3645923089729

5.25133525548176

-4.63969469165756

3.48924279956232E-06

1.23022387363008E-05

ASV_79

365.703296923153

22.2519287157359

4.79861356446158

4.63715788254616

3.53232597378933E-06

1.23022387363008E-05

ASV_101

20.5766389337595

-23.3250375715538

5.02247146906769

-4.64413540528953

3.41503542587228E-06

1.23022387363008E-05

ASV_36

12.752565429768

-24.2795038726383

5.25134315766304

-4.62348453408694

3.77346888488835E-06

1.27040119124575E-05

ASV_81

5.59561681241415

-24.2827332690854

5.25139084874327

-4.62405750562189

3.76305467695414E-06

1.27040119124575E-05

ASV_71

6.09192391268306

-24.0496963257559

5.25138129150166

-4.57968960750872

4.6566647597846E-06

1.54204308438769E-05

ASV_49

3.2581081525213

-23.3705706122682

5.25147452468803

-4.45028734356406

8.57554725412529E-06

2.79396862150534E-05

ASV_123

1.81895697375782

23.1205406957867

5.24402028863096

4.40893425715993

1.03880550974714E-05

3.33077322172893E-05

ASV_45

4.09606860681848

-22.9732486355448

5.25143364177341

-4.37466227370756

1.21620622889299E-05

3.8386509099435E-05

ASV_141

7.60144836284401

-22.620323806539

5.25166172265172

-4.307269775007

1.6528198055086E-05

5.13645539558057E-05

ASV_67

8.23335706718632

-19.7902718276111

5.25360472478446

-3.76698911782386

0.000165228200052614

0.00050569843046406

Supplementary Data 3.2. Significance table of differential ASVs in rumen samples of the ermB gene with treatment as a
comparison.
baseMean

log2FoldChange

lfcSE

stat

pvalue

padj

ASV_6

2488.84418804193

-29.9602219301902

3.41055230494154

-8.78456603253993

1.56969349755659E-18

7.96328222570283E-17

ASV_18

1232.9085523205

30

3.42336461078192

8.7633084438376

1.89601957754829E-18

7.96328222570283E-17

ASV_27

797.102805655042

-29.9706402042871

3.47915977105758

-8.61433282070192

7.03500547177697E-18

1.96980153209755E-16

ASV_44

403.529145292621

-28.3902397769475

3.42595290011668

-8.28681555312119

1.16320811566036E-16

2.44273704288675E-15

ASV_43

422.934693058602

-29.9535952814756

3.90538879878071

-7.66981133628163

1.72249518143722E-14

2.89379190481452E-13

ASV_11

1821.47290922942

-29.9772357865991

3.99883074886505

-7.49650026951186

6.55442818858487E-14

9.17619946401881E-13

ASV_57

260.961630610593

-29.9333781790463

4.04441684700614

-7.40116049145733

1.34999450879967E-13

1.61999341055961E-12

ASV_14

1030.27843408458

-29.462807205313

3.99747595573105

-7.37035257537275

1.701773623444E-13

1.7868623046162E-12

ASV_50

157.951980942456

27.7858333062663

4.10949628981231

6.76137203850241

1.36691013816743E-11

0.000000000127578279562294

ASV_94

36.4291162709901

-24.8188876161414

3.77330981599542

-6.57748470876465

4.78473045526141E-11

0.000000000401917358241958

ASV_10

289.142671476641

-29.9431942680779

4.58737260253434

-6.52730808296136

6.69622234435849E-11

0.000000000511347888114649

ASV_25

75.2766678791992

28.6361464298065

4.56852867683312

6.2681332340146

0.000000000365402081396981

0.00000000255781456977887

ASV_4

478.188771225889

-28.48666071715

4.58737007459176

-6.20980218599108

0.00000000053051339786756

0.00000000342793272468269

ASV_102

27.5565672802422

-24.8219154622537

4.16706395118783

-5.95669175059773

0.00000000257395070046053

0.0000000154437042027632

ASV_15

137.527226597959

-27.0821006996506

4.58737966767201

-5.9036100479109

0.00000000355632206338664

0.0000000199154035549652

ASV_80

6.56301667479629

26.6671761800394

4.56916059539086

5.83634031312884

0.00000000533598539945164

0.0000000280139233471211

ASV_74

57.3038354371388

26.4758269263476

4.56877353525085

5.79495278592178

0.00000000683404043517545

0.0000000337681997973375

ASV_37

116.961930654254

-26.3180407220803

4.58738378993899

-5.73704794000468

0.00000000963409939316436

0.0000000449591305014337

ASV_31

83.526360261328

-26.2064548943928

4.58738836937222

-5.71271773485773

0.0000000111186017571152

0.0000000491559235577726

ASV_73

14.3038769188901

25.9002746889995

4.56899705052601

5.66870024265341

0.0000000143884842551472

0.0000000604316338716182

ASV_77

11.9124835199895

25.8463882903011

4.56914889502256

5.65671832635112

0.0000000154294671429859

0.0000000617178685719438

ASV_35

62.7012210513292

-25.834739583077

4.58739573122781

-5.63167886459239

0.0000000178463758114419

0.0000000681407076436872

ASV_62

56.4490733618533

-25.7364864353503

4.58739900280416

-5.61025679685115

0.0000000202026604042471

0.0000000737836293024676

ASV_53

55.5019557621148

-25.6443771320473

4.58739956050609

-5.59017735294419

0.0000000226837806473441

0.0000000793932322657043

ASV_68

18.3559020796834

-25.0616066448109

4.58746702339147

-5.46305979247848

0.0000000467996877950407

0.000000157246950991337

ASV_63

31.2825456575749

-24.8707048823332

4.58742537505324

-5.42149525038204

0.0000000591025677374658

0.000000190946757305659

ASV_19

27.7185057775308

-24.8228917109151

4.58743295127016

-5.41106365468343

0.0000000626514949858836

0.000000194915762178304

ASV_45

27.852002101777

-24.7083593095685

4.58743265995042

-5.38609744079285

0.0000000720039374101793

0.000000216011812230538

ASV_123

6.68544832708793

24.1519905262358

4.57024654055998

5.28461436640058

0.000000125969832575753

0.000000364878135736664

ASV_129

1.26181703873401

24.1283434420475

4.57152191741001

5.27796735484479

0.000000130624728245067

0.000000365749239086188

ASV_71

18.6005510365399

-24.1390060855948

4.58746568532165

-5.26194804308433

0.000000142537050557698

0.000000386229427317634

ASV_108

12.0080432476255

-23.5498174713325

4.58752029116425

-5.13345249212093

0.00000028447486236888

0.000000746746513718309

ASV_91

7.16875219890365

-22.7509349512094

4.58762417464657

-4.95919763369939

0.0000007078492744706

0.00000180179815319789

ASV_98

5.77182251798165

-22.552198178552

4.58768629629802

-4.91581087328274

0.000000884157239138472

0.00000218438847316564

ASV_115

4.16387367359035

-22.2795729697469

4.5878094149017

-4.85625512197181

0.00000119626556751918

0.00000279128632421141

ASV_132

4.43744544367638

-22.3014671744882

4.58778223675919

-4.86105617563967

0.00000116761111138235

0.00000279128632421141

ASV_104

4.08505203230976

-22.1674386367229

4.58781795987004

-4.83180431974917

0.0000013530120562538

0.00000307170304663024

ASV_118

4.12780492007606

-22.1252904473037

4.58781321641233

-4.82262232650477

0.00000141683084391493

0.00000313194186549615

ASV_122

2.92730369839233

-21.6271566824076

4.58796642298187

-4.71388730616547

0.00000243035109773457

0.00000523460236435139

Supplementary Data 3.3. Significance table of differential ASVs in fecal samples of the ermB gene with treatment as a
comparison.
baseMean

log2FoldChange

lfcSE

stat

pvalue

padj

ASV_3

74.2556845232837

29.6196611118471

4.64038613793437

6.38301646272739

0.000000000173633231495093

0.00000000409844852223696

ASV_12

49.1278466626406

29.3272608437464

4.64040663524164

6.31997649107303

0.000000000261603097164061

0.00000000409844852223696

ASV_17

72.7702639861934

29.5854392665559

4.64038696470738

6.37564054281873

0.000000000182199815220016

0.00000000409844852223696

ASV_5

544.350243383565

-28.4361065248496

4.66183245664822

-6.09977016318916

0.00000000106221086607201

0.00000000756451122547507

ASV_7

74.1958710975809

-28.2115180734413

4.66186097121205

-6.05155714588084

0.00000000143452378228854

0.00000000756451122547507

ASV_13

102.893649028088

28.5440943810633

4.64039783798149

6.15121706751754

0.000000000768905964061093

0.00000000756451122547507

ASV_20

230.957173661145

-28.2429800385391

4.66183856628844

-6.05833506178765

0.00000000137537675965428

0.00000000756451122547507

ASV_34

166.001026699544

-28.235835987641

4.66184272094876

-6.05679721041608

0.00000000138858459821838

0.00000000756451122547507

ASV_41

25.2120432304699

28.0747738739147

4.6404640438202

6.04999276124173

0.0000000014485234261548

0.00000000756451122547507

ASV_32

49.4250068849073

27.5928300985851

4.64044750356732

5.94615714914851

0.00000000274510617661027

0.0000000129019990300683

ASV_1

179.126167934604

-27.6368719714645

4.66184163922656

-5.92831634153271

0.00000000306056463042232

0.0000000130769579663499

ASV_8

206.717890952118

-27.420372481876

4.66183981521595

-5.88187787842423

0.00000000405637599254696

0.0000000147495125568708

ASV_54

13.1059908915902

27.2908892760529

4.64057294904696

5.88093099186333

0.00000000407965240934724

0.0000000147495125568708

ASV_39

129.868717531357

-27.185841151109

4.66184682916429

-5.83156035522997

0.00000000549114424795936

0.0000000184345556895779

ASV_23

184.783316694431

-26.9766820712094

4.66184122144073

-5.78670117444976

0.00000000717821078431565

0.000000022491727124189

ASV_61

9.51607457078666

26.2786841706849

4.64065869128247

5.66270564565535

0.0000000149004638075857

0.000000043770112434783

ASV_55

87.6575085335827

-26.2291461910674

4.66185591605255

-5.62633137175054

0.0000000184082565164858

0.00000005089341507499

ASV_2

100.395562907368

-26.0933849671096

4.66185236914956

-5.59721391861015

0.0000000217823872739314

0.0000000568762334374875

ASV_28

38.8856453326781

-25.1029989996339

4.66189097501187

-5.38472459656136

0.0000000725556545198442

0.000000179479776970141

ASV_21

42.567704778868

-24.9538641488445

4.6618855011466

-5.35274067600051

0.0000000866319615407923

0.000000203585109620862

ASV_64

21.8346581518903

-24.4325538251505

4.66194016335097

-5.24085530252463

0.000000159834014515634

0.000000357723746773085

ASV_56

7.89860672681953

-24.3531158008552

4.66213762674557

-5.22359435747825

0.000000175482978555822

0.000000374895454187438

ASV_29

20.2862098471327

-24.2564023373743

4.66194870201929

-5.20306075587401

0.000000196032745477341

0.000000390640726120079

ASV_79

1.37426769370272

24.1401932159178

4.64250097699291

5.19982512347345

0.000000199476115465572

0.000000390640726120079

ASV_38

17.7458848263451

-24.0426938177473

4.66196595425401

-5.15720064317684

0.000000250669154133317

0.000000471258009770635

ASV_49

15.6491217154149

-23.9755514947053

4.66198444991317

-5.14277809209593

0.000000270705304962231

0.000000489351897431725

ASV_81

11.7298874045434

-23.5364017511462

4.66203663317869

-5.04852355377107

0.000000445237585294628

0.000000775043204031389

ASV_51

8.04540090783063

-23.1546315529985

4.66213195638773

-4.96653285870077

0.000000681605086840725

0.00000114412282433979

ASV_58

9.17769803494357

-23.1159366343464

4.66209459030579

-4.95827276486688

0.000000711226617463323

0.00000115267762140608

ASV_65

8.6195947052135

-23.063214728145

4.6621118525703

-4.9469458171472

0.000000753869493448214

0.0000011810622064022

ASV_25

38.0559573329141

9.95672690201594

4.640482668294

2.14562312020796

0.0319030593221611

0.0483691544561798

CHAPTER 4: CONCLUSION AND FUTURE DIRECTIONS
4.1 CLOSING CONCLUSIONS
Because of rising concerns regarding AMR and its spread, it is important to understand not only
the effects of antibiotics on microbial community structure, but it is also important to develop
tools that gives us a better understanding of the spread and functional traits of AMR genes. In
this study, we aimed to determine the effects of commonly used feed additives Monensin/Tylosin
and injectable antibiotic ceftiofur (Excede), tulathromycin (Draxxin), enrofloxacin (Baytril),
florfenicol (Nuflor) on bacterial community composition by sequencing the 16s rRNA gene to
evaluate baseline and post-antibiotic effects. We observe increased Prevotella abundance in the
rumen following monensin/tylosin feeding and injectible treatment, ii) changes in Ruminococcus
abundance, a key player in rumen degradation, iii) reduced presence of Clostridium and
Lachnospiraceae in fecal samples, and iv) changes in interactions of different taxa as a result of
selection due to antibiotic treatment.

Our second goal with this thesis was a “proof-of-concept” study to show amplicon-based
sequencing of AMR genes as a tool to evaluate ecology and functionality of these genes. We
targeted AMR genes that confer resistance to macrolides (ermB), sulfonamides (sul1), and
tetracyclines (tetW), which represent the most utilized antimicrobial classes in the American beef
production system (Agga et al., 2019). We identified only 1 or 2 differential ASV in the TetW
and sul1 gene, with a much higher abundance of differential ASV observed in the ermB gene,
suggesting gene enrichment and selection based on antimicrobial used. Furthermore, we show
that amplicon-sequencing of AMR genes expands the information that can be gathered when

compared to traditional real-time PCR analysis and can be used as a valuable tool to predict
taxonomy and gene variants that are abundant and important to each environment.

4.2 FUTURE DIRECTIONS
While the changes in bacterial community composition and AMR gene diversity presented in our
two studies present promising results with respect to antibiotic-mediated changes to the
microbiome and resistome, it is unclear how durable these perturbations are and how exactly
they affect structure and function. Identifying the structure (community profile) and function
(metagenomics, metatranscriptomics, and metabolomics) of the microbiome and resistome that
may require methods of assessment still to be developed. While next-generation sequencing and
proteomics has been a promising tool in giving us insights regarding structure and function
without relying on culture-based methods, there have been very few efforts to date that have used
a multi-“omics” approach to study the complex ecosystem in the bovine gut microbiome and
resistome. Integrating information about the identities of microbial community members
(obtained from 16S rRNA gene sequencing), metabolic potential (obtained from metagenome
sequence data), expressed proteins (obtained from metaproteome data), as well as metabolites
produced (metabolomics) would enable explorations of the microbiome and resistome at
multiple molecular levels simultaneously.

